Fall prevention interventions in primary care to reduce fractures and falls in people aged 70 years and over: the PreFIT three-arm cluster RCT by Bruce, J et al.
Journals Library
DOI 10.3310/hta25340
Fall prevention interventions in primary 
care to reduce fractures and falls in 
people aged 70 years and over:  
the PreFIT three-arm cluster RCT 
Julie Bruce, Anower Hossain, Ranjit Lall, Emma J Withers, Susanne Finnegan,  
Martin Underwood, Chen Ji, Chris Bojke, Roberta Longo, Claire Hulme,  
Susie Hennings, Ray Sheridan, Katharine Westacott, Shvaita Ralhan,  
Finbarr Martin, John Davison, Fiona Shaw, Dawn A Skelton, Jonathan Treml,  
Keith Willett and Sarah E Lamb on behalf of PreFIT Study Group
Health Technology Assessment
Volume 25 • Issue 34 • May 2021
ISSN 1366-5278

Fall prevention interventions in primary care
to reduce fractures and falls in people aged
70 years and over: the PreFIT three-arm
cluster RCT
Julie Bruce ,1 Anower Hossain ,1,2 Ranjit Lall ,1
Emma J Withers ,1 Susanne Finnegan ,1
Martin Underwood ,1 Chen Ji ,1 Chris Bojke ,3
Roberta Longo ,3 Claire Hulme ,4 Susie Hennings ,1
Ray Sheridan ,5 Katharine Westacott ,6
Shvaita Ralhan ,7 Finbarr Martin ,8 John Davison ,9
Fiona Shaw ,9 Dawn A Skelton ,10 Jonathan Treml ,11
Keith Willett 12 and Sarah E Lamb 1,4,13* on behalf of
PreFIT Study Group
1Warwick Clinical Trials Unit, Division of Health Sciences, University of Warwick,
Coventry, UK
2Institute of Statistical Research and Training, University of Dhaka, Dhaka, Bangladesh
3Leeds Institute of Health Sciences, University of Leeds, Leeds, UK
4College of Medicine and Health, University of Exeter, Exeter, UK
5General Medicine/Care of the Elderly, Royal Devon and Exeter Hospital, Royal
Devon and Exeter NHS Foundation Trust, Exeter, UK
6Elderly Care Department, Warwick Hospital, South Warwickshire NHS Foundation
Trust, Warwick, UK
7Gerontology Department, John Radcliffe Hospital, Oxford University Hospitals NHS
Foundation Trust, Oxford, UK
8St Thomas’ Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
9Falls and Syncope Service, Newcastle upon Tyne Hospitals NHS Foundation Trust,
Newcastle upon Tyne, UK
10Centre for Living, School of Health and Life Sciences, Glasgow Caledonian
University, Glasgow, UK
11Geriatric Medicine, Queen Elizabeth Hospital Birmingham, University Hospitals
Birmingham NHS Foundation Trust, Birmingham, UK
12Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences,
University of Oxford, Oxford, UK
13Centre for Statistics in Medicine, Nuffield Department of Orthopaedics,
Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
*Corresponding author

Declared competing interests of authors: Julie Bruce is chief investigator or co-investigator
on multiple current research grants from the UK National Institute for Health Research (NIHR).
Julie Bruce reports consultancy fees from Medtronic plc (Medtronic plc, Dublin, Ireland). Julie Bruce
has received travel expenses for speaking at conferences from the professional organisations hosting
the conferences. Julie Bruce is supported by NIHR Research Capability Funding via University
Hospitals Coventry and Warwickshire. Martin Underwood was chairperson of the National Institute
for Health and Care Excellence Accreditation Advisory Committee until March 2017, for which he
received a fee. He is chief investigator or co-investigator on multiple previous and current research
grants from NIHR and Arthritis Research UK and is a co-investigator on grants funded by the
Australian National Health and Medical Research Council. He is a NIHR senior investigator. He has
received travel expenses for speaking at conferences from the professional organisations hosting the
conferences. He is a director and shareholder of Clinvivo Ltd (Kent, UK), which provides electronic
data collection for health services research. He is part of an academic partnership with Serco Ltd
(Hart, UK), which is related to return-to-work initiatives. He is a co-investigator on a study receiving
support in kind from Orthospace Ltd (Caesarea, Israel). He has accepted an honorarium from
Carta (Palo Alto, CA, USA). He is co-investigator on two NIHR-funded research projects receiving
additional support from Stryker Ltd (Kalamazoo, MI, USA). He has accepted an honorarium from
the Confederation for Advanced Research Training in Africa (CARTA). He is an editor of the NIHR
journal series and a member of the NIHR Journals Library Editorial Group (2016–20), for which he
receives a fee. Chris Bojke was a member of the NIHR Health Services and Delivery Research (HSDR)
Board (2018–present). Roberto Longo was a NIHR HSDR Associate Member (2017–18). Claire Hulme
reports being a member of the Health Technology Assessment (HTA) Commissioning Board (2013–17).
Dawn A Skelton reports personal fees from Later Life Training Ltd (Killin, UK) during the conduct of
the study. She is currently co-investigator on a NIHR HTA grant [ELECTRIC (ELECtric Tibial nerve
stimulation to Reduce Incontinence in Care Homes), ongoing]. She has received grants from the
NIHR Collaborations for Leadership in Applied Health Research and Care [PhISICAL (PHysical activity
Implementation Study In Community-dwelling AduLts)], grants from the NIHR Public Health Research
programme [REACT (REtirement into ACTION), ongoing; VIOLET (Visually Impaired OLder people’s
Exercise programme for falls prevenTion), finished] and grants from the Medical Research Council/
NIHR Methodology programme (finished) during the conduct of this study. Sarah E Lamb reports
grants from the NIHR HTA programme during the conduct of the study, and was a member of the
following: HTA Additional Capacity Funding Board (2012–15), HTA Clinical Trials Board (2010–15),
HTA End of Life Care and Add-on Studies Board (2015), HTA Funding Boards Policy Group (formerly
the Clinical Studies Group) (2010–15), HTA Post-Board Funding Teleconference (2010–15), HTA
Maternal, Neonatal and Child Health Methods Group (2013–15), HTA Primary Care Themed Call




This report should be referenced as follows:
Bruce J, Hossain A, Lall R, Withers EJ, Finnegan S, Underwood M, et al. Fall prevention
interventions in primary care to reduce fractures and falls in people aged 70 years and over:
the PreFIT three-arm cluster RCT. Health Technol Assess 2021;25(34).
Health Technology Assessment is indexed and abstracted in Index Medicus/MEDLINE, Excerpta







Health Technology Assessment is indexed in MEDLINE, CINAHL, EMBASE, the Cochrane Library and Clarivate Analytics
Science Citation Index.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE)
(www.publicationethics.org/).
Editorial contact: journals.library@nihr.ac.uk
The full HTA archive is freely available to view online at www.journalslibrary.nihr.ac.uk/hta. Print-on-demand copies can be
purchased from the report pages of the NIHR Journals Library website: www.journalslibrary.nihr.ac.uk
Criteria for inclusion in the Health Technology Assessment journal
Reports are published in Health Technology Assessment (HTA) if (1) they have resulted from work for the HTA programme,
and (2) they are of a sufficiently high scientific quality as assessed by the reviewers and editors.
Reviews in Health Technology Assessment are termed ‘systematic’ when the account of the search appraisal and synthesis
methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others.
HTA programme
Health Technology Assessment (HTA) research is undertaken where some evidence already exists to show that a technology can
be effective and this needs to be compared to the current standard intervention to see which works best. Research can evaluate
any intervention used in the treatment, prevention or diagnosis of disease, provided the study outcomes lead to findings that
have the potential to be of direct benefit to NHS patients. Technologies in this context mean any method used to promote
health; prevent and treat disease; and improve rehabilitation or long-term care. They are not confined to new drugs and include
any intervention used in the treatment, prevention or diagnosis of disease.
The journal is indexed in NHS Evidence via its abstracts included in MEDLINE and its Technology Assessment Reports inform
National Institute for Health and Care Excellence (NICE) guidance. HTA research is also an important source of evidence for
National Screening Committee (NSC) policy decisions.
This report
The research reported in this issue of the journal was funded by the HTA programme as project number 08/14/41. The
contractual start date was in September 2010. The draft report began editorial review in June 2019 and was accepted for
publication in January 2020. The authors have been wholly responsible for all data collection, analysis and interpretation, and for
writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors’ report and would like to
thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages
or losses arising from material published in this report.
This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions
expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR,
NETSCC, the HTA programme or the Department of Health and Social Care. If there are verbatim quotations included in this
publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect
those of the authors, those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health and Social Care.
© Queen’s Printer and Controller of HMSO 2021. This work was produced by Bruce et al. under the terms of a commissioning
contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of
private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for
commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation,
Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.
Published by the NIHR Journals Library (www.journalslibrary.nihr.ac.uk), produced by Prepress Projects Ltd, Perth, Scotland
(www.prepress-projects.co.uk).
NIHR Journals Library Editor-in-Chief
NIHR Journals Library Editors
Professor Ken Stein   Professor of Public Health, University of Exeter Medical School, UK
Professor John Powell Chair of HTA and EME Editorial Board and Editor-in-Chief of HTA and EME journals.
Consultant Clinical Adviser, National Institute for Health and Care Excellence (NICE), UK, and Professor of 
Digital Health Care, Nuffield Department of Primary Care Health Sciences, University of Oxford, UK 
Professor Andrée Le May  Chair of NIHR Journals Library Editorial Group (HS&DR, PGfAR, PHR journals) and 
Editor-in-Chief of HS&DR, PGfAR, PHR journals
Professor Matthias Beck  Professor of Management, Cork University Business School, Department of Management
and Marketing, University College Cork, Ireland
Dr Tessa Crilly  Director, Crystal Blue Consulting Ltd, UK
Dr Eugenia Cronin   Senior Scientific Advisor, Wessex Institute, UK
Dr Peter Davidson   Consultant Advisor, Wessex Institute, University of Southampton, UK
Ms Tara Lamont   Senior Scientific Adviser (Evidence Use), Wessex Institute, University of Southampton, UK
Dr Catriona McDaid  Senior Research Fellow, York Trials Unit, Department of Health Sciences, University of York, UK
Professor William McGuire   Professor of Child Health, Hull York Medical School, University of York, UK
Professor Geoffrey Meads   Emeritus Professor of Wellbeing Research, University of Winchester, UK
Professor James Raftery   Professor of Health Technology Assessment, Wessex Institute, Faculty of Medicine, 
University of Southampton, UK
Dr Rob Riemsma   Reviews Manager, Kleijnen Systematic Reviews Ltd, UK
Professor Helen Roberts   Professor of Child Health Research, UCL Great Ormond Street Institute of Child Health, UK
Professor Jonathan Ross  Professor of Sexual Health and HIV, University Hospital Birmingham, UK
Professor Helen Snooks  Professor of Health Services Research, Institute of Life Science, College of Medicine, 
Swansea University, UK
Professor Ken Stein   Professor of Public Health, University of Exeter Medical School, UK
Professor Jim Thornton  Professor of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, 
University of Nottingham, UK 
Please visit the website for a list of editors: www.journalslibrary.nihr.ac.uk/about/editors
Editorial contact:  journals.library@nihr.ac.uk
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Abstract
Fall prevention interventions in primary care to reduce
fractures and falls in people aged 70 years and over:
the PreFIT three-arm cluster RCT
Julie Bruce ,1 Anower Hossain ,1,2 Ranjit Lall ,1 Emma J Withers ,1
Susanne Finnegan ,1 Martin Underwood ,1 Chen Ji ,1 Chris Bojke ,3
Roberta Longo ,3 Claire Hulme ,4 Susie Hennings ,1 Ray Sheridan ,5
Katharine Westacott ,6 Shvaita Ralhan ,7 Finbarr Martin ,8
John Davison ,9 Fiona Shaw ,9 Dawn A Skelton ,10 Jonathan Treml ,11
Keith Willett 12 and Sarah E Lamb 1,4,13* on behalf of PreFIT
Study Group
1Warwick Clinical Trials Unit, Division of Health Sciences, University of Warwick, Coventry, UK
2Institute of Statistical Research and Training, University of Dhaka, Dhaka, Bangladesh
3Leeds Institute of Health Sciences, University of Leeds, Leeds, UK
4College of Medicine and Health, University of Exeter, Exeter, UK
5General Medicine/Care of the Elderly, Royal Devon and Exeter Hospital, Royal Devon and Exeter
NHS Foundation Trust, Exeter, UK
6Elderly Care Department, Warwick Hospital, South Warwickshire NHS Foundation Trust, Warwick, UK
7Gerontology Department, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation
Trust, Oxford, UK
8St Thomas’ Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
9Falls and Syncope Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon
Tyne, UK
10Centre for Living, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK
11Geriatric Medicine, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS
Foundation Trust, Birmingham, UK
12Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of
Oxford, Oxford, UK
13Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and
Musculoskeletal Sciences, University of Oxford, Oxford, UK
*Corresponding author s.e.lamb@exeter.ac.uk
Background: Falls and fractures are a major problem.
Objectives: To investigate the clinical effectiveness and cost-effectiveness of alternative falls
prevention interventions.
Design: Three-arm, pragmatic, cluster randomised controlled trial with parallel economic analysis.
The unit of randomisation was the general practice.
Setting: Primary care.
Participants: People aged ≥ 70 years.
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Interventions: All practices posted an advice leaflet to each participant. Practices randomised to active
intervention arms (exercise and multifactorial falls prevention) screened participants for falls risk using
a postal questionnaire. Active treatments were delivered to participants at higher risk of falling.
Main outcome measures: The primary outcome was fracture rate over 18 months, captured from
Hospital Episode Statistics, general practice records and self-report. Secondary outcomes were
falls rate, health-related quality of life, mortality, frailty and health service resource use. Economic
evaluation was expressed in terms of incremental cost per quality-adjusted life-year and incremental
net monetary benefit.
Results: Between 2011 and 2014, we randomised 63 general practices (9803 participants): 21 practices
(3223 participants) to advice only, 21 practices (3279 participants) to exercise and 21 practices (3301
participants) to multifactorial falls prevention. In the active intervention arms, 5779 out of 6580 (87.8%)
participants responded to the postal fall risk screener, of whom 2153 (37.3%) were classed as being
at higher risk of falling and invited for treatment. The rate of intervention uptake was 65% (697 out of
1079) in the exercise arm and 71% (762 out of 1074) in the multifactorial falls prevention arm. Overall,
379 out of 9803 (3.9%) participants sustained a fracture. There was no difference in the fracture rate
between the advice and exercise arms (rate ratio 1.20, 95% confidence interval 0.91 to 1.59) or between
the advice and multifactorial falls prevention arms (rate ratio 1.30, 95% confidence interval 0.99 to 1.71).
There was no difference in falls rate over 18 months (exercise arm: rate ratio 0.99, 95% confidence
interval 0.86 to 1.14; multifactorial falls prevention arm: rate ratio 1.13, 95% confidence interval
0.98 to 1.30). A lower rate of falls was observed in the exercise arm at 8 months (rate ratio 0.78, 95%
confidence interval 0.64 to 0.96), but not at other time points. There were 289 (2.9%) deaths, with no
differences by treatment arm. There was no evidence of effects in prespecified subgroup comparisons,
nor in nested intention-to-treat analyses that considered only those at higher risk of falling. Exercise
provided the highest expected quality-adjusted life-years (1.120), followed by advice and multifactorial
falls prevention, with 1.106 and 1.114 quality-adjusted life-years, respectively. NHS costs associated
with exercise (£3720) were lower than the costs of advice (£3737) or of multifactorial falls prevention
(£3941). Although incremental differences between treatment arms were small, exercise dominated
advice, which in turn dominated multifactorial falls prevention. The incremental net monetary benefit of
exercise relative to treatment valued at £30,000 per quality-adjusted life-year is modest, at £191, and for
multifactorial falls prevention is £613. Exercise is the most cost-effective treatment. No serious adverse
events were reported.
Limitations: The rate of fractures was lower than anticipated.
Conclusions: Screen-and-treat falls prevention strategies in primary care did not reduce fractures.
Exercise resulted in a short-term reduction in falls and was cost-effective.
Future work: Exercise is the most promising intervention for primary care. Work is needed to ensure
adequate uptake and sustained effects.
Trial registration: Current Controlled Trials ISRCTN71002650.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health
Technology Assessment programme and will be published in full in Health Technology Assessment;
Vol. 25, No. 34. See the NIHR Journals Library website for further project information.
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LR likelihood ratio
MCS mental health composite scale
MD mean difference
MFFP multifactorial falls prevention
MI multiple imputation
MLM multilevel linear model
NICE National Institute for Health and
Care Excellence
NPV net present value
OEP Otago exercise programme
OR odds ratio
PCS physical health composite scale
PreFIT Prevention of Falls Injury Trial
ProFaNE Prevention of Falls Network
Europe
PSA probabilistic sensitivity analysis
PSS Personal Social Services
PSSRU Personal Social Services
Research Unit
QALY quality-adjusted life-year
QoL quality of life
RaR rate ratio
RCT randomised controlled trial
SAE serious adverse event
SD standard deviation
SE standard error
SF-12 Short-Form questionnaire-12 items
TSC Trial Steering Committee
TUG timed up and go test
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What is the problem?
Falls are a major problem for older people. Current practice is to give people advice leaflets. Another
approach is exercise, especially balance and strength training. A third alternative is to invite older
people to attend a falls assessment with a health-care professional, either a doctor or a trained nurse.
This usually involves a careful check of prescribed tablets, blood pressure, eyesight and other problems
that might cause falls.
What did we do?
We compared three strategies. We recruited 9803 people aged 70–101 years from 63 general
practices across England. We randomly allocated practices in clusters into three treatment groups.
The participants in one group were given a Staying Steady advice leaflet (Age UK. Staying Steady.
London: Age UK; 2009). Participants in the second group received the same leaflet and were assessed
to see if they were at higher risk of falling. Those participants identified as being at higher risk (about
1000 people) were invited to take part in an exercise programme, supported by an exercise therapist.
These people did balance and strength training at home for up to 6 months. In the third group, we
again identified participants who were at higher risk of falling (about 1000 people) and invited them
for a detailed falls assessment with a trained nurse or doctor. This last group of participants were
referred for other treatments if any health problems were found. In all groups we counted fractures
and falls and measured changes in quality of life, frailty and the cost of the treatments over 18 months
of follow-up.
What did we find out?
We found no difference in the number of fractures over 18 months between the different treatments.
The exercise programme reduced falls in the short term but not over the longer term. The exercise
programme was cheaper and led to a slightly better overall quality of life.
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Falls are the leading cause of accident-related mortality in older adults and are a major public health
problem. Falls can lead to serious injury, with fractures necessitating hospitalisation occurring in 5%
of community-dwelling adults with a history of falling. The evidence base for exercise interventions or
multifactorial falls prevention programmes reducing fractures in the general population is lacking.
Here, we report a cluster randomised trial testing the hypothesis that a ‘screen-and-treat’ approach
to providing these interventions to older adults living in the community is clinically effective and
cost-effective.
Objectives
To undertake a cluster randomised controlled trial to determine comparative clinical effectiveness and
cost-effectiveness of three primary care falls prevention interventions: advice leaflet (Age UK. Staying
Steady. London: Age UK; 2009) only or advice leaflet plus postal screening for falls risk, followed by either
exercise or a multifactorial falls prevention for people aged ≥ 70 years, on outcomes of fractures, falls,
quality of life and mortality. Secondary objectives were to estimate the relative clinical effectiveness of
interventions in people by age, sex and falls history, to measure the uptake of the active interventions
(i.e. exercise and multifactorial falls prevention) and to assess the relative costs of each intervention and
determine the most cost-effective approach.
Methods
Study design and setting
This was a three-arm, pragmatic, cluster randomised controlled trial, with a parallel economic analysis.
The unit of randomisation was the general practice. The setting for the trial was primary care in England.
Participants
People aged ≥ 70 years living in the community and identified from general practice registers took part.
Interventions
After completing recruitment we randomised practices. All practices provided a postal falls prevention
advice leaflet to each participant. In addition, the practices randomised to the active intervention
arms (exercise and multifactorial falls prevention) screened for falls risk using a postal questionnaire.
For those participants identified as being at higher risk of falling, treatments were arranged and
delivered in accordance with a standardised protocol.
Outcomes
Our primary outcome was fracture rate over 18 months. Secondary outcomes included the proportion
of people with at least one fracture, falls, health-related quality of life, mortality, frailty and health
service resource use over 18 months. Health-related quality of life was measured using the EuroQol-5
Dimensions, three-level version, and Short-Form questionnaire-12 items. Frailty was measured using
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the Strawbridge questionnaire. We captured patient-reported outcomes using participant questionnaires
and falls diaries. Fractures were captured from Hospital Episode Statistics, general practice records and
participant self-reporting.
Randomisation and allocation sequence generation
The unit of cluster randomisation was the general practice. Participants aged ≥ 70 years were
randomly selected from each practice and were recruited prior to practice randomisation. We aimed
to recruit 9000 people to show a 2% absolute reduction in the proportion of older people sustaining
a fracture over 1 year. Hence, we aimed to recruit approximately 150 participants each from at least
60 general practices. To ensure that local services could cope with the additional demand placed on
them by the trial, we randomised practices in blocks of three from the same service area. We used
a computer-generated algorithm held and controlled centrally in the Warwick Clinical Trials Unit
by an independent programming team. Blocks of practices were randomised at the same time.
Blinding
The interventions were allocated at practice level and, therefore, although participants had agreed to
participate in a research study about older people and falls, they were blind to the treatment allocation
of their practice on recruitment. Practices were aware of their allocation. Practices randomised to the
active interventions posted the falls risk screening questionnaire, and responding participants deemed
at higher risk of falling were invited for treatment, either exercise or multifactorial falls prevention.
Exercise therapists were aware that participants had been referred to exercise, but did not know which
arm of the trial the participants had been allocated to. Other clinicians involved in multifactorial falls
prevention were aware of the allocation. Follow-up was by postal questionnaire and routine data.
Personnel involved in collection, data entry and analysis of outcomes were blind to the treatment
allocation of the practice and participant. Allocation of treatment was coded but unavailable to the trial
management team. Treatment codes were accessed only after data lockdown occurred for analysis.
Fracture adjudication took place blind to treatment allocation.
Statistical analysis
The primary statistical analysis was intention to treat. A nested intention-to-treat analysis was undertaken
in those participants identified as being at higher risk and complier-average causal effect analysis
conducted. Fracture and falls rates were assessed over the 18 months, and for each time interval (from
baseline to 4 months, 4 to 8 months, 8 to 12 months and 12 to 18 months). Fracture rates were expressed
as per person per 100 years. Negative binomial models were used using a random- or fixed-effects
model, whichever model better fitted the data. All models were adjusted for baseline variables: general
practice deprivation score, participant falls history, age and sex. A Cox proportional hazards model was
fitted to the data to compare time to first fracture across treatment arms. The total number of fracture
episodes and rate of fracture per episode were summarised by treatment arm. Frequency and proportion
of hip and wrist fractures were compared by treatment arms using the chi-squared test. The Short-Form
questionnaire-12 items score was analysed using random-effect linear regression models. Frailty status
was fitted using the random-effect logistic regression model, with the odds of being frail compared with
non-frail modelled by treatment arm (exercise vs. advice; multifactorial falls prevention vs. advice). The
cognition test was summarised as higher compared with lower cognitive functioning.
SCIENTIFIC SUMMARY
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Health economic analysis
A within-trial evaluation comparing the incremental costs and quality-adjusted life-year captured over
the 18 months of the trial was conducted. The EuroQol-5 Dimensions, three-level version, was used to
measure health-related quality of life over time and quality-adjusted life-years were constructed by
using the area under the curve approach. The cost perspective was that of the UK NHS and Personal
Social Services. Multilevel linear modelling was used to account for the multiple observations over time
of the health-related quality of life and costs per patient, clustered within practices. We discounted
costs and outcomes at 3.5% per annum and we conducted a probabilistic sensitivity analysis using Monte
Carlo simulation methods, with simulations of expected costs and quality-adjusted life-years drawn from
the variance–covariance matrices from the health-related quality of life and cost regressions. To account
for the possibility that the within-trial cost-effectiveness argument might be artificially censored at the
18-month trial period, a decision-analytic model was planned to extrapolate the economic argument
over a lifetime horizon. This may be necessary if the trends of costs, outcomes or the mechanisms
(rate of falls/fractures) that drive costs and outcomes are differentially changing over time for different
treatment groups such that a longer time perspective is required to understand the full health
economic picture.
Results
We randomised 63 general practices from six English localities: (1) Birmingham and the Black Country,
(2) Cambridgeshire, (3) Devon, (4) Herefordshire and Warwickshire, (5) Newcastle upon Tyne and
(6) Worcestershire. We randomised 21 practices to each intervention. We initially recruited 9819
participants; nine withdrew and seven died before randomisation. Our randomised population was
therefore 9803 people aged 70–101 years. Among these, 3223 (32.9%) were randomised to receive an
advice leaflet and 6580 were allocated to receive an advice leaflet supplemented with risk screening
and referral to either exercise (3279/9803, 33.4%) or multifactorial falls prevention (3301/9803,
33.7%). The mean age of participants was 78 years (standard deviation 5.7 years), 5150 out of 9803
(52.5%) were female, and most participants had scored highly on a cognition screener test (8751/9803,
89.3%). One-third of participants had fallen in the year prior to recruitment (3854/9803, 39.3%).
Postal questionnaires and core outcome data were obtained for 9064 out of 9803 (92.5%) participants
at 4 months, 8578 out of 9803 (87.5%) at 8 months, 8136 out of 9803 (83.0%) at 12 months and
7490 out of 9803 (76.4%) at 18 months after randomisation. Following postal screening, 88% of falls
risk screeners were returned to practices randomised to exercise or multifactorial falls prevention
(5779/6580). The postal falls risk screener performed moderately well at predicting falls over 12 months
(area under the curve 0.66, 95% confidence interval 0.64 to 0.68). Among the 5579 participants screened,
2153 (37.3%) were identified as being at higher risk of falling and were referred to treatment, either to
exercise (n = 1079) or multifactorial falls prevention (n = 1074). In the exercise arm, 697 out of 1079
(64.6%) participants attended exercise and, among these, 454 (65.1%) completed the prescribed 6-month
exercise programme. Among the 1074 participants referred to the multifactorial falls prevention, 762
(70.9%) attended falls assessment. Over half of those assessed were referred for a detailed general practice-
led medication review and over one-third of participants were referred to exercise because of balance
and/or gait problems (299/762, 39.2%). Among these 762 participants, 203 (26.6%) attended multifactorial
falls prevention exercise and 124 (16.3%) completed the prescribed 6-month exercise programme.
Primary outcome
Fracture data were available from Hospital Episode Statistics for 9802 out of 9803 participants (99.99%)
and from 62 out of 63 (98.4%) general practices. A total of 379 out of 9803 (3.9%) participants sustained
a fracture over 18 months. Although there was a trend towards an increased fracture rate in both
intervention arms (exercise compared with advice: rate ratio 1.20, 95% confidence interval 0.91 to 1.59;
multifactorial falls prevention compared with advice: rate ratio 1.30, 95% confidence interval 0.99 to 1.71),
neither difference achieved statistical significance. There were no differences in the number of hip or
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wrist fractures by treatment group, nor in time to first fracture. Time to first fracture was approximately
2 months longer in the exercise group and 1 month longer in the multifactorial falls prevention group
than in the advice group, although these differences were not statistically significant.
Secondary outcomes
Participants reported a total of 13,428 falls over 18 months. There was no difference in falls rate
over the entire 18 months: rate ratio 0.99 (95% confidence interval 0.86 to 1.14) and rate ratio 1.13
(95% confidence interval 0.98 to 1.30) for exercise and multifactorial falls prevention, respectively.
There was a lower falls rate over months 4–8 among those randomised to exercise than among those
receiving advice only (rate ratio 0.78, 95% confidence interval 0.64 to 0.96). However, this was not
sustained over time. A total of 289 (2.9%) participants died, with no differences by treatment arm.
There were no differences in quality-of-life scores between groups over time, although interim
improvements in subdomains (mobility, pain) were noted in the exercise group compared with the
advice group. There were no differences in the rate of fractures and falls over 18 months in the
stratum of people who were at higher risk of falling, among those who complied with the intervention
or in the prespecified subgroups. The prevalence of frailty increased slightly over time, but there were
no differences in odds of being frail by treatment comparison.
Economic analysis
The within-trial analysis found that, after allowing for clustering, a participant allocated to exercise
would expect to enjoy 1.120 quality-adjusted life-years over 18 months and generate costs of £3720
to the NHS. These figures discount the costs and quality-adjusted life-years from months 12–18 by
3.5%. For the same participant allocated to advice, the net present value quality-adjusted life-years
and costs are 1.114 and £3737, respectively. For multifactorial falls prevention, these figures are
1.106 quality-adjusted life-years and costs of £3941. Inspection of the data shows that the majority
of the costs occur in secondary care and are largely unrelated to falls (e.g. cancer treatment). From
an economic perspective, because exercise delivers the highest expected quality-adjusted life-years
at the lowest expected costs, it dominates both advice and multifactorial falls prevention. Similarly,
as multifactorial falls prevention delivers the lowest quality-adjusted life-year expectation at the
highest cost, it is dominated by both advice and exercise. The incremental differences are rather
modest, particularly between advice and exercise. Advice is expected to add roughly £1 per month
over exercise to the expected costs, and the incremental quality-adjusted life-year difference amounts
to approximately an additional 2 days in perfect health over the 18 months. Nevertheless, the large
sample size, balance across cohorts and small numbers of missing data mean that the results are
largely robust to probabilistic sensitivity analyses.
The within-trial analysis showed a consistent picture of cost-effectiveness over time, with exercise
being the most cost-effective treatment at all time points and with an increasing dominance over time.
Furthermore, the trial analysis showed no significant impact on the trends of fractures and falls and,
therefore, there is no mechanism for a more structured model to alter the trends observed in the trial.
It is therefore clear that extending the perspective of the model from 18 months to lifetime would
offer little additional insight and could not change the substantive conclusions that exercise dominates
advice, which in turn dominates multifactorial falls prevention.
Harms
No serious adverse events directly related to the interventions were reported. One participant
sustained a fractured neck of femur during a trial procedure not related to the intervention: a fall
sustained when returning from posting a follow-up questionnaire.
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Limitations
The incidence of fractures was lower than anticipated in the original sample size calculation, although
we used more efficient statistical methods than originally planned.
Conclusions
This large, high-quality cluster randomised controlled trial recruited almost 10,000 older people aged
70–101 years from across England; we found that a primary care-led screen and referral to falls
prevention treatment did not reduce fractures. Exercise reduced falls in the time period around the
end of intervention, but this benefit was not sustained over time. Screening for higher risk and
provision of multifactorial falls prevention from primary care is not a worthwhile investment. Of the
three treatments, exercise was both marginally cheaper and delivered the best health-related quality
of life, and was therefore a dominant cost-effective treatment relative to both advice and multifactorial
falls prevention. The multifactorial falls prevention intervention was found to be the least cost-effective,
with the lowest quality-adjusted life-years and high costs (a result robust to probabilistic and other
sensitivity analysis).
Future work
Falls and fracture prevention remains an important target of preventative health care. Improving
uptake and adherence to strength and balance programmes in primary care is an important focus for
future research, and should be tested as part of a framework or family of interventions to target
geriatric syndromes.
Trial registration
This trial is registered as ISRCTN71002650.
Funding
This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 34.
See the NIHR Journals Library website for further project information.
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Falls and fractures are a major public health burden. Falls can be associated with loss of independence
and reduced functionality and are a major contributor to premature admission to nursing home or
long-term care.1,2 The risk of falling increases with age. Half of people aged ≥ 80 years fall at least once
per year.3 Most falls result in no injury, but can lead to fear of falling and loss of confidence in mobility.
Falls can cause serious injury: each year, fracture and hospitalisation occurs in about 5% of community-
dwelling older adults with a history of falling.4 In 2016, there were 255,000 falls-related emergency
hospital admissions in England among people aged ≥ 65 years. Demographic change means that the
number and proportion of older people in the population is rising. In 2016 there were 1.6 million people
in the UK aged ≥ 85 years (2% of total population), and this is projected to double to 3.2 million by
2036.5 Fractures in older people will become increasingly common and this will have a major impact
on use of health-care resources and service provision.
Costs of fractures and fall-related injury
The health and social care costs associated with fractures and fall-related injuries are high. Fractures
and falls in those aged ≥ 65 years account for 4 million bed-days per year in England alone, at an
estimated cost of £2B.6 Direct health-care and associated social costs arise from the management of
these injurious falls and fractures (the majority of costs arise from hip fracture).7 Mortality is high in
people who sustain a hip fracture: 10% die within 1 month and 30% die within 1 year of fracture.8
Falls services in the UK NHS
Falls are a hallmark of age and becoming frail.1 Falls have a multifactorial aetiology, with many risk
factors, some of which are modifiable. Risk factors include impairments or instability of gait and
balance, visual problems, cardiac rhythm abnormalities and syncope, polypharmacy and certain classes
of ‘culprit’ or psychotropic medication, cognitive impairment, multiple comorbidity, foot disorders, and
home and environmental hazards. Early clinical trials from the USA targeted the assessment and
treatment of multiple risk factors and intervention strategies, termed multifactorial falls prevention
(MFFP). These early trials were promising, indicating that multiple risk factor intervention strategies
reduced risk of falling among community-dwelling older people.9 These studies from the 1990s
provided the basis for the mandatory establishment of secondary prevention in the UK:10 falls services
providing MFFP interventions for people with a history of falling were subsequently introduced in
England.11 Multifactorial risk assessment, followed by targeted treatment of individual risk factors,
is recommended for falls prevention in the UK, supported by clinical organisations [e.g. the American
Geriatrics Society, the British Geriatrics Society and the National Institute for Health and Care
Excellence (NICE)].2,3 These UK NHS services vary considerably in terms of service design, models of
delivery and professional skill mix.12,13
Evidence of effectiveness of falls prevention interventions
At the time of preparing the Prevention of Falls Injury Trial (PreFIT), numerous small trials had
investigated the effectiveness of alternative falls prevention strategies. A 2012 Cochrane review14
(59 trials, n = 13,264) of falls prevention strategies found that exercise programmes, particularly those
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focused on strength and balance retraining, reduced rate of falls (i.e. number of falls) by 30% and risk
of falling (i.e. number of people falling) by 18%.14 Certain strength and balance interventions were found
to be effective, especially those including targeted, individualised programmes progressed over time.
However, adherence to exercise remained a challenge. Among the 59 falls prevention trials investigating
exercise, only six had recorded fractures outcomes, totalling 45 fracture events.
The same Cochrane review14 identified 40 trials (n = 17,195) of MFFP studies. The review identified
evidence for weaker effectiveness of MFFP interventions on falls outcomes, reporting that these
interventions may reduce the rate of falls but not number of fallers (falls risk).14,15 Among the 40 falls
prevention trials investigating MFFP, only 11 had recorded fracture outcomes (totalling 289 events),
but some trials included non-fracture injury.14 Typically, the interventions identified by the Cochrane
review were too poorly specified to be reproducible. These Cochrane reviews have since been updated;
however, the overall conclusions are unchanged.16 The reviews continue to highlight methodological
deficiencies in existing trials, with many studies being underpowered and lacking robust data on
important outcomes, including quality of life (QoL), fracture, costs of intervention and cost-effectiveness.
There is a need for robust evidence, with economic evaluation, to justify NHS provision of these falls
prevention services.
Rationale for the PreFIT
Falls prevention services are widely implemented throughout the NHS, yet gaps remain in evidence
regarding the prevention of falls. One of the main purposes of falls prevention is to reduce fractures
and other serious injuries.17 Adequately powered studies are required to investigate the effectiveness
of such initiatives on clinical and patient-reported outcomes. This cluster randomised controlled trial
(RCT) was designed to compare the effectiveness of alternative falls prevention strategies, using a
screen-and-treat approach embedded within primary care, to investigate the prevention of falls and
fractures in older adults.
The aim of the PreFIT was to determine the comparative clinical effectiveness and cost-effectiveness
of three alternative primary care-led fall and fracture prevention strategies for older people living in
the community: advice only; advice with screening for falls risk, with referral to an exercise programme
for those at higher risk; and MFFP. Outcomes included fractures, falls, QoL, mortality and health-care
resource use.
Research objectives
To estimate the clinical effectiveness and cost-effectiveness of the three alternative falls prevention
interventions (advice only; advice supplemented with risk screening and referral to either exercise;
and MFFP) in older adults. Our intention was to conduct a pragmatic trial and to include a process
evaluation and a within-trial cost-effectiveness analysis.
Overview of the report
This report is structured across six chapters. We present methods (see Chapter 2), intervention
development and description (see Chapter 3) and trial results (see Chapter 4) and describe the findings of
the economic evaluation (see Chapter 5). Finally, we provide an overarching discussion and conclusion of
our findings (see Chapter 6).
INTRODUCTION
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Chapter 2 Methods
Trial design and setting
We conducted a three-arm, pragmatic, cluster RCT design, with a parallel economic analysis. The setting
was English primary care. We have published a detailed description of the trial protocol elsewhere.18
Eligibility criteria
Cluster level
Practice identification and eligibility
We sought general practices (GPs) via existing research networks, including the Primary Care Research
Network and Local Comprehensive Research Network. We placed advertisements in regional research
newsletters and displayed posters at primary care events. We recruited triads of GPs in England with
the infrastructure and services to support the trial. Specifically, we required practice agreement to
adhere to a predetermined treatment pathway for the allocated intervention (advice, exercise or MFFP),
local resources to deliver the active interventions and the technical capacity to undertake electronic




Community-dwelling older people aged ≥ 70 years and resident in the community or in sheltered
housing were eligible for invitation by their GP. Exclusions included those housed in long-term
residential or nursing care homes and those with terminal illness or expected shortened lifespan
(defined as < 6 months). No specific restrictions or exclusions by age, sex, cognitive functioning,
comorbidity or falls history were applied.
Participant identification
We sought to recruit an average of 150 participants per GP. A study researcher and/or practice staff
member searched GP electronic databases to identify all people aged ≥ 70 years. A computer program
selected a random sample of 400 of these. With an uptake rate of 35–40%, this would yield
140–60 participants per GP.
Participant exclusions by general practitioner
After generation of the random sample lists, general practitioners screened lists to remove patients
who should not be approached (if not already removed via electronic search criteria). Predetermined
reasons included any illness with an end-of-life prognosis of < 6 months or residence in nursing or
residential accommodation.
Postal invitation and participant consent
Practices posted an invitation pack containing a participant information sheet, baseline questionnaire
and consent form. We sought consent for multiple levels of access to medical data, including medical
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records and routine data held by the NHS Health and Social Care Information Centre (HSCIC) (NHS
Digital from April 2016). At the time of trial launch, the wording of consent forms was appropriate
for access to HSCIC data and approved by the Research Ethics Committee and relevant monitoring
committees. Ethics issues were considered in relation to the cluster trial design.18
Allocation sequence generation and randomisation
The unit of cluster randomisation was the GP. Once we had recruited approximately 150 participants
from each of the three GPs, or no further responses were being received, GPs were then randomised.
To ensure allocation concealment, we did this in blocks of three (one allocated to each treatment arm).
No stratification was used. Randomisation was based on a computer-generated randomisation algorithm
held and controlled centrally in Warwick Clinical Trials Unit by an independent programmer. Trial
administration staff members were informed of GP allocation by e-mail. Treatment allocation was
coded and unavailable to the trial management team.
Blinding
We adhered to the Consolidated Standards of Reporting Trials (CONSORT) statement 2010 update
extension for cluster randomised trials.19 Owing to the nature of the interventions, it was not possible
to blind therapists or services delivering exercise or MFFP. Senior members of the research team
were blind to GP and treatment allocation for the duration of the trial. We undertook data cleaning
and fracture adjudication of suspected and confirmed events blind to treatment allocation.
Trial interventions (advice, exercise and multifactorial falls prevention)
We describe trial interventions in Chapter 3 and in two intervention development papers.20,21 In brief,
we randomised practices to deliver one of three interventions: advice leaflet only; advice leaflet
supplemented with screening for falls risk, followed by exercise; or MFFP. The Age UK (www.ageuk.org.uk;
accessed 21 April 2020) Staying Steady booklet22 was used for the advice intervention. This was mailed
out after practice randomisation. Those randomised to active interventions received the Age UK advice
leaflet with the falls risk balance screener. The exercise intervention was based on the Otago exercise
programme (OEP), targeting lower-limb strength, balance retraining and walking.23 Practices randomised
to intervention invited participants identified to be at high risk of falling to attend a 6-month PreFIT
exercise programme or the MFFP programme (Table 1). The MFFP intervention comprised an individualised,
1-hour falls assessment with appropriate onward referral for treatment, including referral to the PreFIT
exercise intervention if gait or balance risk factors were identified. We based the MFFP intervention on
evidence-based guidelines for falls risk assessment and treatment pathways.2,11
Screening and referral to active intervention
All participants received the advice booklet by post. Advice arm GPs delivered no further trial interventions.
We used a primary care screening approach to determine onward referral of participants to the active
interventions of exercise or MFFP. A short self-complete falls risk screening survey, based on previous
research,24 was posted from, and returned to, GPs. Participants were categorised as being at risk of falling
based on responses to falls and balance questions (high risk =multiple faller; intermediate risk= one fall or
balance problems). These participants were offered the opportunity to attend for further assessment and
treatment, either exercise or MFFP. Participants deemed to be at low risk (no history of falls or balance
problems) received no further intervention other than the advice leaflet.
METHODS
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TABLE 1 Overview of PreFIT interventions
Referral: exercise
programme Therapist/venue
PreFIT exercise programme (6 months’ duration)
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No restrictions were placed regarding other agencies or health-care services contacting participants
about fall prevention strategies. At trial closure, participants continued with usual health care and no
further ancillary care was provided.
Baseline data: practices and participants
Descriptive data collected on GPs included practice-level deprivation at randomisation, using the
UK National Index of Multiple Deprivation, which scores from 1 to 10 (from most deprived to least
deprived).25 Baseline descriptive data on participants included mobility, difficulties with mobility,
cognition and activities of daily living (ADL). Mobility questions, adapted from population surveys of
older adults,26,27 captured difficulties when balancing on a level surface, ability to walk outside the
house, average time spent walking and difficulties with balance when performing common ADL
(e.g. taking a bath, dressing). A clock-drawing test cognitive screener was included at baseline only.28
Scoring was a 6-point system according to visuospatial aspects and the correct denotation of time:
normal cognition (score 6), minor visuospatial errors (score 5), mild (score 4), moderate (score 3) or severe
(score 2) visuospatial disorganisation of time or no reasonable representation of a clock (score 1).
Outcomes
Selection of primary outcome
Given the burden of injury, disability and dependence associated with fractures in older people,
we selected fractures, rather than falls or falls-related QoL, as the primary outcome for the trial.
Primary outcome: fracture rate
The primary outcome was the fracture rate over 18 months, expressed as per person per 100 years, from
date of GP randomisation and per time period. Number of fractures per participant was based on fractures
identified in Hospital Episode Statistics (HES) and GP records, confirmed by adjudication panel. The
fracture rate was derived for each participant, by accounting for time as an offset in statistical modelling.
Definition of fracture
We included all fractures, defined according to an internationally agreed definition:29 any fracture to
bones in the peripheral (appendicular) skeleton, thus limbs, limb girdles, ribs and cranial and facial
bones. We excluded compression fractures in the vertebral column that could not be attributed to a
fall. Updates to the protocol are described in Monitoring and approval. We also estimated differences in
number of proximal femoral (hip) fractures and fractures involving the distal radius or wrist to allow
comparison with other reports from more recent fracture prevention trials.30 We defined hip fractures
as verified fractures with a specific description of neck of femur or proximal femur [International
Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10)31 code S72].
Fracture data sources
Fracture data were collected from three sources: HES, GP records and participant self-report postal
questionnaires. Successive waves of NHS Digital data were purchased covering years 2010/11 to
2015/16. Fractures were screened and identified from the following sources:
l HES acute patient care – searches of fracture codes in inpatient admissions using ICD-10
S00-T88 codes for ‘Injuries, poisoning and certain other consequences of external causes’ and
M/T/W codes (as reported in the statistical analysis plan).
l HES accident and emergency (A&E) – fracture codes in A&E diagnosis and treatment codes,
including diagnosis codes (three level) 052 and 053, treatment codes (two level) 05 and 33, and
treatment codes (three level) 101 and 102.
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l HES outpatient data – orthopaedic and trauma clinic attendances (main specialty codes).
l GP records – electronic searches of Read codes (clinical terms version 2 and 3: S/N/T code searches),
with additional free-text searches undertaken for fracture/#. We extracted copies of any clinical
records or correspondence relating to actual or suspected fractures.
l Participant self-reports of fall-related fractures were captured via postal surveys administered at
baseline (fractures in previous year) and at 4, 8, 12 and 18 months after randomisation.
We searched all data sources to identify any potential or suspected fracture report in HES acute
patient care, HES A&E, GP records or self-report. Detailed searches on GP records were undertaken
for all self-reported fractures. All events were identified for cross-checking against other sources by
the adjudication panel. HES outpatient data were not used beyond the first wave because this data
set did not yield usable fracture codes. Additional checks in the HES acute patient care data set were
made for operations in the same hospital admission or adjacent time period by checking the Office of
Population Censuses and Surveys’ Classification of Surgical Operations and Procedures codes.
Fracture adjudication
Two clinically qualified members of the study team adjudicated fracture events (SEL and MU). When
needed, further adjudication was made by KW. Adjudicators were blind to practice allocation and all
personal-identifiable data were redacted before records were presented to the adjudication panel.
A fracture event was included if it corresponded to the updated, revised fracture protocol. Fractures
identified on HES acute patient care were considered confirmed with or without participant self-report
or GP record; any fracture identified on HES A&E supported by a GP record was confirmatory with or
without participant self-report. Primary care records were considered confirmatory when supported by
hospital or clinic discharge letters or radiology (X-ray) reports confirming a fracture. Whenever possible,
fractures ascertained from GP record searches were assigned an event date and corresponding ICD-10
fracture code by the panel. Fractures reported using self-report alone were discounted.
Secondary fracture outcomes
Fracture episodes
Some participants experienced multiple fractures from one fall. We characterised all fractures occurring
on the same date as one episode. Statistical modelling was used to account for fractures occurring in the
same individual and in the same episode.
Time to first fracture
The adjudication panel dated all fractures using HES, GP data and self-report. When data were not
available on the date of fracture, then date of hospital admission or attendance was taken as date of
fracture. Time to first fracture was defined as the interval, in days, between randomisation and first
fracture in the study period.
Proportion of people sustaining one or more fractures or fracture episodes
over 18 months
As participants might have multiple fractures as a result of one or more falls during the 18-month
follow-up, the proportion of participants with at least one fracture episode was calculated.
Secondary outcomes
Secondary outcomes included falls, health-related quality of life (HRQoL), frailty, mortality and
health-care resource use.
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Falls
Rate per 100 person-years observation over 18 months and per time period
Our primary falls outcome was the falls rate, expressed as falls per person per 100 years, over
18 months from date of practice randomisation. The definition for falls was consistent with the
Prevention of Falls Network Europe (ProFaNE) consensus.29 The number of falls per participant
was based on retrospective self-report in postal questionnaires, recorded at baseline (falls in the last
12 months) and at each follow-up time point, by asking about falls in the previous 4 months. This was
the primary method of falls data collection. The number of falls between each of the follow-up time
points and the number of people sustaining one or more falls were also reported.
Prospective diary
All participants were asked to complete monthly prospective falls diaries for a period of 4 months
during the first year of the trial. Prospective data collection is considered the gold-standard method for
falls recording, but given the large sample size this was not practical. We allocated participants to one
of three time periods (randomisation to 4 months, 5–8 months or 9–12 months after randomisation)
using random sampling without replacement. Prepaid postal diaries were completed daily and returned
to the research office every month.
Health-related quality of life: measured over 18 months and each time period
The Short-Form questionnaire-12 items (SF-12) measures physical function, engagement in usual activities
and mental functioning.32 The physical health composite scale (PCS) and mental health composite scale
(MCS) combined items allow comparison with national norms [mean score 50.0, standard deviation
(SD) 10.0]. The EuroQol-5 Dimensions, three-level version (EQ-5D-3L), is a standardised measure
of self-reported HRQoL that includes five domains: (1) mobility, (2) self-care, (3) usual activities,
(4) pain/discomfort and (5) anxiety/depression.33
Frailty: measured at baseline and 18 months
Frailty was measured using the Strawbridge questionnaire, a 16-item questionnaire comprising four
frailty subdomains: (1) physical (four items), (2) nutritional (two items), (3) cognitive (four items) and
(4) sensory (six items).34 Scoring is on a four-point ordinal scale (rarely or never, sometimes, often,
or very often), with those scoring ≥ 3 on at least one item being considered to have a problem or
difficulty in that domain. Participants were classed as ‘frail’ if they reported having problems in two
or more domains.35
Mortality: over 18 months
Date of death was obtained from multiple sources, including notifications to the study team from
family members or from primary care, HES data and searches of practice medical records on
completion of the trial.
Health-care resource use (baseline and at 4, 8, 12 and 18 months)
We describe these data in more detail in Chapter 5. In brief, questions addressed attendance at
health-care services, including GP, the district nurse, any time spent in a nursing or residential home
and contact with physiotherapy services.
Data collection: postal questionnaires
Questionnaires were printed in large font, with a freephone number on the front page of the booklet
and final free-text section for comments. Draft versions were modified after feedback from older
people attending a community social group. We posted questionnaires with an explanatory cover letter.
We collected core outcome data on fractures, falls, mobility, EQ-5D-3L and health-care resource by
telephone if no response was received after one postal reminder. Any participant who reported a
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fracture event in the questionnaire was sent a separate questionnaire to elicit date, site of fracture
(e.g. upper arm, wrist) and details of any hospital admission and/or radiographs taken. Participants
reporting more than one fracture were contacted by telephone for further details.
Process evaluation
We measured a range of process evaluation indicators relating to intervention uptake and delivery,
including time from randomisation to postal risk screener administration, uptake and predictive utility
of the postal screener, uptake of active interventions, and duration and ‘dose’ of treatments delivered
by exercise therapists or MFFP assessors.
The response rate to postal falls risk screeners was assessed for screening yield and utility by assessment
of prediction of falls over 12 months, using area under the curve (AUC) and 95% confidence intervals
(CIs), as per recommended guidance for evaluation of prediction models.36 Intervention-related process
measures for exercise included changes in strength and balance over time; thus, first and final assessments
using the chair stand test (CST), the 4-test balance scale (4TBS), weights (kg) and repetitions were
prescribed. We defined ‘work’ done as the product of the number of repetitions and amount of weight
prescribed at each contact point (weights × repetitions).37 We recorded the number of contacts and
reported participants as having either fully or partially adhered to the exercise programme (fully
adhered = six contacts or until discharge by therapist; partially adhered = fewer than six contacts).
We recorded the number of MFFP assessments among those invited to attend. The skill mix of assessors
was recorded by region, and participant uptake of interventions was explored by region.
Process evaluation: general practice medication prescribing
We extracted prescribing data for selected medications from GP records for two time periods captured
1 year apart: 3 calendar months pre randomisation and from 9 to 12 months post randomisation.
The aim was to determine the rate of prescriptions of culprit medications (i.e. those targeted in any
of the interventions) over time. In addition, we estimated the use of bisphosphonates and mineral
supplementation as contextual data. We planned to undertake drug data searches on a random subsample
of GPs stratified by intervention arm, but pilot searches suggested that this would be unreliable owing to
differences in primary care electronic systems, which resulted in variation in format and quality of drug
data. Therefore, medication searches were undertaken at all GPs. We developed a medication search
protocol detailing Read codes for two drug classes of interest: (1) psychotropics and psychotropic-related
medication and (2) bisphosphates and mineral supplementation. Psychotropics can increase risk of falling,
and we included antidepressants, psychotropics, sedatives, hypnotics, anxiolytics and antimanic
medications, as per British National Formulary38 classes 4.1.1—4.3.1. Bisphosphonates (British National
Formulary class 6.6.2), are often prescribed with mineral supplementation (calcium and vitamin D
preparations that include calcium carbonate, British National Formulary classes 5.1 and 9.6.4), as can slow
bone loss and may decrease the risk of fractures. We collected data at practice level only, on the total
number of trial participants prescribed psychotropics and bone protection drugs (mean/proportion
participants per practice) and changes pre–post randomisation. Completeness of data varied by practice
electronic system.
Data management
Questionnaires were scanned using FORMIC FUSION™ software (Formic Ltd, Staines, UK), which
includes internal system validation checks. All scanned questionnaire entries were manually checked
by the research office. All other data were manually entered by data clerks onto the bespoke database
designed for the trial. All data were validated using range checks, outliers, missing data and date
discrepancies. Anomalies were checked against original data sources for rectification.
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Data analyses
Definition of higher falls risk
We established risk of falling using two methods, based on responses to (1) the GP-administered postal
falls risk screener mailed to treatment arms only and (2) the baseline questionnaire completed by all
participants. Details of response options used to classify risk of falling for each data source are provided
on the project webpage (URL: www.journalslibrary.nihr.ac.uk/programmes/hta/081441/#/; accessed
16 March 2020). The risk algorithm from the baseline questionnaire used falls and balance difficulty
questions analogous to the falls risk screener, but this enabled identification of risk across the full trial
population. Comparisons of risk of falling were made across treatment arms.
Sample size calculation
As reported in the published protocol,18 the study was powered using the proportion of people with
at least one fracture. We used a conservative method of estimating the sample size based on a
comparison in the proportion of people with fractures, recognising that this would be more than
adequate for comparison of both proportions and fracture rates per person over 18 months of follow-up.
There were surprisingly few data available from which to draw estimates of fracture rates for the
UK older population. The sample size was based on the annual fracture incidence from UK statistics,
estimated to be 6 per 100 (6%) for people aged > 70 years.39 We prespecified a target of reduction to
4% in the intervention arm.
A total of 5700 participants, thus 1900 per arm, were required to achieve 80% power for detecting a
statistically (p < 0.05) and clinically relevant (2%) reduction in proportion sustaining a fracture, from
6% to 4%, for the comparisons of advice compared with exercise and advice compared with MFFP.
We aimed to recruit an average of 150 participants from each GP. To adjust for varying degrees of
modest clustering, intracluster correlation (ICC) set at 0.003 inflated this sample size estimate from
5700 to 7800, or 2600 per arm. The choice of ICC was driven by data reported by Smeeth and Ng,40
who, although they did not provide information relating to fractures, reported ICC related to an
outcome of ‘at least one fall’. This estimate was 0.0061. We used a slightly smaller ICC of 0.003, as the
number of fracture events would be lower than number of falls. Allowing for 15% loss to follow-up,
this yields a minimum target sample size of 9000 participants from a minimum of 60 practices. To reduce
the possible effects of variable cluster size on statistical power, we sought to keep final cluster sizes
in the range of 129 to 179.
Statistical analyses
Statistical analyses were carried out using StataSE® version 15 and 16 (StataCorp LP, College Station,
TX, USA). All statistical tests were two sided and performed at the 5% significance level. We undertook
three levels of analysis: (1) intention to treat (ITT), (2) a nested ITT on data from those at higher risk of
falling and (3) complier-average causal effect (CACE) analyses. Unadjusted and adjusted estimates were
obtained for all statistical regression models. Adjustment was made for the corresponding baseline
variable (participant age, sex, falls history and GP deprivation score). The main ITT analysis included all
randomised participants. In a nested ITT analysis, we compared treatments just among those at higher
risk of falling, classified in accordance with the baseline questionnaire.
Treatment comparisons
The primary analysis compared all participants randomised to advice with all participants randomised
to exercise and, separately, all participants randomised to advice with all participants randomised to
MFFP. Only if there was evidence of a statistically or clinically important difference for either of these
did we plan to proceed with comparing exercise with MFFP.
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Descriptive analyses
Data were summarised and reported in accordance with the CONSORT guidelines for cluster RCTs.19
Recruitment and participant flow are reported using CONSORT flow diagrams at the level of GP and
participants in Chapter 4 (see Figures 1 and 2). Participant data from randomisation to 18 months were
analysed by treatment arm and by risk classification using falls and balance questions from the baseline
questionnaire. Sociodemographic variables were summarised by intervention arm, with mean (SD),
median (range) and missingness reported for continuous variables, and number (%) for categorical
variables. Unadjusted and adjusted estimates were obtained for all statistical regression models.
Adjustment was made for the corresponding baseline variables: GP deprivation score, participant falls
history, age and sex.
Primary analyses
Cook and Major41 reviewed two different approaches to the analysis of events per person-years,
examining estimation of the rate by (1) dividing total number of events across all participants by total
duration of participant follow-up and (2) fitting a random-effect Poisson model to accommodate
the expected variation in the rate between different participants.41 They found that the events-per-
person method substantially underestimated variation in the data and felt that this method was not
appropriate to summarise the incidence of rate-related data.41 Others have described different statistical
models to assess count data when there is overdispersion and excess zeros.42–44 These models include the
Poisson, negative binomial, zero-inflated Poisson, zero-inflated binomial, hurdle Poisson, hurdle binomial,
Andersen–Gill and marginal Cox regression models. There is consistent evidence to suggest that the
negative binomial models provide the best fit.42 We therefore used these to analyse fracture and falls
rates per person time observation.
Fractures were expressed as the fracture rate per person per 100 years of observation. Using the
negative binomial model, we incorporated the random effect for GP, and this provided the unadjusted
and adjusted estimates of the fracture rate per person per 100 years, taking account of all data collected
over 18 months. The adjusted model accounted for baseline falls, sex, age and GP deprivation score.
An offset variable was incorporated to account for the time the participant was in the study. In the
light of the extremely skewed distribution of the baseline falls count, the log of the baseline falls count
was used.45 The fracture rates per person per 100 years of observation (with 95% CIs) are presented
by treatment arm. The rate ratio (RaR) (95% CI) is given for advice compared with exercise and advice
compared with MFFP. The standard errors (SEs) for the rates were obtained using bootstrapping methods.
Model fit was assessed using the likelihood ratio (LR) test, which compared the random-effect model with
the standard negative binomial model.
The fracture rate based on per person per time period was also computed for each follow-up time
point to 18 months. Negative binomial models were fitted similar to those described above but without
an offset variable, because the time interval was standard for all participants.
Secondary analyses
The proportion of participants who sustained one or more fractures over 18 months was analysed
using random-effects logistic regression models, with the random effect as GP. Responses were taken
as ‘no fracture’ (0) and ‘at least one fracture’ (1) where one or more fractures were recorded. Model
fit was assessed using the LR test, comparing the standard with the random-effect logistic regression
model. Unadjusted and adjusted odds ratios (ORs) (95% CI) for the odds of incurring at least one
fracture compared with no fracture were calculated.
Time to first fracture was analysed using survival methods, accounting for the random effect (GP) and
other key predictors, as above. A Cox proportional hazards model was fitted to the data to compare time
to first fracture across treatment arms; assumptions for models were checked. The total number of fracture
episodes and rate of fracture per episode were summarised by treatment arm. Frequency and proportion
of hip and wrist or forearm fractures were compared by treatment arms using the chi-squared test.
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Using the negative binomial model with random effect for GP, unadjusted and adjusted falls rates
per 100 person-years were calculated using all data collected over 18 months. The adjusted model
accounted for baseline falls, sex, age and GP deprivation score. An offset variable was incorporated
into the model to account for time in the study. In the light of the extremely skewed distribution of
the baseline falls count, the log of the baseline falls count was used.45 The negative binomial model
provided a rate per participant per month, expressed as per 100 person-years of observation. The falls
rate per 100 person-years (95% CI) was calculated by treatment arm. The RaR (95% CI) was calculated
for exercise compared with advice and for MFFP compared with advice. The SEs for rates were
obtained using bootstrapping methods. Model fit was assessed using the LR test, which compared the
random-effect model with the standard negative binomial model.
We analysed the proportion of participants who sustained one or more fall over 18 months, similar
to the fracture analyses. At 18 months, the questionnaire time period covered 6 months (from 12 to
18 months). However, the written question enquired about falls in the previous 4 months; therefore,
4 months was used for rate calculations. Only reported data were used in rate calculations. For example,
when a participant returned falls data at 4, 12 and 18 months but had not responded at 8 months,
then the falls rate was based on the observation periods for data returned (in this example, 4, 12 and
18 months).
The number (proportion) of fallers was calculated. In addition, the falls rate (per 100 person-years) was
calculated as a 4-monthly rate for each time interval analysed using random-effect negative binomial
models. The falls rate per person per month based on diary card responses was summarised and analysed
using similar methods for each time interval (baseline to 4 months, 4 to 8 months and 8 to 12 months).
A comparison was made by method of reporting (retrospective vs. prospective).
Other secondary outcomes and baseline measures
Other clinical outcomes and baseline measures were summarised by treatment arm (SF-12, EQ-5D-3L,
frailty, mobility and difficulties with ADL, cognitive impairment and self-reported health conditions).
Mean values (SD), median (range) and missingness were reported for continuous variables, and number
(%) for categorical variables. For secondary analyses, we estimated treatment effects by age, sex, falls
history, frailty and cognition. Frailty status was fitted using the random-effect logistic regression model,
unadjusted and adjusted, with the odds of being frail compared with non-frail by each active treatment
arm compared with advice modelled. We followed validated scoring guidelines for all measures.
Descriptive data for the cognition test were summarised as having higher compared with lower cognitive
functioning. An additional secondary analysis was undertaken on fractures occurring after the 18-month
follow-up period for the entire observation period for which HES data were available. For these events,
confirmed fractures were based on only hospital statistics, as GP and self-report were not gathered
beyond 18 months. We report events from the extended period as per events for the main trial.
Nested intention-to-treat analysis
In a nested ITT analysis, we compared treatment just in those at higher risk of falling, classified according
to responses to falls and balance questions in the baseline questionnaire, completed by all trial participants
before randomisation. This provided information on those at higher risk of falling across all three treatment
arms, including the advice only group, who did not receive the falls risk screener.
Complier-average causal effect analysis
In a CACE analysis we assessed treatment effect in compliers compared with non-compliers. We defined
a ‘complier’ as a participant who returned a postal falls risk screener who was deemed at risk of falling
METHODS
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and attended their first exercise or MFFP assessment or one who returned the falls risk screener but
had a low risk of falling. We defined non-compliers as those who returned a falls risk screener and were
at risk of falling but did not attend treatment, or who did not return a falls risk screener.
Subgroup analyses
We prespecified subgroup analyses to explore intervention effectiveness by age, sex, falls history,
cognitive impairment and frailty.46,47 We did not expect to include large numbers of community-dwelling
older people with severe cognitive impairment, but mild to moderate cognitive impairment may affect
ability to engage in falls prevention strategies. Subgroup effects were tested through formal interaction
tests.48 Random-effects negative binomial models were fitted using the interaction of treatment and
subgroup as the covariates. We did not adjust for other baseline covariates. RaRs (95% CI) were
obtained for the treatment comparisons for advice compared with exercise and advice compared with
MFFP, respectively.
Missing data
As fracture data were available for all participants from combinations of HES and GP records, we had
no missingness for the primary outcome. We assessed missing data for the falls outcome. It was not
possible to perform multiple imputation (MI) owing to skewness in the distribution of the data. Instead,
we assessed missingness (no response) by looking at the proportion of missing data across treatment
arms for the falls data within each time interval.
Adverse event reporting
A safety-reporting protocol for related and unexpected serious adverse events (SAEs) and directly
attributable adverse events (AEs) was developed. An AE was defined as any untoward medical occurrence
in a participant that did not necessarily have a causal relationship with treatment. All participants were
aged ≥ 70 years; thus, we expected common chronic diseases associated with age (e.g. osteoarthritis and
musculoskeletal conditions). It was expected that some participants would experience uncomfortable
effects from exercising, such as muscle or joint discomfort. These effects were anticipated and, provided
they were short-lived, were not reported as AEs. AEs were reported if they occurred during any contact
time with the therapist or assessor delivering an intervention, during an intervention session or when
undertaking prescribed exercise, either supervised or unsupervised. All AEs were reported to the trial
team and chief investigator within the required timelines, in accordance with the PreFIT safety-reporting
protocol. A SAE was an AE occurring as a direct consequence of treatment that resulted in death, threat
to life, hospitalisation, disability or incapacity. Any event that required professional medical attention
included, but was not restricted to, serious sprains, joint dislocation, falls or other injuries occurring as a
direct consequence of the intervention. All events were reported to the trials unit immediately after the
therapist became aware of them, within 24 hours for SAEs. The SAEs and AEs were recorded in the trial
database. Any event related to trial interventions was referred to and reviewed by the Data Monitoring
and Ethics Committee (DMEC).
Pilot phase and protocol revisions
A pilot phase was undertaken in one locality from September 2010 to March 2012. Key changes during
the pilot phase included to increase postal mail-out from 300 to 400 people to increase yield from initial
invitation. Other changes over time included an update to the primary outcome. The original trial protocol
defined peripheral fracture as any fracture to bones in the appendicular skeleton, thus limbs and limb
girdles as well as cranial and facial bones, but with exclusion of compression fractures in bones constituting
the vertebral column (lumbar, thoracic and cervical vertebrae, sacrum and coccyx). This definition of
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appendicular skeleton also excludes the thoracic cage (sternum and ribs), as per the internationally
agreed definition published by the ProFaNE network.29 However, the definition of fracture events had
evolved since protocol development. There was broad recognition among the clinical community that
the ProFaNE consensus, published in 2005, required updating to reflect the contemporary epidemiology
of trauma-related fractures in older people.49 As populations age, the incidence of trauma-related skull,
rib, vertebral and facial fractures increases.50–53 During the pilot phase, we had developed methods for
extracting accurate fracture data from both HES and GP records. It was apparent that fracture reporting
was of sufficient quality to distinguish compression fractures of the vertebral column.We updated the
PreFIT protocol and trial registry to include these fractures from HES and GP records when these were
clearly consistent with a trauma mechanism. Therefore, when there was a clear description of trauma or
fall, or when the fracture presentation was consistent with trauma and clearly mapped to the ICD-10, falls
codes were generated from HES. Reports of vertebral osteoporotic compression fractures in GP records
were excluded unless clearly linked to a report of trauma or fall.
Statistical models were revised from generalised estimating equations to generalised linear mixed-method
models to account for data type and dispersion. These model revisions (updated from the original
application) were reported in the prespecified analysis plan, approved by external committees and
described in the published trial protocol.18
Monitoring and approval
Regional and site-specific approvals were obtained from regional NHS research and development
departments. The study was approved by the National Research Ethics Service (Research Ethics
Committee reference 10/H0401/36, version 3.1, 21 May 2013), with approval granted by the Derbyshire
Research Ethics Committee on 29 April 2010 (Table 2). Funder-led monitoring meetings to review pilot
study recruitment and intervention data were held on 4 April 2012 and 14 September 2012, and written
approval to proceed to the main trial was received in October 2012. Of the amendments approved by the
Research Ethics Committee, seven were substantial and one was non-substantial.
TABLE 2 Overview of ethics approvals and amendments by date
Date amendment approved Overview of modifications
29 April 2010 Ethics approval for trial
16 March 2011 Sample size refinement, edits to primary outcome data collection, refinements
to postal questionnaires and related participant materials
17 August 2011 Amendments relating to HES data
1 March 2012 Participant materials and consent form
7 September 2012 Post-pilot protocol revisions. Increase in invitations from 300 to 400 per practice.
Extension of follow-up to 18 months
24 June 2013 Participant materials for 18-month follow-up
7 April 2017 Protocol addendum for additional follow-up
22 August 2017 Approval for a related PhD study
PhD, Doctor of Philosophy.
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Patient and public involvement
User groups and patient public representatives were involved in the design of materials and
implementation of the trial. Older people attending a community support group and social lunch
group in the Warwickshire region were invited to review patient-facing materials, including
questionnaires, balance screening, cover letters and patient information sheets. The Trial Steering
Committee (TSC) included an independent lay member. A patient dissemination event, attended
by 48 participants and their partners or carers, was held at a University of Warwick conference
centre on completion of the trial.
Trial Steering Committee
The TSC was responsible for monitoring and supervision of trial progress.
Data Monitoring and Ethics Committee
The independent DMEC monitored ethics, safety and data integrity aspects of the trial. Pilot data
were reviewed by the TSC and DMEC; we proceeded to the main trial after approval by the DMEC,
TSC and funder.
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Chapter 3 Trial interventions
Introduction
This chapter presents a description of the trial interventions; sections are based on published work
describing the exercise and MFFP interventions.20,21 Intervention development was undertaken using
Medical Research Council guidance54 for the development of complex interventions and following
methodology used in other rehabilitation trials supported by the National Institute for Health Research
Health Technology Assessment programme.55,56 A key consideration was the selection of interventions
suitable for testing and implementation in the UK primary care setting.
Advice intervention
A scoping survey of UK falls services, referral pathways and information materials for older people
had been completed before we started the PreFIT.12 Falls prevention leaflets for older adults were
reviewed for content and clarity. The Age UK’s Staying Steady booklet22 was selected for the advice
intervention because of the positive emphasis on remaining steady and physically active. The Age
UK leaflet contained useful advice about improving strength and balance rather than focusing on the
consequences of falling. This 29-page colourful booklet provides clear information about eyesight,
hearing, foot care, managing medications, checking the home environment for falls risks and dealing
with anxiety about falling. It contains practical advice on seeking help from the NHS, contact details
and telephone numbers for other organisations for older people and links to further reading. The
leaflet was provided free of charge by Age UK. All trial participants received this booklet by post after
the GP was randomised. Those randomised to the advice arm received a booklet with a covering letter
only, then no further planned intervention.
Rationale and scientific principles for the exercise intervention
Evidence for exercise type and dose
Multiple systematic reviews have explored exercise type and dosage, finding that programmes that
included balance training programmes and those delivering higher doses of exercise had the greatest effect
on falls reduction.57,58 Programmes of walking-only interventions and those without any balance challenge
were ineffective in preventing falls. These systematic reviews led to best-practice recommendations that
exercise-based falls prevention programmes should provide a moderate to high balance challenge, should
be undertaken for at least 2 hours per week and should be delivered in either a group format or home-
based setting.58 Programmes should be of sufficient dose to induce changes in muscle strength and
neuromuscular function and be delivered by either trained health professionals or suitably qualified
exercise instructors. Other public health guidance for maintaining musculoskeletal and cardiorespiratory
health in older adults from the World Health Organization59 and American College of Sports Medicine60
recommended that strength training, or resistance exercises, targeting the major muscle groups should
be undertaken two or three times per week. Given these recommendations, we reviewed the theoretical
principles of balance and strength exercises during the process of selecting a suitable programme for
testing in the PreFIT. A detailed description of the PreFIT exercise intervention is presented elsewhere.21
An overview of principles and definitions used is given here.
Balance control in older age
Balance control is a prerequisite for successful mobility. Balance is defined as the ability to maintain
the projection of the body’s centre of mass within manageable limits of the base of support, as in
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standing, sitting or in transit to a new base of support.61,62 Balance is also a generic term describing the
dynamics of body posture to prevent falling,61 and it can be quantitatively assessed by measuring the
body’s centre of mass in relation to the base of support (e.g. sway on a force platform). It can also be
measured using self-report or by using observation and functional testing.62
Our ability to maintain balance depends on many inter-related processes (e.g. sensory information
received from visual, vestibular, proprioceptive and exteroceptive sources).62,63 Ageing is associated
with a loss of reserve capacity in several bodily systems engaged in the control of balance and gait.
Walking patterns change with increasing age: steps become shorter, push-off power is decreased and
landing becomes more flat-footed.64
Balance retraining in older people
For balance to improve, it should be challenged.65 Progression to dynamic balance exercises is
recommended, as static balance training is less likely to translate into improvements in balance during
functional activities and ADL.66 Many daily activities involve balance, such as moving from a sit to
stand position, turning while walking or bending to retrieve objects from the floor. Traditional balance
‘challenges’ include reducing the base of support or moving the body’s centre of gravity out of the base
of support, or a combination of both. Balance retraining exercises can lead to improvements in physical
activity and function. Systematic reviews have found that balance training in older adults is most
effective when exercises are performed three times per week and for at least 3 months.58,67
Evidence for strength training in older people
Evidence for strength training in older adults was also considered. Muscle strength is greatest when
young, with maximum strength peaking at age 20–40 years. By the age of 50 years, about 10% of
muscle mass has gone and, thereafter, the rate of decline accelerates.60,68 This decline is thought to be
due, in part, to decreasing levels of physical activity. The consequences of loss of muscle mass include
increased susceptibility to falls and fractures, and inability to perform everyday tasks.
Strength training is a system of physical conditioning in which muscles are exercised by being worked
against an opposing force to increase strength.62 There is good evidence to show that sedentary older
adults, with support and regular training, can achieve a two- to threefold increase in muscle strength
after 3 months of training.60 In addition to effects on muscle mass, strength training can also lead to
improvements in insulin action, bone density, energy metabolism, functional status and physical activity.60,69
There is debate about the reasons why muscles become weak and atrophied over time; lack of use may be
the major contributory factor rather than the ageing process alone. However, this may be a new concept
for many older people and for some health-care professionals. Strength training challenges our accepted
view of activity in older populations.
Selection of a suitable exercise intervention
Given the robust evidence base supporting the effectiveness of interventions targeting balance and
strength, we aimed to incorporate these elements of best practice into the exercise intervention.
The process for selection of the most suitable exercise intervention has been described in detail
elsewhere.70 In brief, we reviewed all exercise interventions reported in clinical trials included in
systematic reviews published up to 2011. We considered all exercise interventions and programmes,
although many interventions were not reported in sufficient detail to allow replication. Three
established exercise programmes were shortlisted for consideration for the PreFIT: (1) the Tinetti et al.9
exercise programme, (2) the Falls Management Exercise Programme (FaME)71 and (3) the OEP.23,72
The Tinetti et al.9 exercise programme, developed in the USA, includes progressive strength and balance
exercises, gait and transfer training and a range of motion exercises.9 The intervention also includes
upper-limb exercises, with general recommendations for weights and progression. Starting-level exercises
are predominantly chair based, and the programme also targets training in how to transfer from lying to
sitting and sitting to standing, etc. This exercise programme is not widely used in the UK.
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FaME, developed in the UK, is a 36-week group and home exercise programme incorporating fitness
with progressive ‘chain’ exercises (movement sequences to get up and down to the floor), functional
exercises and adapted tai chi.71 The FaME intervention had been tested in one secondary prevention
trial71 and was effective in reducing falls among frequent fallers when participants were provided with
transport to attend classes (this encouraged attendance). The programme was not widely used in the
UK setting at the time of the design stage of this trial. It has subsequently been proven to be an
effective primary prevention falls intervention that also increases habitual physical activity.73,74
The OEP, developed in New Zealand, is a programme of muscle-strengthening and balance-retraining
exercises delivered at home or in the clinic setting by trained health professionals. This programme
had been tested in four community-based primary prevention RCTs by the original research team,75–78
with two of these trials77,78 undertaken with those aged ≥ 80 years. The programme is individually
prescribed by a physiotherapist or trained nurse and delivered via a series of home visits. It is based
on robust physiological principles, incorporating progressive lower-limb strengthening exercises using
ankle weights and moderate- to high-challenge balance exercises, and includes a walking plan. A meta-
analysis by the Otago group of its own trials, totalling 1016 adults aged 65–97 years, randomised to
either the OEP or control, reported a 35% reduction in falls (incidence RaR 0.65, CI 95% 0.57 to 0.75)
and a reduction in fall-related injuries (OR 0.56, CI 95% 0.44 to 0.71).79 A subsequent meta-analysis
from an independent research group also found that the OEP reduced rate of falls compared with
non-exercise control intervention (six studies; incidence RaR 0.68, CI 95% 0.56 to 0.79).80
Rationale for selection of Otago exercise programme
In addition to the evidence base and consideration of essential components for inclusion in an exercise
programme, we reviewed models and configurations of service delivery identified from a national survey
of health and social care-funded UK falls services.81 The 2007 national scoping audit of UK falls clinics
reported that most localities provided group or home programmes, usually two sessions per week, over
approximately 8–12 weeks.81 As PreFIT was designed to be pragmatic rather than explanatory, we
wanted to test an exercise intervention suitable for our proposed screen-and-treat approach in primary
care, thus deliverable to older people living in the community. After further consultation with clinical
experts in falls prevention and rehabilitation, we selected the OEP for PreFIT. In addition to the robust
evidence base for clinical effectiveness, in terms of reducing falls, with clear guidance for prescription
and progression, the OEP was familiar and recognised by many services and was implemented across
a number of regions; in addition, established training schedules for different health-care personnel
already existed (a range of national accreditations were available). We also informed the original
research group from Otago, New Zealand, of our intention to test in the UK setting (approval from
Professor John Campbell, University of Otago, Otago, New Zealand, 2011, personal communication).
Public Health England has since recommended both OEP and FaME as cost-effective interventions for
use in the UK.82
Content of the PreFIT exercise intervention
Overview of programme
The PreFIT exercise intervention was entirely based on the OEP, with adaptions to the duration of the
programme to reflect the commonly used formulations in the NHS setting.81 It consisted of three core
components: (1) strength training, (2) balance retraining and (3) a walking plan. It was a home-based
programme, individually prescribed, adapted and progressed by ability. We delivered the programme
over a 6-month period, with support provided by trained physiotherapists, occupational therapists,
therapy assistants or exercise assistants. A menu of five strength exercises and 12 balance exercises was
available, with exercises prescribed according to ability. Participants were assessed at the first appointment
and then reviewed at regular intervals and progression introduced over time. We recommended six
contacts over 6 months: three face-to-face appointments and three telephone contacts. Further details
DOI: 10.3310/hta25340 Health Technology Assessment 2021 Vol. 25 No. 34
© Queen’s Printer and Controller of HMSO 2021. This work was produced by Bruce et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
19
of the exercise plan, training intensity, progression and procedures are described below, along with
minor adaptations made for trial delivery.
Prescription of strength exercises
Five strength exercises were undertaken three times per week, allowing for rest days in between.
Exercises targeted the main muscle groups in the lower limbs, including the knee flexors, knee
extensors, hip abductors, ankle dorsiflexors and ankle plantarflexors. Strength training was achieved
using ankle cuff weights starting from 0.5 kg and body weight as resistance. The aim was for
participants to achieve moderate- to high-intensity training.
Level of intensity in the PreFIT
The therapists were trained in all aspects of the programme, including how to assess intensity and
progress in individual participants. The aim was for participants to work at a moderately difficult or
difficult level during leg exercises.62 For a training stimulus to be effective, completion of 10 repetitions
should be moderately difficult or hard without loss of quality of contraction. If the leg exercises were
too easy, then the starting weight was insufficient, and if very hard, then the weight was too high.
The physiotherapist observed a participant undertaking 10 repetitions of leg exercises in a slow,
controlled manner, holding the position and then returning to the start position in a controlled way.
If the participant started to hurry movements, or used trick movements (compensation), then the weight
was adjusted. Number of repetitions and weights prescribed were based on baseline assessment using the
CST to assess lower-leg strength, as recommended in the original programme.
Principles of progression
Progression of exercise is necessary to maintain improvement and to prevent plateau or potential
reversal of training effects. Progression refers to the training load or overload, with overload meaning
having to work longer or harder than normal; this is required for adaptation. The body gradually adapts
to exercise repetitions and increasing weights over time; thus, overload should be applied again to
progress and improve further.83 If prescribed exercises are increased too quickly, this can hamper
progression, lead to demotivation and result in injury. Related to progression, the principles of rest and
recovery are also important because the amount of rest between different sets of resistance exercises
can affect the metabolic, hormonal and cardiovascular response to exercise. Overexercising can lead to
pain and muscle injury; thus, it was important to ensure that rest days were included in the programme,
to allow muscle fibres a chance to rebuild and recover.
Prescription of balance exercises
The OEP includes a menu of 12 static and progressively dynamic balance exercises of varying levels
of challenge. Balance exercises are done on at least 3 days per week, although they can be done every
day. Exercises at appropriate level were prescribed according to ability during the first appointment
and assessment using the 4TBS. These exercises progressed from supported balance challenge movements,
(e.g. tandem stand holding onto a work surface) to more complex, unsupported movements (e.g. backwards
heel-to-toe walking).
Prescription of a walking plan
Research investigating the effectiveness of walking-only interventions has found no impact on falls or
fall-related injuries. Indeed, some studies have reported an increased risk of falls in certain environments,
such as walking outdoors on uneven pavements.84 However, general public health guidance and the
American College of Sports Medicine recommend that older people should walk 5 days per week.60
The OEP includes a walking plan of 30 minutes at least twice per week to increase physical capacity.
The PreFIT adhered to the original programme; thus, it recommended walking, but only in conjunction
with the strength and balance exercises. The walking plan advice was to walk at the usual pace for up
to 30 minutes at least twice per week. Outdoor walking was recommended if the physiotherapist felt
that it was safe for participants. Walks could be broken up into shorter sessions (e.g. three 10-minute
daily walks) and recommendations were given about how to incorporate walking into daily activities.
TRIAL INTERVENTIONS
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Procedures for delivery of the PreFIT exercise intervention
Staff expertise and training
To ensure standardisation of intervention delivery, two research physiotherapists became fully
qualified OEP leaders [Vivien Nichols and Susanne Finnegan; Later Life training (Later Life Training
Ltd, Killin, UK) completed 2012]. Training was supported by the research team (JB; Later Life training
completed March 2011). Trial staff members provided a 5-hour structured staff training session to all
therapists responsible for delivering the exercise intervention. Therapists included physiotherapists,
occupational therapists, therapy assistants and exercise therapists or instructors. Training included
the key skills and competencies for delivery, including correct exercise techniques, motivational and
support strategies for adherence, and the roles and responsibilities expected of therapists participating
in a research trial. Each therapist received a comprehensive manual containing a detailed description of
all intervention procedures along with a training certificate for continuing professional development.
Location of intervention delivery
We designed the exercise intervention for completion by participants at home, but exercises could be
undertaken in a group venue or exercise class led by the trained therapist if this option was available
within a region. However, it was a prerequisite that any group-based session delivered the exact
PreFIT programme, with individual adaption for each participant.
Recommended number of contacts throughout the intervention
In the original OEP trials every trial participant received up to five home visits (after the assessment)
over 12 months. This model of multiple home visits to older people was not feasible in the UK NHS
setting. For the PreFIT, six contacts were recommended, of which at least three were to be face-to-face
sessions (including the assessment) in the outpatient or community clinic setting and the remainder could
be telephone calls. The first and final appointments were individual clinic appointments to last for 1 hour,
with interim appointments being shorter (up to 30 minutes each). The purpose of the follow-up sessions
was to assess progress, to increase resistance by providing heavier ankle weights or increasing repetitions
and to prescribe more challenging balance exercises.
Duration of PreFIT exercise intervention
We recommended a 6-month supported exercise programme. This is longer than current usual NHS
practice: most services provide strength and balance training for between 8 and 12 weeks.12,13 There is
good evidence to suggest that exercise programmes of longer duration, that is > 3 months, are required to
sustain physical benefits.58 We considered our 6-month programme to be the most we could reasonably
expect the NHS to provide.
First appointment with trial participant
The first 1-hour appointment was arranged in an outpatient clinic, community venue or at home.
The purpose of the first assessment was to conduct a brief health check, undertake baseline tests of
strength and balance and to prescribe the exercise programme. The therapist first assessed general
health, current fitness and walking ability before undertaking strength and balance tests. General
health was screened by asking about any cardiovascular disease, osteoarthritis or rheumatoid arthritis,
chronic lung disease or Parkinson’s disease, cerebrovascular disease and whether or not an inhaler
or angina spray was used. The baseline tests were simple and quick, and valid and reliable tests of
lower-limb strength and balance were used to determine starting level of exercise prescription.85
Assessment of strength: chair stand test
The CST, a proxy measure of lower limb strength, was used to inform the prescription of strength
exercises and to determine the starting level of ankle cuff weights. The test involves timing how long
it takes to perform five consecutive sit-to-stand movements starting in a sitting position in a straight-
backed firm chair, preferably with no arms, placed against a wall for safety.23 We developed a detailed
trial intervention protocol to standardise all procedures and tests.21 The findings of the CST were used
to determine starting weight and/or repetitions based on performance during the test (Table 3).
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Balance assessment: 4-test balance scale
The 4TBS, used in the original programme, involves four increasingly difficult, timed, static balance
challenges: (1) the feet-together stand, (2) the semi-tandem stand, (3) the tandem stand and (4) a
single-leg stand.66,85 The test is performed with the participant in bare feet, standing close to a wall or
solid object for safety, but without aids. The assessor can help the participant assume the correct foot
position, but progression to the next test is allowed only if a stance can be held independently for
10 seconds (see Table 3). If this is not achieved, or if support is required, then the test is then stopped
and the participant is scored at the level that can be completed.
Overview of exercises
Strength and balance exercises were carried out three times per week, but balance exercises could be
undertaken daily.
Warm-up exercises
Warm-up exercises comprised five gentle mobility movements of the neck, shoulders, trunk, hips,
knees and ankles, and it was recommended that these be undertaken before any strength and
balance exercise.
TABLE 3 The PreFIT assessment criteria for strength and balance23
Level
CST: criteria for prescribing strength
exercises 4TBS: criteria for prescribing balance exercises Score
1 Poor strength: completed CST using arms or
took > 2 minutes with arms folded (failed test).
These individuals are very weak
Weight: start with a light weight (e.g. 0.5 kg)
and possibly no weight at all
Repetitions: consider a lower number of
repetitions (e.g. five to eight repetitions)
Failed balance test: poor balance, has difficulty
with feet together stand or can only achieve
feet-together stand
Select from only level 1 balance exercises
1
2 CST successfully completed between 1 and
2 minutes: able to stand from chair but still
fairly weak
Weight: start with a lighter weight (e.g. 0.5 kg)
Repetitions: aim for 8 to 10 repetitions if
comfortable
Managed some of balance test. Fairly good
balance. Can achieve semi tandem stand
Start by selecting level 2 balance exercises
and moderate according to how the participant
manages
2
3 CST successful: good strength (e.g. five stands
within 1 minute)
Weight: use a reasonable starting weight
(e.g. 1 kg)
Repetitions: prescribe either one or two sets of
10 repetitions
Managed most but not all of balance test. Good
balance. Can achieve semi-tandem stand and can
partially or completely hold the tandem stand
Start by selecting both level 2 and 3 balance
exercises and moderate according to how the
participant manages
3
4 CST successful: very good strength (e.g. five
rises within 30 seconds)
Weight: use heavier weights (e.g. 1 kg or
possibly 1.5 kg)
Repetitions: you may need to prescribe more
than 10 repetitions for patients to feel that the
challenge has been moderately difficult
Balance test successful. Excellent balance
that will need quite a challenge to improve it.
Can achieve single-leg stand
Consider starting with level 4 exercises, but
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Strength exercises
Strength exercises included front and back knee strengthening (knee extensors and flexors), side
strengthening (hip abductors), and calf and toe raises (ankle plantarflexors and dorsiflexors). Ankle
cuff weights were used for the knee and hip exercises, with training in how to safely apply and
remove weights.
Balance exercises
Twelve static and dynamic balance exercises of four levels of difficulty were included, from a tandem
stand with support (level 1) to backwards heel-to-toe walking without support (level 4).
The programme took approximately 30 minutes to complete, excluding the walking plan. The therapist
explained and demonstrated each prescribed exercise and observed the participant performing the
exercises to ensure that participants were confident in undertaking them independently at home.
Materials given to trial participants
At the first appointment, participants received an A5-sized PreFIT exercise folder with pictures and
instructions for every exercise, with supporting information written in large font. The folder included
exercise diaries and general advice about physical activity and walking. The therapist could personalise
each folder by adding his/her name, contact details, details of next appointments and any additional
instructions about which exercises to focus on from the longer menu, according to ability. A set of
ankle cuff weights were provided and these were replaced with heavier weights as people progressed
over time.
Follow-up appointments and telephone calls
Follow-up appointments were recommended at 3 and 6 weeks and at 3, 4 and 5 months, with a final
assessment at 6 months. The purpose of the follow-up contacts was to modify exercise prescription
and to review, adapt and progress exercises when appropriate. Progression was essential to ensure
that physiological challenges continued as fitness and functional ability improved.58 Therapists were
encouraged to provide additional behavioural support to encourage compliance and motivation.23
Follow-up telephone calls were expected to last approximately 10 minutes, although actual duration
varied. The Otago research team recommended a schedule of regular telephoning to enhance
compliance.66 We provided therapists with a simple checklist of points to discuss during follow-up
telephone calls.
Final appointment
The final face-to-face appointment, lasting 1 hour, was arranged at approximately 6 months after the
initial appointment and baseline tests were repeated. On discharge, participants were encouraged to
continue with their exercise programme and were given a ‘staying active’ leaflet, which was designed
for the trial. This leaflet outlined information about purchasing weights, the benefits of continued
exercise and details of other opportunities for exercising in the local area.
Comparison between the PreFIT intervention and original Otago exercise programme
Differences between the trial intervention and the original OEP included a 6-month rather than 1-year
intervention, and reduction from approximately six home visits to a recommended minimum of three
face-to-face contacts (and three telephone calls) with a trained therapist at a suitable venue. Given the
pragmatic nature of the trial, it was not feasible to investigate a highly resource-intensive intervention
that would not be suitable for large-scale roll-out across the NHS. Other than these adaptations,
the original OEP was delivered as recommended. We developed additional trial-related supporting
materials for therapists, to aid with exercise prescription, progression and telephone calls, but no
changes were made to participant materials, exercise diagrams or instructions.
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Exercise adherence
Adherence to exercise can be challenging, especially over long periods.66 Therapists were trained to
encourage participants to be actively involved in the decision-making process regarding exercise
selection and goal-setting. The positive outcomes associated with exercise and walking were emphasised,
such as maintaining independence and remaining active, rather than reduction or prevention of falls.86
Calendars or diaries can improve adherence to exercise.87 These were provided in participant folders
to serve as a reminder to exercise and as a prompt to self-monitor behaviour. Diaries were reviewed
at follow-up appointments and therapists provided positive and constructive feedback.88 Additional
behaviour change techniques included action planning, identification of barriers to exercise and use
of problem-solving strategies, including SMART (specific, measurable, achievable, relevant and timely)
goal-setting to motivate participants to continue exercising.88
Data collection
Therapists completed a detailed exercise treatment log for each participant. At the final assessment,
participants and therapists were asked to report whether or not they felt that they had improved in
strength, balance and walking. Complete copies of anonymised treatment logs were returned to the
study office for data entry and analysis.
Exercise quality control assessments
A research physiotherapist (SF) visited intervention sites to conduct quality control assessments. Every
therapist responsible for intervention delivery was visited at least once. These visits were arranged
shortly after completion of training and after the therapist had undertaken one or more assessments
of trial participants. The aim was to ensure that the intervention was delivered in a standardised manner,
in accordance with the trial protocol and therapist training. The quality control assessor considered
therapist competency in all aspects of intervention delivery. At least one appointment, either the
baseline or a follow-up contact, was observed by the quality control assessor. We used a standardised
checklist to monitor exercise prescription and effective and safe delivery of the programme, including
progression and adherence to the protocol. Checks were made of all trial-related documentation, including
appointment spreadsheets, prescription logs, treatment forms, withdrawal forms and procedures for
AE reporting. Each therapist received a written, graded report (satisfactory, minor concerns or serious
concerns) and follow-up visits were arranged if necessary. The research physiotherapist provided
regular clinical supervision and support to therapists throughout the duration of the trial. A password-
protected online forum was developed for all therapists to post questions or comments and share
experiences about the trial.
Multifactorial falls prevention intervention
Connecticut multifactorial falls prevention model
For the PreFIT, we selected the original MFFP intervention developed by Tinetti et al.9 as the model
of choice. This programme was one of the first developed and reported the greatest reduction in
falling, that is, by more than 30%.9 This falls prevention programme was developed and tested by the
Connecticut Collaboration for Fall Prevention, based at Yale University School of Medicine, New Haven,
CT, USA.9,89 The common problems and hazards associated with falling included difficulties with walking
or moving around, multiple medications, tripping hazards, postural hypotension, visual problems, foot
problems and unsafe footwear. The original 1994 protocol was developed using a consensus approach
with experienced geriatricians, physical therapists, and home care and rehabilitation nurses. The core
components of the ‘Tinetti MFFP model’ included assessment and treatment of different risk factors,
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including (1) impairments of gait, transfers or balance, (2) four or more medications or culprit medications,
(3) postural hypotension or dizziness, (4) perception and sensory deficits, including of vision or hearing or
decreased sense of foot positioning, (5) foot or footwear problems (pain, numbness, bunions, etc.) and
(6) environmental hazards. The clinical model has been tested and found to be effective in clinical trials,
with practitioners adhering to assessment and treatment components.9 A detailed description of the
PreFIT MFFP intervention is presented elsewhere.20 An overview of principles and definitions used is
given here.
Falls services in the UK
At the time of PreFIT development, many different models of MFFP services were being delivered across
the UK. The 2007 national scoping audit of UK falls clinics found that most MFFP services consisted
of multidisciplinary teams (92%), although these varied widely in size, format and clinical professional
representation.81 All of the 231 UK services responding to the national audit conducted multifactorial
assessment, with the most common risk factors assessed being gait and balance (91%), environment
hazards (76%), medications (72%), cardiovascular health (69%) and, to a lesser extent, vision (58%). Fewer
than half of services assessed feet, bone health or hearing, although some clinics involved podiatrists and
specialist dietetic staff. Most MFFP clinics surveyed (83%) reported matching treatment to the findings of
assessments, and the most frequently provided treatments were provision of information (e.g. leaflets or
education; 94%), exercise (89%) and referral for medication review (66%).81
Adaption of Tinetti et al.9 multifactorial falls prevention model for PreFIT
The protocol and materials developed by the Connecticut research team are publicly available for use
by other clinical teams.9,90 We reviewed the risk factors and US treatment pathways, with modifications
to align with current UK recommendations for falls risk assessment and treatment, and considered
suitability for widespread administration within UK primary care. We adapted and updated the original
Tinetti et al.9 programme to comply with the latest evidence at time of intervention development
(e.g. NICE,11 American Geriatrics Society and British Geriatrics Society2 guidelines), developed from
in-depth, high-quality systematic reviews of falls prevention and treatment literature. The PreFIT
MFFP intervention therefore complied with latest research evidence and policy guidance at the time
of trial launch.
Overview of PreFIT multifactorial falls prevention intervention delivery
The most feasible and generalisable model, given the large trial population involved, was for MFFP
delivery to be embedded within primary care services or local community, multidisciplinary falls
services. Assessment and treatment by secondary care specialist services, when available, was also an
acceptable model of delivery. The final PreFIT MFFP intervention comprised an assessment performed
in the GP, community or general hospital, by a GP nurse, research nurse or equivalent registered
health-care professional, or by a community or hospital-based falls team. The location of the falls
assessment varied by region. Appointments with participants were booked for 1 hour. The core
components of the MFFP intervention included assessment and treatment of seven risk factors. The
assessor conducted a detailed falls history interview, with careful consideration of potential red flags,
followed by screening assessment of balance and gait [timed up and go test (TUG)], vision (Snellen eye
chart test), medication screen, cardiac screen (lying and standing blood pressure), feet and footwear
screen, and home environment assessment. Every risk factor is assessed in every person referred to
the MFFP. The PreFIT MFFP assessment is followed by recommendations or further onward referral to
another service, when indicated. Risk assessment was linked to recommended treatment pathways;
however, treatment or intervention was required only when a particular risk factor was identified.
Participants with impaired gait and balance or fear of falling were referred to the PreFIT exercise
intervention. Onward referral to exercise therapy was consistent with all models of MFFP delivery and
this did not represent contamination between the intervention arms. Content of PreFIT MFFP assessment
describes the individual risk factors in detail, with brief explanation about the rationale for inclusion.
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Content of PreFIT MFFP assessment
Sections of text in this chapter have been published in an open access journal and adhere to the




The purpose of eliciting a falls history is to identify and explore any predisposing factors leading to a
fall, because careful exploration of context can provide clues about causation. Eliciting a falls history
involves good communication skills and systematic enquiry about fall-related events. Assessors are
trained in obtaining a clear story of one specific event, usually the most recent fall. Falls can occur
in those with mixtures of characteristics, some of which might increase falls risk in a specific context.
The risk of falling increases as the number of these risk factors increases; thus, any context can
be described in terms of the ‘falls hazards’ that they contain. The magnitude of association of a
fall with any intrinsic or environmental factor is not fixed; rather, it is contingent on additional
factors influencing performance of the specific activity in question. The question is not only why
the participant is prone to falling, but also why they fell on that particular occasion. This approach
leads to identification of intrinsic risk factors, hazardous activities and environmental challenges,
any of which may then be amenable to modification.
The PreFIT health-care assessors were trained in systematic enquiry, including the elicitation of
symptoms and contextual factors that occurred before, during and after any fall-related ‘event’,
including trips and stumbles. Another factor they explored was fear or worry about falling. Fear of
falling is common in older adults and is associated with poor balance, falls, anxiety and depression.
These fears may be reasonable, and suggest that the individual has good awareness about actual falls
risk, or may be exaggerated, suggesting that the person might be overly anxious. The assessment of
‘red flags’ is integrated with the taking of falls history, although it is listed as a separate risk factor on
intervention materials. Training sessions covered how to follow relevant leads in a conversation and the
use of open, exploratory and closed questions. Interviews were conducted at an appropriate pace and
interviewers were instructed not to rush the participants and not to interrupt inappropriately while
participants were explaining events.
Screen for red flags
‘Red flags’ are any warning signs from the falls assessment that warrant referral to medical care from
a general practitioner or medical specialist (e.g. suspected cardiac abnormalities, history of syncope).
Assessors were trained in exploration of the combination of risk characteristics, which requires clinical
judgement and the ability to link different risk factors. There are no standard, validated algorithms or
interview templates, despite clinical guidelines recommending that detailed falls history interviews
should be taken with every older person who falls. Therefore, with input from experienced consultant
geriatricians, and after observation of falls interviews with hospitalised older adults, we developed a
PreFIT template of prompt questions for a falls interview. The list of prompt questions was included in
the MFFP intervention manual.
Balance and gait
Mobility is assessed using the TUG, which is a simple test to assess functional mobility.91 The TUG
involves observation and measurement of the time taken for someone to stand up from a standard
chair, with arms of height 40–50 cm from the seat, walk forwards a distance of 3 metres at a normal
walking pace, turn and walk back to the original sitting position. Total time taken is recorded in
seconds. The chair arms can be used to push off, if needed.92 The test is undertaken while wearing
shoes and using any usual walking aid. The exact distance is measured and marked on the floor using
coloured tape. Assessors are trained to look for any gait problems during the test and also at other
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times (e.g. on entering the assessment room). Observations are made of walking, including stride
length, foot clearance, veering to one side and grabbing or lunging for room furniture. Many different
cut-off points on the TUG have been used. For the PreFIT, a 14-second cut-off point on the test was
taken as being predictive of falls in community-dwelling older adults.92 This threshold was then used to
generate onward referral to the PreFIT exercise programme for strength and balance retraining. Any
other deficits, gait or balance problems, or fear of falling, were criteria that could warrant referral to
the local PreFIT exercise programme.
Postural (orthostatic) hypotension
The prevalence of postural hypotension increases with age as a result of deterioration of the postural
compensatory mechanisms. Postural hypotension can occur in people with neurodegenerative disorders,
Parkinson’s disease and disorders that affect the autonomic nerves.93 Postural hypotension can be a
benign, transient event (e.g. light-headedness due to dehydration, fever, infection, overexertion or from
exercise). Symptoms of postural hypotension include light-headedness, dizziness, presyncope or feeling
faint, and syncope (fainting)]. Some patients present with more general complaints, including fatigue,
weakness, cognitive slowing, leg buckling, visual disturbances or chest pain.93 Loss of consciousness is
usually of gradual onset but may occur suddenly. Syncope refers to a transient loss of consciousness
with spontaneous recovery within minutes, and can be caused by loss of blood flow to the brain. Syncope
is usually a transient occurrence that resolves as soon as pulse and blood pressure return to normal.
Syncope may not necessarily mean serious medical disease; however, it is important to determine the
cause. Other causes of loss of consciousness may be traumatic or non-traumatic.93
We used a standard definition for postural or orthostatic hypotension: ‘a sustained reduction of systolic
blood pressure of at least 20mmHg or a drop in systolic blood pressure to below 100mmHg, or a reduction
of diastolic blood pressure of 10mmHg within three minutes of standing’.93 All participants were asked
about previous symptoms or episodes of dizziness or light-headedness, and lying and standing blood
pressure were measured using a calibrated, manual or electronic, sphygmomanometer. The radial pulse
was taken for a full minute while the participant was lying down and electrocardiography was carried out if
any abnormalities were suspected. The assessor enquired about symptoms of dizziness or light-headedness
during the standing phase. Symptomatic participants received a postural hypotension leaflet, which provides
advice about changing position, fluid intake, etc. Any participant with postural hypotension was referred for
a full general practitioner-led medication review. If postural hypotension continued after medication review
and modification, then referral to a local consultant-led falls service was recommended. The intervention
manual details the recommended onward referral pathways if other problems are suspected.
Polypharmacy
With increasing age, people take increasing numbers of prescription medications, over-the-counter
medications and other supplements. Four in five adults aged > 75 years take at least one regular prescribed
medicine, and one-third take four or more medications.94 Multiple medications compromise adherence and
increase the likelihood of adverse medication effects. Some studies report that patients take, on average,
only half of their prescribed medications as intended, and the more medications prescribed, the lower
the adherence.95 Ageing also affects capacity to absorb and excrete medicines. The risk of an AE increases
10% with each additional medication, approaching 100% for persons taking 10 or more medications.9
Many adverse reactions to medicines could be prevented, and symptom prevention and control should
be carefully balanced against the AEs of multiple medications.94 In the absence of an easy method for
determining net benefit compared with the harm of a total medication regimen, we trained GP staff in
both general principles and specific steps that can lessen the likelihood of AEs of multiple medications.
Culprit medications
The original Tinetti et al.9 programme, from 1994, highlighted specific classes of high-risk or ‘culprit’
medications. These included antihypertensives, antiarrhythmics, anticonvulsants and antidepressants
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among many others. Others96 have since defined the main culprit medications contributing to risk of
falls as those targeting the central nervous system. Other classes of drugs, although the evidence
base for the causal relationship with falls is weaker, include urinary anticholinergics and alpha-
blockers.96,97 In 2010, the National Audit of Falls and Bone Health in Older People specifically
highlighted psychotropic medication and night sedation as potential causes of falling.6 We considered
the available evidence to inform the format of the PreFIT medication review. We used the national
audit6 and the UK Department of Health and Social Care (DHSC) policy as guidance.94 This policy
document described different levels of review (from level 0 to level 3), relating to intensity of review,
skill of assessor and whether or not the review was conducted in the presence of the patient.
PreFIT medication reviews
In the PreFIT, two levels of medication reviews were carried out: first, the assessor screened all drugs
prescribed to every participant attending a MFFP assessment. This involved a face-to-face discussion
about prescribed drugs and use of over-the-counter drugs during the MFFP assessment, as per DHSC
level-1 review. This initial screen was for high-risk medications based on our own PreFIT classification
and listing of (1) psychotropics and (2) other culprit medications. Psychotropic medications included
any antidepressant, antipsychotic, sedative or anxiolytic, or mood stabiliser drugs. Other culprit
medications included antihypertensives, antiarrhythmics, diuretics, vestibular suppressants, analgesics,
anticonvulsants, anti-Parkinson drugs and vasodilators. Any participant prescribed one or more of
these drugs was then referred for a more detailed review, that is, a general practitioner-led clinical
medication review, corresponding to a level-3 review.94 This involves a separate appointment between
only the participant and general practitioner, either face to face or by telephone if the medication
revision is considered minor. One or more nominated general practitioners from each practice were
given training on high-risk medications in older adults, risks of polypharmacy and how to conduct
a falls-related medication review. A consultant geriatrician or specialist registrar, supported by a
member of the trial team, delivered training to general practitioners. Every GP randomised to MFFP
intervention received medication review training.
Risk assessment: visual acuity
Vision makes an important contribution to balance. Control of posture, balance and movement involves
a co-ordinated set of sensory processes that continuously encodes information from visual, body-
awareness (proprioception), sensorimotor and cognitive sources.98 The impact of visual information in
the role of maintaining balance can be demonstrated by standing with our eyes closed; postural sway
increases by between 20% and 70%.99 As we age, our ability to judge distances, to detect low-contrast
hazards and to process moving visual information reduces. Older people take longer to adapt to multiple
sensory cues, particularly moving visual information, which can increase the risk of postural instability
and falls. Impaired visual acuity (sharpness or fine detail of vision) is a risk factor for falls. Impairments
in other systems, such as vestibular function, increase the importance of vision for maintaining balance
during movement.
Conditions affecting vision in older adults include degenerative changes and loss of ability to accommodate
to close objects (the process by which the eye can focus and adjust to different distances from objects).
Eye disease in older adults can include cataracts, glaucoma and age-related macular degeneration.
Cataracts develop mostly in those aged > 55 years and can interfere with vision. Signs and symptoms
include blurred or hazy vision, reduced intensity of colours, increased sensitivity to glare from lights,
increased difficulty with nocturnal vision and changes in the eye’s refractive error. These changes can
be very gradual; however, as they worsen, visual symptoms increase in severity. Early research studies
examining whether or not having glaucoma or cataracts increased the risk of falls were inconsistent.
However, one high-quality trial found that expedited (within 1 month) surgery in women with cataract
reduced the risk of recurrent falls and fractures compared with the usual NHS 12-month wait.100
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Other common visual problems in older adults relate to the wearing of glasses with an outdated
prescription. People may be unaware of their declining vision or may not perceive the benefits of
regular vision assessments.99 Cost and/or reduced access to eye care may also be a barrier to regular
vision checks, although eye checks are free for adults aged > 70 years in the UK. Studies have found
that wearing bifocal glasses impairs the ability of older people to negotiate obstacles and can alter
normal step pattern.57 When followed for 1 year, older adults who wore bifocal glasses were found to
be twice as likely to fall as those who wore single-vision lens glasses.98 Bifocal glasses can add to the
risk of falls because near-vision lenses impair distance vision and change depth perception, affecting
the ability to detect environmental hazards.99 Therefore, older people prone to falls should avoid
wearing multifocal or bifocal glasses.
The NICE clinical practice guideline11 reviewed studies of visual interventions and concluded that there
was insufficient evidence that single interventions targeting vision impairment alone prevented falls,
but that referral for visual correction within a multifactorial intervention was recommended. Additional
benefits from visual interventions include improvements in QoL.11,101
Vision assessment
We asked assessors to test visual acuity using a standard 3-metre Snellen eye chart test; we chose
this chart because it is used more often in primary care than a 6-metre chart because of typical room
size. The Snellen chart is a screening tool and is used in conjunction with questions about last eye
check and changes in eyesight to detect any visual problems.20 Participants were asked to bring their
spectacles because distance vision spectacles can be worn during the sight test. The test is carried out
with the individual standing or sitting 3 metres from the chart, with the distance clearly marked on the
floor using tape.20 Anyone scoring less than 6 out of 6 in either eye should be referred to an optician
for an eye test. Participants were encouraged to take advantage of the free annual eye check to which
they are entitled. Whether or not treatment of cataracts was recommended was based on the level of
visual impairment. If vision is barely affected, no treatment is necessary, although regular check-ups
are recommended.20 When a cataract affects QoL, surgery is recommended.102,103 However, in the
PreFIT, if we suspected a cataract and that this was having an impact on functional activities,
we recommended immediate referral to an optician in the first instance.
Risk assessment: foot problems
Up to one-third of older people suffer from foot problems, such as foot pain, toe deformity, weakness
or restricted range of motion.104,105 These problems are common reasons for attending primary care
services. Other UK foot surveys suggest that the main foot conditions affecting older people include
nail problems, corns, calluses and toe deformities.106 Foot problems can lead to falling: studies of
multiple fallers suggest that they are more likely to have foot pain or foot deformity.104 Inappropriate
footwear and the presence of a corn or bunion are also independent risk factors for falls.107 Shoes with
an elevated heel of even medium height (4.5 cm) can increase postural sway and impair overall balance
performance.108 Other types of inappropriate footwear include shoes without straps or buckles, shoes
with reduced sole contact area, soft-soled shoes and those without heel support.104,108,109
The efficacy of including foot, footwear or podiatry assessments within MFFP has been reviewed
by NICE and in Cochrane systematic reviews.11,15,57,110 These assessments found no overall conclusive
evidence of benefit of a stand-alone foot assessment and treatment interventions for preventing falls.
Although policy statements agree that examination of the feet and simple footwear advice should be
included within any MFFP programme, these guidelines do not specify the type or composition of
assessment or specific interventions.11
One trial104 found that a multifaceted podiatry intervention reduced the rate of falls in community-
dwelling older adults with disabling foot pain compared with routine podiatry care. Rate of falls and
fractures were lower in the intervention group and strength, balance and foot range of motion were
also significantly improved compared with those receiving usual podiatry care.104 Given that UK policy
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falls assessment guidance recommends that feet and footwear examination and appropriate treatment
should be undertaken, albeit unspecified, we developed a bespoke PreFIT foot assessment protocol and
onward referral pathway.
Foot and footwear assessment
All participants were screened for foot problems, including pain, numbness, diabetes and regular
attendance at chiropody or podiatry. A visual examination was made to check for bunions, hammertoes,
calluses or toenails that may cause pain or gait disturbances. Tests were undertaken for proprioception
(big-toe positioning with eyes closed) and for sensation by brushing a cotton wool ball lightly across both
feet, with the sternum used as normative reference. Assessment of footwear was undertaken and an
advice leaflet was given on proper-fitting shoes (e.g. wide fitting, low heel height, slightly bevelled heel,
good supportive heel collar, a thin firm midsole to allow sensory input and slip-resistant sole). Referrals
were made to podiatry or chiropody if these services were available in the local area.
Risk factor: environmental hazards
Policy-makers and older people often cite environmental hazards in the home as risk factors for falling.2,11
However, it is difficult to single out the most effective intervention within any home environment
assessment or modification programme. One good-quality trial111 found that home hazard assessment
with a supervised modification programme reduced falls in those recently discharged from hospital.
However, the association between domestic hazards and falling has been controversial. In those without
a history of falls, there is no evidence of clinical effectiveness of home hazard asessments.11 Six secondary
prevention trials of home hazard modification interventions have reported effectiveness, although this
observed effect is unlikely to be from the home interventions alone, because of the reductions in falls that
occurred outside the home.11,15 Home hazard removal and advice about functional activities is likely to be
most effective in reducing falls in those individuals with visual impairment.15
Benefit is achieved only if home hazard assessment includes a comprehensive functional assessment
followed up with specific intervention. This, however, applies to all components of assessment and
intervention programmes, not just home hazards. There is no evidence to support screening for
home hazards without direct observation of the individual carrying out functional tasks in their
home environment.112,113 The American Geriatrics Society and British Geriatrics Society guidance2
states that interventions should include the adaptation or modification of the home environment to
mitigate hazards as well as evaluation and intervention to promote the safe performance of daily
activities. Joint problem-solving is also recommended.114
Assessment of environmental hazards
It was not intended that all participants would have a home assessment, but if assessors had any concerns
about the home situation or participants’ safety when performing activities then they made an onward
referral to occupational therapy or social services. In 2004, NICE guidance specified that a suitably trained
member of the health-care team (clinician, occupational therapist, nurse, physiotherapist or other trained
assessor) could conduct home hazard assessments.11 Home environment screening questions were used as
per the intervention manual and in conjunction with observation during the walking test.20 All participants
in the MFFP arm who might benefit from simple advice on home safety received the home safety tip
sheet. This advice sheet covers common hazards and tripping risks, putting lights on when rising to the
bathroom in the middle of the night, how to seek help for installation of handrails, raised toilet seats, etc.
Factors not included in the PreFIT multifactorial falls prevention assessment
Detailed tests of urinary incontinence, hearing, osteoporosis risk and comprehensive assessment of
neurological and cardiac systems are not part of the MFFP package. The falls interview included screening
questions on urinary incontinence in relation to any fall or near-miss event. At the time of development,
none of the published clinical trials investigating MFFP included screening of osteoporotic risk, although
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in many cases the description of intervention content was inadequate.15 We purposefully excluded the
addition of a protocol that included provision of bisphosphonates and bone medications to avoid the
possibility of interpreting MFFP as effective when medications could have been responsible for any
observed effect. We were cognisant of the different clinical backgrounds of assessors and barriers to
accessing trained medical practitioners in some settings. Safety was also a consideration; for example,
we did not ask assessors to undertake carotid artery stimulation to check for carotid sinus hypersensitivity.
Staff training
Health-care staff responsible for delivering the MFFP intervention received 4–5 hours of structured
training, either in the GP or in hospital. Health-care staff members undertaking falls assessments
ranged from experienced falls team personnel (consultant geriatricians, falls nurses, occupational
therapists or physiotherapists) to GP or research staff members (e.g. advanced nurse practitioners,
practice nurses and/or research nurses). Staff members were required to have a nursing or allied
health-care background with professional registration. Training in medication reviews was given either
to one nominated lead general practitioner or to all general practitioners in each GP randomised to
MFFP as a scheduled educational session. A geriatrician with extensive experience in falls assessment
(RS, KW, SR or JT) and senior researcher from the trial team jointly provided training (JB). Each
assessor received a detailed intervention reference manual before training, which described risk
factors, treatment pathways, trial procedures, flow charts for onward referral, etc. Laminated prompt
charts and easy-to-use instruction sheets were provided (e.g. for medication assessments).
Recommended treatments
Assessors provided verbal and written advice to trial participants and also arranged onward referrals to
consultant-led falls services, physiotherapy, GPs, occupational therapy, social services, etc., as per the
treatment pathways we recommended for each risk factor and as per detailed manuals and the published
intervention paper.20 Trial intervention manuals will be available from the University of Warwick repository
(http://wrap.warwick.ac.uk/85689/; accessed 7 October 2020).
Data collection
Assessors completed a MFFP risk assessment form for every participant randomised to MFFP. All risk
factors and test findings were recorded. For onward actions or referrals, the date of referral was recorded,
as was the name of person or doctor referred to. Completed copies of falls risk assessment forms with
study identification number (name redacted) were returned to the study office for data entry and analysis.
Multifactorial falls prevention quality control assessments
Each trained assessor was observed while carrying out a falls assessment (with verbal permission from
the participant) to ensure compliance with the intervention procedures. These quality control visits
were carried out, after the assessor had been trained and carried out one or more MFFP assessments,
by trial staff members (JB or SF) or by a consultant geriatrician (RS) or, in the Devon region, by a medical
registrar with expertise in falls assessments (Lindsey Rohan or Meera Sritharan). A 37-item standardised
checklist was developed and used to ensure that all aspects of the MFFP assessment were reviewed during
each quality control visit. No input was given during the quality control assessment, unless the assessor
queried a specific issue. A written, signed, graded (satisfactory, minor concerns or serious concerns)
report was given to assessors, with a follow-up visit arranged if necessary. The research team provided
regular supervision and support to therapists throughout the duration of the trial. Experienced medical
staff members were available to deal with any complex clinical queries (KW and RS).
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Trial recruitment started in September 2010, with a pilot phase conducted in 12 GPs in Devon to
refine procedures. Recruitment paused from March to September 2012, while pilot data were reviewed
by the funder, and restarted in September 2012. The final GPs were randomised in June 2014 and
postal follow-up finished in 2016. NHS Digital provided final HES data sets including data up to the end
of March 2016 in 2018. Data from all phases of the trial were combined for the analysis because there
were minimal changes after the pilot.
Cluster (general practice)-level data
Information and advertisements about the trial were widely distributed via primary care newsletters
and regional primary care research events. We received expressions of interest from 82 GPs. Sixty-three
GPs were randomised from six localities across England: Birmingham and the Black Country (n = 2),
Cambridgeshire (n = 6), Devon (n = 18), Warwickshire and Herefordshire (n = 12), Newcastle upon Tyne
(n = 11) and Worcestershire (n = 14). We exceeded our GP recruitment target because we had three GPs
already prepared for study entry at the time we randomised our 60th GP. The final triad of GPs was
randomised and split across two different regions (Newcastle upon Tyne, and Birmingham and the Black
Country). No GPs withdrew from the study. One GP closed down after recruitment and completion of
intervention delivery, and the participants were registered with a new GP. This did not affect participant
follow-up. We were, however, unable to obtain GP records for participants from this surgery. Figure 1
presents the cluster CONSORT flow chart for GPs.19
Sociodemographic characteristics of recruited general practices
Of the 63 GPs, 13 (21%) were in areas of social deprivation (score 1–3), 22 (35%) were in affluent
areas (score 8–10) and the remainder were categorised as moderate [n = 28 (44%); score 4–7].
Participant recruitment and allocation
Participant-level flow is presented in the CONSORT diagram for participants (Figure 2). We invited
29,010 people to take part in the trial (see Appendix 1, Table 31). The mean number of people invited
per GP was 387 (range 170–608). Out of the 29,010 participants, 9819 (33.8%) gave consent and
returned baseline questionnaires. Nine people withdrew and seven died after providing consent and
prior to GP randomisation. We randomised 9803 out of 29,010 participants (33.8% of those invited).
The mean number of participants randomised per GP was 156 (range 115–201). Trial arms were well
balanced for size, with 3223 (32.9%), 3279 (33.4%) and 3301 (33.7%) out of 9803 participants being
allocated to advice, exercise and MFFP, respectively (see Appendix 1, Table 32).
Completeness of primary outcome data
Useable fracture data were available for all participants for the whole study period. We obtained HES
data for 9802 out of 9803 participants, with only one participant not providing permission for access.
No participants withdrew consent for access to HES data after randomisation. Participant data were
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missing from one GP randomised to the exercise arm (159/9803, 1.6%), although HES data were
available. There were 458 fractures confirmed by the adjudication panel during the 18-month follow-up
period. Fractures were identified in both HES and GP records for 279 out of 458 (60.9%) fractures, only
in HES records for 88 out of 458 (12.2%) fractures and only in GP records for 91 out of 458 (19.9%)
fractures. Therefore, for 458 fracture events, source of fracture confirmation was from HES data for
367 (80.1%) participants and from GP records for the remaining 91 (19.9%) participants. The level of
agreement (kappa statistic) between HES and GP records was 0.75 (95% CI 0.71 to 0.78; p < 0.001).
Completeness of secondary outcome data
Over the 18-month follow-up period, 1213 (12.4%) participants withdrew from the trial and 289 (2.9%)
died. Response rates to postal questionnaires were good: 9064 (92.5%), 8578 (87.5%), 8136 (83.0%)
and 7490 (76.4%) at 4, 8, 12 and 18 months’ follow-up, respectively (see Appendix 1, Table 32). There
were no between-group differences in the numbers or characteristics of withdrawals and dropouts by
treatment arm over the 18-month follow-up period. Participants who withdrew were more likely to
be female, older, frailer and have a history of falling and poorer physical and mental health than those
who remained in the trial. The characteristics of the randomised and analysed sample were very similar
at baseline. Missingness in reporting of falls outcomes increased as the study progressed, similar to
response rates. Missingness of falls outcome data was 10.0% at 4 months, 13.9% at 8 months, 18.1%
at 12 months and 24.6% at 18 months.
Assessed for eligibility
(number of GPs, n = 82)
Excluded (number of GPs,  n = 19)
• No data collection forms returned, n = 9 (47%)
• Agreement not returned, n = 10 (53%)   
Randomised (number of GPs, n = 63) 
Allocated to advice 
[number of GPs, n = 21;
mean (range) participants
per GP, n = 154 (132–180)]
Delivered allocated intervention
[number of GPs, n = 21;
mean (range) participants
per GP, n = 153 (132–180)]  
Did not deliver allocated intervention 
(number of GPs, n = 0)
Allocated to exercise 
[(number of GPs, n = 21;
mean (range) participants per
GP, n = 156 (114–201)]
Delivered allocated interventiona
[number of GPs, n = 21;
mean (range) participants
per GP, n = 51 (34–75)]
Did not deliver allocated intervention
(number of GPs, n = 0) 
Allocated to  MFFP 
[(number of GPs, n = 21;
mean (range) participants per
GP, n = 157 (128–187)]     
Delivered allocated interventiona
[number of GPs, n = 21;
mean (range) participants per
GP, n = 51 (37–66)]    
Did not deliver allocated intervention
(number of GPs, n =  0) 
Lost to follow-up; give reason
(number of GPs, n = 0)
Lost to follow-up; give reason
(number of GPs, n = 0)
Discontinued intervention
(number of GPs, n = 0)
Lost to follow-up; give reason
(number of GPs, n = 0)
Discontinued intervention
(number of GPs, n = 0)
Primary outcome: analysed
• HES data: number of GPs, n = 21
• GP data:  number of GPs, n = 21
Primary outcome: analysed
• HES data: number of GPs, n = 21
• GP data:  number of GPs, n = 20
Primary outcome: analysed
• HES data: number of GPs, n = 21
























FIGURE 1 Cluster CONSORT flow diagram by GPs. a, Fall risk screener and attended treatment.
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Baseline characteristics of trial participants
Overall, our three groups were well balanced at baseline (Table 4). Participants’ mean age was 78 years
(range 70–101 years) and just over half were female (5150/9803, 52.5%). The majority of participants
were white and either married or cohabiting, and one-third lived alone. The mean age at leaving full-time
education was 17 years. Sociodemographic characteristics were well balanced across treatment arms.
Most participants were able to go outside unaided, although 20% (1913/9803) required a stick or support.
Overall, participants were moderately active, with three-quarters self-reporting that they walked ≥ 1 hour
every day. The majority of participants had no cognition impairment, although 9% (870/9803) had lower
scores (0–4) on the clock-drawing test, indicating a degree of cognitive impairment.
Total approached
(number of participants, n = 29,010)
Excluded (number of participants),
n = 19,207 (66.2%)
• Do not want to participate, n = 19,191
    (99.9%)
Participants recruited when general practices randomised
(number of participants, n = 9803)
Allocated to advice
(number of participants, n = 3223)
Received allocated intervention
(number of participants, n = 3223)
Did not receive allocated 
intervention, n = 0
Allocated to exercise
(number of participants, n = 3279)
Received allocated intervention
[number of participants, n = 2929
(89.3%)]a
• Blank balance screeners, n = 4 (0.1%)
• Not eligible for treatment (low risk),
    n = 1846 (63.0%)
• Eligible for treatment (high/
    intermediate risk), n = 1079 (36.9%)
Did not receive allocated 
intervention, n = 350 (10.7%) 
Allocated to MFFP
(number of participants, n = 3301)
Received allocated intervention
[number of participants, n = 2862
(86.7%)]a
• Blank balance screener, n = 8 (0.3%)
• Not eligible for treatment (low risk),
    n = 1780 (62.2%)
• Eligible for treatment (high/
    intermediate risk), n = 1074 (37.5%)
Did not receive allocated
intervention, n = 439 (13.3%) 
Over 18 months (primary outcome),
n = 3223 (100%)
Over 18 months (primary outcome),
n = 3279 (100%) 
Over 18 months (primary outcome),
























Over 18 months (secondary
outcomes)
• Participants (end of 18 months),
    n = 2777
• Withdrawals, n = 353 (11.0%)
• Deaths, n = 93 (2.9%)
Over 18 months (secondary
outcomes)
• Participants (end of 18 months),
    n = 2766
• Withdrawals, n = 424 (12.9%)
• Deaths, n = 89 (2.7%)
Over 18 months (secondary
outcomes)
• Participants (end of 18 months),
    n = 2758
• Withdrawals, n = 436 (13.2%)
• Deaths, n = 107 (3.2%)
Consent and have baseline, n = 9819 (33.8%)
Died, n = 7 (0.07%)
Withdrawn from study, n = 9 (0.09%)
          
FIGURE 2 A CONSORT flow diagram by participants. a, Fall risk screener and attended treatment.
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Age (years), mean (SD) 77.9 (5.7) 78.1 (5.7) 77.8 (5.7) 77.9 (5.7)
Age (years), range 70–101 70–100 70–101 70–101
Age bands (years), n (%)
70–79 2140 (66.4) 2168 (66.1) 2247 (68.1) 6555 (66.9)
80–89 992 (30.8) 990 (30.2) 952 (28.8) 2934 (29.9)
≥ 90 91 (2.8) 121 (3.7) 102 (3.1) 314 (3.2)
Female, n (%) 1666 (51.7) 1724 (52.6) 1760 (53.3) 5150 (52.5)
Ethnicity, n (%)
White 3166 (98.2) 3225 (98.3) 3239 (98.1) 9630 (98.2)
Other 30 (1.0) 25 (0.8) 39 (1.2) 94 (1.0)
Missing 27 (0.8) 29 (0.9) 23 (0.7) 79 (0.8)
Marital status, n (%)
Married/cohabiting 2050 (63.6) 2035 (62.1) 2085 (61.3) 6170 (62.9)
Widowed 857 (26.6) 887 (27.0) 833 (25.2) 2577 (26.3)
Divorced/separated 175 (5.4) 236 (7.2) 212 (6.4) 623 (6.4)
Single 130 (4.0) 108 (3.3) 157 (3.8) 395 (4.0)
Missing 11 (0.4) 13 (0.4) 14 (0.4) 38 (0.4)
Living arrangement, n (%)
Live alone 1048 (32.5) 1104 (33.7) 1065 (32.3) 3217 (32.8)
Live with others 2155 (66.9) 2154 (65.7) 2219 (67.2) 6528 (66.6)
Missing 20 (0.6) 21 (0.6) 17 (0.5) 58 (0.6)
Age left FTE (years), mean (SD) 16.8 (4.6) 16.7 (4.6) 16.9 (4.8) 16.8 (4.7)
BMI (kg/m2), mean (SD) 26.4 (4.7) 26.5 (4.5) 26.4 (4.6) 26.5 (4.6)
Balance difficulties walking on level, n (%)
Never/sometimes 2923 (90.7) 2994 (91.3) 2988 (90.5) 8905 (90.8)
Often/very often/always 280 (8.7) 268 (8.2) 301 (9.1) 849 (8.7)
Missing 20 (0.6) 17 (0.5) 12 (0.4) 49 (0.5)
Able to get outside, n (%)
Unaided 2580 (80.0) 2599 (79.3) 2632 (79.7) 7811 (79.7)
With stick/support or help only 611 (19.0) 656 (20.0) 646 (19.6) 1913 (19.5)
Cannot get outside at all 16 (0.5) 11 (0.3) 12 (0.4) 39 (0.4)
Missing 16 (0.5) 13 (0.4) 11 (0.3) 40 (0.4)
On average, hours/day walking
< 1 822 (25.5) 847 (25.8) 897 (27.2) 2566 (26.2)
1–2 1213 (37.7) 1271 (38.8) 1212 (36.7) 3696 (37.7)
> 2 1167 (36.2) 1145 (34.9) 1180 (35.7) 3492 (35.6)
Missing 21 (0.6) 16 (0.5) 12 (0.4) 49 (0.5)
HRQoL (EQ-5D-3L), mean score (SD)a 0.76 (0.23) 0.78 (0.23) 0.77 (0.24) 0.77 (0.23)
Missing 143 (4.4) 146 (4.5) 170 (5.2) 459 (4.7)
HRQoL (SF-12 PCS), mean score (SD)b 50.3 (10.2) 50.5 (10.3) 50.0 (10.5) 50.3 (10.3)
HRQoL (SF-12 MCS), mean score (SD)b 50.2 (9.3) 50.3 (8.9) 50.1 (9.3) 50.2 (9.2)
Missing 320 (9.9) 326 (9.9) 338 (10.2) 984 (10.0)
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One-quarter of the sample selected no comorbidity from the list of common conditions, over half
selected one or two conditions and 20% reported having three or more medical conditions diagnosed
by a doctor (see Table 4). The most common self-reported comorbidity was arthritis, with almost
half reporting rheumatoid arthritis or osteoarthritis (4403/9803, 44.9%). Heart troubles or angina
(2679/9803, 27.5%) and diabetes (1403/9803, 14.3%) were also common. The prevalence of frailty
was 21% (2005/9803). HRQoL scores indicated good levels of physical health-related and mental
health-related QoL on both the SF-12 and EQ-5D-3L measures (see Table 4). Pain and discomfort was
common, with 60% reporting moderate or severe pain. One-fifth of respondents reported moderate or
severe anxiety and depression. The most frequently reported ADL difficulty was taking a bath, with
15% reporting a lot of difficulty or being unable to do. Most participants (> 90%) reported no difficulty
or only a little difficulty performing other ADL.
History of falls and fractures in previous year
Out of 9803 people randomised, 3150 (32.1%) had fallen at least once in the previous year (see Table 4)
and 4291 (43.8%) were deemed at higher risk of falling based on responses to the questions in the baseline
questionnaire. A total of 324 (3.3%) participants reported having suffered a fall-related fracture in the year
prior to recruitment. Although the proportions of participants falling, sustaining a fracture and being at risk
of falling were similar across all three treatment groups on entry to the trial, participants in the MFFP arm










Clock-drawing test score, n (%)c
0–4 294 (9.1) 271 (8.3) 305 (9.2) 305 (9.2)
5–6 2882 (89.4) 2952 (90.0) 2917 (88.4) 2917 (88.4)
Missing 47 (1.5) 56 (1.7) 79 (2.4) 79 (2.4)
Frailty, n (%)
Frail 647 (20.1) 625 (19.1) 733 (22.2) 2005 (20.5)
Non-frail 2535 (78.6) 2603 (79.4) 2528 (76.6) 7666 (78.2)
Missing 41 (1.3) 51 (1.5) 40 (1.2) 132 (1.3)
Comorbidities, n (%)
None 752 (23.3) 767 (23.4) 792 (24.0) 2311 (23.5)
One or two 1873 (58.1) 1902 (58.0) 1897 (57.5) 5672 (57.9)
Three or more 598 (18.6) 610 (18.6) 612 (18.5) 1820 (18.6)
Fallen in previous year, n (%)
Yes 1019 (31.6) 1033 (31.5) 1098 (33.3) 3150 (32.1)
No 2179 (67.6) 2225 (67.9) 2183 (66.1) 6587 (67.2)
Missing 25 (0.8) 21 (0.6) 20 (0.6) 66 (0.7)
n (%) with fall-related fracture in previous year,
self-report
106 (3.3) 112 (3.4) 106 (3.1) 324 (3.3)
n (%) at higher risk of falling, baseline
questionnaire
1382 (42.9) 1422 (43.4) 1487 (45.1) 4291 (43.8)
Missing 2 (0.06) 5 (0.2) 1 (0.03) 8 (0.1)
BMI, body mass index; FTE, full-time education.
a EQ-5D-3L scale range 0–1, with higher score indicating better HRQoL.
b SF-12 scale range 0–100, with higher score indicating better HRQoL.
c Clock-drawing test scale range 0–6, with higher score indicating better cognitive function.
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reported a non-statistically significant higher falls rate in the previous year than those in the advice and
exercise arms (87.3 vs. 70.6 and 73.5 falls per 100 years, respectively). This was due to five extreme fallers
and, when extreme observations were removed, falls rates were very similar by treatment arm.
Primary outcome: fractures
We had a total mean follow-up period of 18.4 (SD 0.3) months, with a total of 14,853 person-years of
follow-up data. There were no differences by treatment arm. The number of participants sustaining
one or more fractures over 18 months’ follow-up was 379 out of 9803 (3.9%) (Tables 5 and 6). The
total number of fractures by treatment arm was 133, 152, and 173 in those randomised to advice,
exercise and MFFP, respectively. The unadjusted fracture rates were 2.76, 3.06 and 3.50 per person per
100 years in those randomised to advice, exercise and MFFP, respectively (see Table 5).
TABLE 5 Fracture outcomes by treatment arm
Outcome Advice Exercise MFFP Total
From randomisation to 18-month follow-up
Randomised, n 3223 3279 3301 9803
Fractures, n 133 152 173 458
Unadjusteda fracture rate
over 18 months (95% CI) per
person per 100 years
2.76 (2.76 to 2.76) 3.06 (3.06 to 3.06) 3.50 (3.50 to 3.50) 3.10 (3.10 to 3.10)
Adjustedb fracture rate over
18 months (95% CI) per
person per 100 years
2.59 (2.53 to 2.67) 3.24 (3.15 to 3.33) 3.50 (3.39 to 3.60) 3.12 (3.06 to 3.17)
Participants with one or
more fractures, n (%)
110 (3.4) 126 (3.8) 143 (4.3) 379 (3.9)
Total number of person-
years of follow-up
4868.5 4981.2 4985.3 14,853.0
Participants with two or
more fractures, n
17 22 22 61
Fracture episodes, n 118 131 153 402
Time to first fracture
(months), median (IQR)
8.5 (3.9–14.5) 10.4 (5.1–14.1) 9.1 (4.6–12.9) 9.4 (4.4–13.6)
Time to first fracture, HRc (95% CI; p-value)
Exercise vs. advice 1.12 (0.87 to 1.45; 0.38)
MFFP vs. advice 1.28 (0.99 to 1.63; 0.055)
Site of participant fracture
Hip (S72), n (%) 33 (1.0) 26 (0.8) 28 (0.9) 87 (0.9)







Wrist (S62.1, S62.8, S52.5),
n (%)
20 (0.6) 23 (0.7) 34 (1.0) 77 (0.8)
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Primary analysis
For the primary ITT analyses, the fracture RaR for comparison of advice with exercise was 1.20 (95% CI
0.91 to 1.59), indicating a statistically non-significant increase in fracture rate in the exercise group
(Table 7). For the comparison of advice with MFFP, the fracture RaR was 1.30 (95% CI 0.99 to 1.71),
indicating an increase in fracture rate of borderline statistical significance in the MFFP group. The ICC
value for between-cluster variance was almost zero (ICC 0.00001).
Other fracture analyses
We found no differences in time to first fracture between the exercise arm and the advice arm [hazard
ratio (HR) 1.12, 95% CI 0.87 to 1.45; p = 0.38]. Time to first fracture was shorter for those randomised
to MFFP than for those randomised to advice, but the difference was of borderline statistical significance
(adjusted Cox regression model HR 1.28, 95% CI 0.99 to 1.63; p= 0.055). The Kaplan–Meier survival
curve for time to first fracture, among all participants, by treatment group is shown in Figure 3. We found
no difference in number of people with hip or wrist fractures by treatment arm (see Table 5). A total of
87 participants sustained a hip fracture over the 18-month follow-up period and, of these, one participant
in the exercise arm sustained more than one hip fracture. Seventy-seven participants sustained a wrist or
forearm fracture and, of these, three participants had more than one fracture (exercise, n = 1; MFFP, n= 2).
TABLE 5 Fracture outcomes by treatment arm (continued )
Outcome Advice Exercise MFFP Total
Fracture outcomes from randomisation to maximum follow-upd
Fractures, n 213 234 248 695
Participants with one or
more fracture, n (%)
171 (5.3) 188 (5.7) 198 (6.0) 557
Total number of person-
years of follow-up
9089.1 9221.1 9189.9 27,500.0
Unadjusteda fracture rate
(95% CI) per person per
100 years
2.36 (2.36 to 2.36) 2.54 (2.54 to 2.54) 2.73 (2.73 to 2.73) 2.54 (2.54 to 2.55)
Adjustedb fracture rate
(95% CI) per person per
100 years
2.26 (2.20 to 2.31) 2.67 (2.59 to 2.74) 2.80 (2.72 to 2.89) 2.58 (2.54 to 2.62)
Hip (S72) 57 (1.8) 51 (1.6) 47 (1.4) 155 (1.6)
Wrist (S62.1, S62.8, S52.5) 31 (1.0) 32 (1.0) 42 (1.3) 105 (1.1)
AIC, Akaike information criterion; HR, hazard ratio; IQR, interquartile range.
a Rate data are correct (identical values to five decimal places).
b Adjusted for age, sex, GP deprivation code and log of baseline falls count. Regression model AIC = 3363.6.
c Cox regression with adjustment.
d Fractures by site reported with ICD-10 codes.
TABLE 6 Number of fractures by time point
Time point (months) Advice (N= 3223), n Exercise (N= 3279), n MFFP (N= 3301), n Total (N= 9803), n
0–4 35 35 37 107
4–8 26 25 38 89
8–12 28 36 47 111
12–18 44 56 51 151
Total (%) fractures 133 (4.1) 152 (4.6) 173 (5.2) 458 (4.7)
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Nested intention-to-treat analysis by higher risk
Overall, more people determined from the baseline questionnaire to be at higher risk of falling sustained
a fracture. A total of 4291 out of 9803 (43.8%) participants were at higher risk of falling and, out of
these, 227 (5.3%) sustained one or more fractures over 18 months, compared with 152 out of 5504
(2.8%) participants considered at lower risk of falling. For the nested ITT comparison of those at higher
risk of falling in the advice arm and exercise arms, the adjusted fracture RaR was 0.94 (95% CI 0.65 to 1.35)
TABLE 7 Fracture RaRs by treatment: ITT, nested ITT and CACE analysis
Analysis
Exercise vs. advice,
RaR (95% CI) p-value
MFFP vs. advice,
RaR (95% CI) p-value
Primary outcome: fracture rate over 18 months (total 458 fractures), ITT analysis
Unadjusted RaR 1.11 (0.84 to 1.46) 0.45 1.27 (0.97 to 1.66) 0.08
Adjusteda RaR 1.20 (0.91 to 1.59) 0.19 1.30 (0.99 to 1.71) 0.06
Fracture rate over 18 months (total 227 fractures), nested ITT by higher-risk strata only
Unadjusted RaR 0.86 (0.60 to 1.24) 0.43 1.20 (0.85 to 1.68) 0.29
Adjusteda RaR 0.94 (0.65 to 1.35) 0.73 1.26 (0.89 to 1.78) 0.20
Fracture rate over 18 months (total 458 fractures), CACE
Unadjusted RaR 1.10 (0.64 to 1.87) 0.73 1.40 (0.80 to 2.50) 0.26
Adjusteda RaR 1.80 (0.81 to 4.05) 0.15 1.64 (0.95 to 2.81) 0.08
a Adjusted for age, sex, GP deprivation score and log of baseline falls count in standard negative binomial regression.
Notes


















































FIGURE 3 Kaplan–Meier curve for time to first fracture over 18 months (n= 9803).
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over 18 months, indicating no difference in fracture rates between treatment groups (see Table 7).
For the comparison of those at higher risk in the advice arm and the higher-risk MFFP arm over
18 months’ follow-up, the fracture RaR was 1.26 (95% CI 0.89 to 1.78).
Complier-average causal effect
Out of the 6580 participants randomised to active treatment, 5085 (77.3%) complied with the postal
fall risk screener and attended treatment. Compliance with screening and treatment was similar
between the active intervention arms [exercise, 2543/3279 (77.6%); MFFP 2542/3301 (77.0%)].
We found no statistically significant difference in rate of fractures over 18 months by compliance
status (see Table 7).
Subgroup analyses
We undertook subgroup analyses as per the prespecified analysis plan; thus, treatment effects were
compared by age, sex, history of falling, frailty and cognitive impairment (Table 8). No statistically
significant subgroup effects were found in the RaR of fractures over 18 months by baseline participant
characteristics.
Fracture events beyond 18 months
Using HES to examine fracture events to the maximal available follow-up (27,500 person-years), total
number of fractures increased from 458 to 695 events (see Table 5). Therefore, 557 participants sustained
a fracture over the longer term. For the comparison of advice with exercise (ITT analysis only), the fracture
RaR was 1.14 (95% CI 0.91 to 1.43; p = 0.26). For the comparison of advice with MFFP, the fracture RaR
was 1.20 (95% CI 0.96 to 1.50; p = 0.11). The number of participants sustaining a hip or wrist fracture
increased over time (155 and 105 participants, respectively) (see Table 5).
TABLE 8 Subgroup analyses of unadjusted fracture RaR over 18 months
Subgroup
Advice vs. exercise Advice vs. MFFP
Fracture, RaR (95% CI) p-valuea Fracture, RaR (95% CI) p-valuea
Age (years)
≤ 80 (n= 7022) 1.33 (0.92 to 1.91) 0.16 1.40 (0.98 to 2.00) 0.55
> 80 (n= 2781) 0.90 (0.59 to 1.35) 1.19 (0.79 to 1.78)
Sex
Male (n = 4653) 1.13 (0.72 to 1.77) 0.92 1.03 (0.65 to 1.63) 0.33
Female (n = 5150) 1.10 (0.78 to 1.54) 1.36 (0.98 to 1.90)
Fallen in previous year
No (n = 6587) 1.26 (0.89 to 1.80) 0.41 1.26 (0.88 to 1.79) 0.92
Yes (n= 3150) 1.00 (0.65 to 1.54) 1.29 (0.85 to 1.95)
Frailty
Non-frail (n = 7666) 1.17 (0.85 to 1.62) 0.44 1.19 (0.86 to 1.65) 0.92
Frail (n = 2005) 0.97 (0.59 to 1.62) 1.23 (0.76 to 1.98)
Cognition
Score 0–4 (n= 870) 1.20 (0.56 to 2.56) 0.81 1.17 (0.56 to 2.44) 0.90
Score 5–6 (n= 8751) 1.09 (0.81 to 1.46) 1.23 (0.92 to 1.65)
a p-value of interaction term.
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Secondary outcomes
Falls reported in questionnaires
We found no differences in falls rates over the 18-month follow-up by treatment group (Table 9).
However, the falls rate was lower over months 4–8 in those randomised to exercise than in those
randomised advice (adjusted RaR 0.78, 95% CI 0.64 to 0.96; p < 0.001). No differences were observed
in fall RaRs at other interim time points, from randomisation to 4 months, months 8–12 months or
months 12–18 (see Tables 9 and 10). Falls distribution by treatment arm over time is shown in Figure 4.
The characteristics of participants who provided falls outcomes, that is, who returned questionnaires at
18 months, were also considered (Table 11).
Falls reporting by diary card
Diary cards were sent to 9375 out of 9803 participants (95.6%) due to receive them [428 participants
(4.4%) had either withdrawn or died before their allocated time period; Figure 5], of whom 7762 (82.8%)
returned one or more completed diaries. Diary card response rate dropped slightly over each subsequent
4-month time period [randomisation to 4 months, 2758/3256 (84.7%); months 5–8, 2539/3093 (82.1%);
months 9–12, 2465/3026 (81.5%)] (Table 12). Diary card non-responders were older and had poorer
HRQoL scores on recruitment to the trial. Among the 6418 participants reporting falls in both data
sources (diary card and questionnaire), there was substantial agreement in reporting (Cohen’s unweighted
kappa test statistic 0.638). When there was lack of agreement, falls reporting was higher in diary
cards than in the questionnaires. A separate manuscript reported on patterns of return (Table 13)
and differences by data collection method.115 In brief, we found an average 32% difference in the
falls rates between the prospective diary cards and retrospective reporting.115
Complier-average causal effect analysis: falls
A CACE analysis was conducted to estimate the treatment effect at each time point, having adjusted for
non-compliance, as defined in Chapter 2. Among those participants randomised to treatment (exercise
and MFFP; 6580 participants), 5085 (77.3%) complied with the screener and treatment and 1495 (22.7%)
were non-compliers. Similar to the ITT findings, the CACE results found no difference in fracture rate or
falls rate over 18 months by compliance status.
TABLE 9 Falls outcomes by treatment arm by time period
Analysis Advice Exercise MFFP Total
Randomised, n 3223 3279 3301 9803
One or more falls over 18 months, n (%) 1276 (39.6) 1277 (38.9) 1301 (39.4) 3854 (39.3)
Two or more falls over 18 months, n (%) 715 (22.2) 687 (21.0) 743 (22.5) 2145 (21.9)
Fallers, n (%)
0–4 months 586 (18.2) 605 (18.5) 605 (18.3) 1796 (18.3)
4–8 months 539 (16.7) 458 (14.0) 555 (16.8) 1552 (15.8)
8–12 months 514 (16.0) 500 (15.3) 502 (15.2) 1516 (15.5)
12–18 months 455 (14.1) 450 (13.7) 470 (14.3) 1375 (14.0)
Unadjusted fall rate over 18 months









Adjusteda falls over 18 months









a Adjusted for age, sex, GP deprivation score and log of baseline falls count in standard negative binomial regression.
Notes
Variable follow-up time is used as an offset in the model. Model fit = LR test of alpha = 0 (LR test vs. standard
Poisson regression).
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TABLE 10 Unadjusted and adjusteda RaRs of falls by time period for each treatment comparison
Time period
Exercise vs. advice MFFP vs. advice
RaR (95 CI%) p-value RaR (95% CI) p-value
Over 18 months
Unadjusted RaR 0.96 (0.80 to 1.16) 0.69 1.12 (0.93 to 1.34) 0.22
Adjusted RaR 0.99 (0.86 to 1.14) 0.91 1.13 (0.98 to 1.30) 0.10
0–4 months
Unadjusted RaR 1.05 (0.79 to 1.39) 0.74 1.20 (0.91 to 1.58) 0.21
Adjusted RaR 1.12 (0.87 to 1.45) 0.47 1.19 (0.92 to 1.53) 0.18
4–8 months
Unadjusted RaR 0.77 (0.61 to 0.98) 0.03 1.11 (0.88 to 1.41) 0.37
Adjusted RaR 0.78 (0.64 to 0.96) 0.02 1.13 (0.93 to 1.37) 0.24
8–12 months
Unadjusted RaR 1.05 (0.86 to 1.28) 0.63 1.00 (0.82 to 1.22) 0.12
Adjusted RaRb 1.04 (0.91 to 1.21) 0.61 0.97 (0.84 to 1.13) 0.74
12–18 months
Unadjusted RaR 1.11 (0.88 to 1.40) 0.37 1.14 (0.90 to 1.43) 0.28
Adjusted RaR 1.10 (0.91 to 1.34) 0.33 1.13 (0.93 to 1.38) 0.21
a Adjusted for age, sex, GP deprivation score and log of baseline falls count in random-effects negative binomial
regression. Variable follow-up time was used as an offset in the model and sources of random effects are GPs.
Model fit = LR test vs. standard negative binomial regression.
b Results from standard negative binomial regression as LR test of random-effects negative regression model are
not significant.










Age (years), mean (SD) 77.5 (5.5) 77.6 (5.5) 77.3 (5.4) 77.5 (5.5)
Age (years), range 70–101 70–96 70–98 70–101
Age band (years), n (%)
70–79 1721 (69.0) 1739 (69.5) 1777 (71.17) 5237 (69.9)
80–89 716 (28.7) 994 (27.8) 664 (26.6) 2074 (27.7)
≥ 90 56 (2.3) 67 (2.7) 56 (2.2) 179 (2.4)
Female, n (%) 1293 (51.9) 1286 (51.4) 1303 (52.2) 3882 (51.8)
Ethnicity, n (%)
White 2455 (98.5) 2456 (98.2) 2456 (98.4) 7367 (98.4)
Other 20 (0.8) 22 (0.9) 22 (0.9) 64 (0.8)
Missing 18 (0.7) 22 (0.9) 19 (0.8) 59 (0.8)
Marital status, n (%)
Married/cohabiting 1622 (65.1) 1593 (63.7) 1607 (64.4) 4822 (64.4)
Widowed 647 (25.9) 632 (25.3) 599 (24.0) 1878 (25.0)
Divorced/separated 120 (4.8) 176 (7.0) 159 (6.4) 455 (6.1)
Single 97 (3.9) 88 (3.5) 121 (4.8) 306 (4.1)
Missing 7 (0.3) 11 (0.5) 11 (0.4) 29 (0.4)
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Living arrangement, n (%)
Live alone 785 (31.5) 800 (32.0) 779 (31.2) 2364 (31.6)
Live with others 1695 (68.0) 1684 (67.4) 1708 (68.4) 5087 (67.9)
Missing 13 (0.5) 16 (0.6) 10 (0.4) 39 (0.5)
Age left FTE (years), mean (SD) 17.0 (4.7) 16.7 (4.1) 17.0 (4.8) 16.9 (4.4)
BMI (kg/m2), mean (SD) 26.4 (4.7) 26.4 (4.4) 26.4 (4.4) 26.4 (4.5)
Balance difficulties walking on level, n (%)
Never/sometimes 2312 (92.7) 2341 (93.6) 2333 (93.4) 6986 (93.3)
Often/very often/always 169 (6.8) 147 (5.9) 156 (6.3) 472 (6.3)
Missing 12 (0.5) 12 (0.5) 8 (0.3) 32 (0.4)
Able to get outside, n (%)
Unaided 2078 (83.3) 2076 (83.0) 2108 (84.4) 6262 (83.6)
With stick/support or help only 396 (15.9) 409 (16.4) 378 (15.1) 1183 (15.8)
Cannot get outside at all 10 (0.4) 3 (0.1) 4 (0.2) 17 (0.2)
Missing 9 (0.4) 12 (0.5) 7 (0.3) 28 (0.4)
On average, hours/day walking
< 1 583 (23.4) 590 (23.6) 613 (24.6) 1786 (23.9)
1–2 936 (37.5) 959 (38.4) 910 (36.4) 2805 (37.4)
> 2 960 (38.5) 938 (37.5) 966 (38.7) 2864 (38.2)
Missing 14 (0.6) 13 (0.5) 8 (0.3) 35 (0.5)
HRQoL (EQ-5D-3L), mean score (SD) 0.79 (0.22) 0.80 (0.21) 0.79 (0.21) 0.80 (0.21)
Missing 88 102 108 298
HRQoL (SF-12 PCS), mean score (SD) 51.0 (9.9) 51.5 (9.8) 51.0 (10.1) 51.1 (10.0)
Missing 217 199 207 623
HRQoL (SF-12 MCS), mean score (SD) 50.7 (8.8) 51.0 (8.4) 51.0 (8.7) 50.9 (8.6)
Missing 217 199 207 623
Clock-drawing test score, n (%)
0–4 170 (6.8) 163 (6.5) 162 (6.5) 495 (6.6)
5–6 2294 (92.0) 2306 (92.2) 2283 (91.4) 6883 (91.9)
Missing 29 (1.2) 31 (1.3) 52 (2.1) 112 (1.5)
Frailty, n (%)
Frail 444 (17.8) 398 (15.9) 484 (19.4) 1326 (17.7)
Non-frail 2024 (81.2) 2067 (82.7) 1988 (79.6) 6079 (81.2)
Missing 25 (1.0) 35 (1.4) 25 (1.0) 85 (1.1)
Comorbidities, n (%)
None 600 (24.1) 613 (24.5) 620 (24.8) 1833 (24.5)
One or two 1229 (49.3) 1239 (49.6) 1226 (49.1) 3694 (49.3)
Three or more 664 (26.6) 648 (25.9) 651 (26.1) 1963 (26.2)
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Fallen in previous year, n (%)
Yes 764 (30.6) 741 (29.6) 805 (32.2) 2310 (30.8)
No 1715 (68.8) 1743 (69.7) 1680 (67.3) 5138 (68.6)
Missing 14 (0.6) 16 (0.7) 12 (0.5) 42 (0.6)
Participants with fall-related fracture in
previous year, self-report, n (%)
31 (1.2) 31 (1.2) 26 (1.0) 88 (1.2)
Participants at higher risk of falling, baseline
questionnaire, n (%)
1028 (41.2) 1019 (40.8) 1063 (42.6) 3110 (41.5)
Missing 1 (0.04) 5 (0.2) 1 (0.04) 8 (0.1)
BMI, body mass index; FTE, full-time education.
Randomised patients
(n = 9808)
Patients who received diary card
(n = 9375)
Patients who returned
at least one diary card
(n = 7762)
0–4 months




















(n = 2465 patients)
5–8 months
(n = 2539 patients)
Patients who didn’t returned
any of the diary cards
(n = 1613)
Patients who didn’t received diary card
(n = 428)
Reason: withdrawn or died before the
allocated period for posting diary card
FIGURE 5 Flow chart for diary card data for prospective falls reporting.
TABLE 12 Diary card response rate by time period and intervention
Time period
(months)
Participants returning diary cards, n (%)a
Advice Exercise MFFP Total
0–4 917 (33.2) 926 (33.6) 915 (33.2) 2758
5–8 847 (33.4) 849 (33.4) 843 (33.2) 2539
9–12 828 (33.6) 819 (33.2) 818 (33.2) 2465
All 2592 2594 2576 7762
a Row percentage.
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Subgroup analyses
We undertook subgroup analyses as per the prespecified analysis plan, that is, treatment effects were
compared by age, sex, history of falling, frailty and cognitive impairment (Table 14). No statistically
significant interaction effects were found in the RaR of falls by baseline participant characteristics.
Health-related quality of life over time by intervention
We assessed HRQoL over time by treatment group. Table 15 presents mean (SD) SF-12 scores and
missingness for PCS and MCS scores. Findings for EQ-5D-3L scores are presented in Chapter 6.
Differences in mean SF-12 scores were found at interim time points; however, no differences were found
in overall mean SF-12 change scores between the advice and exercise groups or between the advice and
MFFP groups over time (Table 16).
TABLE 13 Pattern of diary card response rate by time period
Time period
(months)
Diaries returned, n (%)a
TotalOne Two Three Four
0–4 62 (2.3) 97 (3.5) 284 (10.3) 2315 (83.9) 2758
5–8 64 (2.5) 91 (3.6) 319 (12.7) 2065 (81.2) 2539
9–12 49 (2.0) 64 (2.6) 224 (9.1) 2128 (86.3) 2465
All 175 252 827 6508 7762
a Row percentage.
TABLE 14 Subgroup analyses of falls RaR over 18 months
Subgroup
Exercise vs. advice MFFP vs. advice
Falls RaR (95% CI) p-valuea Falls RaR (95% CI) p-valuea
Age (years)
≤ 80 (n= 7022) 0.96 (0.78 to 1.16) 0.87 1.11 (0.92 to 1.36) 0.73
> 80 (n= 2781) 0.97 (0.76 to 1.25) 1.16 (0.90 to 1.50)
Sex
Male (n = 4653) 1.03 (0.83 to 1.26) 0.21 1.10 (0.89 to 1.35) 0.64
Female (n = 5150) 0.90 (0.73 to 1.10) 1.15 (0.94 to 1.41)
Fallen in previous year
No (n = 6587) 1.05 (0.89 to 1.24) 0.21 1.24 (1.05 to 1.46) 0.06
Yes (n= 3150) 0.92 (0.76 to 1.11) 1.02 (0.85 to 1.23)
Frailty
Non-frail (n = 7666) 0.99 (0.83 to 1.16) 0.97 1.09 (0.92 to 1.29) 0.99
Frail (n = 2005) 0.99 (0.77 to 1.27) 1.09 (0.86 to 1.38)
Cognition
Score 0–4 (n= 870) 1.11 (0.75 to 1.64) 0.44 1.19 (0.81 to 1.75) 0.71
Score 5–6 (n= 8751) 0.95 (0.79 to 1.15) 1.11 (0.93 to 1.33)
a p-value for interaction term.
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TABLE 15 Health-related QoL (SF-12) summary scores by treatment arm at each time point
Outcome Advice (n= 3223) Exercise (n= 3279) MFFP (n= 3301) Total (n= 9803)
At 4 months
SF-12 PCS 50.2 (10.3) 50.4 (10.2) 50.0 (10.5) 50.2 (10.4)
SF-12 MCS 50.3 (9.0) 50.4 (9.1) 50.1 (9.4) 50.3 (9.2)
Missing 570 585 616 1771
At 8 months
SF-12 PCS 50.3 (10.2) 50.5 (10.2) 50.0 (10.3) 50.3 (10.2)
SF-12 MCS 50.0 (9.1) 50.4 (9.1) 49.8 (9.7) 50.1 (9.3)
Missing 675 708 717 2100
At 12 months
SF-12 PCS 50.3 (10.1) 50.6 (10.1) 49.9 (10.4) 50.3 (10.2)
SF-12 MCS 49.9 (9.3) 50.3 (9.1) 50.0 (9.5) 50.1 (9.3)
Missing 796 835 891 2522
At 18 months
SF-12 PCS 49.9 (10.0) 50.4 (10.0) 49.8 (10.3) 50.0 (10.1)
SF-12 MCS 50.0 (9.0) 50.3 (9.1) 49.9 (9.5) 50.1 (9.2)
Missing 989 1065 1085 3139
TABLE 16 Adjusted HRQoL (SF-12) scores over time by treatment comparisona
Outcome
Exercise vs. advice MFFP vs. advice
MD (95% CI) p-value MD (95% CI) p-value
Over 18 months
SF-12 PCS 0.04 (–0.22 to 0.31) 0.75 –0.22 (–0.49 to 0.05) 0.12
SF-12 MCS 0.13 (–0.17 to 0.43) 0.41 –0.21 (–0.51 to 0.09) 0.17
At 4 months
SF-12 PCS 0.09 (–0.24 to 0.42) 0.59 –0.07 (–0.42 to 0.26) 0.67
SF-12 MCS 0.09 (–0.30 to 0.47) 0.67 –0.17 (–0.55 to 0.22) 0.39
At 8 months
SF-12 PCS 0.03 (–0.32 to 0.37) 0.83 –0.34 (–0.69 to 0.01) 0.05
SF-12 MCS 0.25 (–0.15 to 0.65) 0.23 –0.21 (–0.61 to 0.19) 0.30
At 12 months
SF-12 PCS 0.02 (–0.34 to 0.38) 0.92 –0.38 (–0.74 to –0.02) 0.04
SF-12 MCS 0.14 (–0.27 to 0.56) 0.50 –0.16 (–0.58 to 0.26) 0.45
At 18 months
SF-12 PCS 0.24 (–0.15 to 0.64) 0.23 0.08 (–0.32 to 0.47) 0.70
SF-12 MCS 0.02 (–0.41 to 0.45) 0.93 –0.19 (–0.62 to 0.25) 0.40
MD, mean difference.
a Linear mixed model was used, adjusted for age, sex, deprivation score and baseline SF-12 score. A negative value
indicates a decline in mean HRQoL.
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Frailty
The proportion of responding participants classified as frail was slightly higher at 18 months (1672/7490,
22.3%) than at baseline (2005/9803, 20.5%) (Table 17). There were no differences in the odds of being
frail at follow-up by treatment comparison (Table 18).
Serious adverse events
No SAEs directly related to the interventions were reported. One participant sustained a fractured neck of
femur during a trial procedure not related to the intervention [a fall sustained when returning from posting
a follow-up questionnaire (exercise arm)]. Other AEs included a fall by one participant during MFFP
assessment. This participant was a frequent faller and had been investigated by consultant-led services,
with no cause identified. Another participant with a known history of angina reported experiencing
angina when exercising at home (exercise arm). Both participants continued with interventions.
Process evaluation
This section presents overall key findings for screening utility and intervention uptake for the active
interventions, that is, for those referred to exercise and MFFP and also for those in MFFP who were
referred to exercise therapy. Findings are then presented in more detail for each intervention arm.
Primary care screening
Fall risk screener response rate
Referral to active treatment was determined using the primary care postal screener. Forty-two GPs,
randomised to either exercise or MFFP, mailed out 6580 screeners, of which 5791 (88.0%) were returned
(of which 12 were blank). Risk stratification was based on 5779 out of 6580 (87.8%) participants who
returned a completed fall risk screener. There were no differences in response rate by treatment arm
[exercise 2925/3279 (89.2%), MFFP 2854/3301 (86.5%)]. Over one-third of responding participants
(2153/5779, 37.3%) were identified as being at higher risk of falling and eligible for invitation to treatment.
TABLE 17 Prevalence of frailty by intervention arm at 18 months
Outcome Advice Exercise MFFP Total
Not frail, n (%) 1859 (74.6) 1906 (74.9) 1870 (74.9) 5635 (75.2)
Frail, n (%) 576 (23.1) 538 (21.5) 558 (22.4) 1672 (22.3)
Missing Strawbridge questionnaire, n (%) 58 (2.3) 56 (2.2) 69 (2.8) 183 (2.4)
Total, n 2493 2500 3301 7490
TABLE 18 Odds ratio of being frail at 18 months by intervention comparison
Analysis
Exercise vs. advice MFFP vs. advice
OR (95% CI) p-value OR (95% CI) p-value
Unadjusted 0.91 (0.80 to 1.04) 0.17 0.96 (0.84 to 1.10) 0.58
Adjusteda 0.96 (0.82 to 1.13) 0.62 0.89 (0.76 to 1.05) 0.17
a Adjusted for age, sex, baseline frailty and GP deprivation score. Standard logistic regression model.
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The proportion of participants randomised who were at risk of falling was similar across arms [exercise,
1079/3279 (32.9%); MFFP, 1074/3301 (32.5%)]. There were no differences by age or sex between the
responders and non-responders to the postal screener; however, non-responders had a slightly lower
mean clock-drawing test score [responders, mean score 5.6 (SD 0.9), vs. non-responders, mean score
5.4 (SD 0.9); p < 0.001] and were more likely to be frail [responders, 1146/5779 (19.5%); non-responders,
212/801 (26.5%)].
Falls risk screener predictive utility
The postal falls risk screener performed moderately well in predicting falls over 12 and 18 months. The
unadjusted AUC was 0.66 (95% CI 0.64 to 0.68; p< 0.001; n= 5438 participants) over 12 months and 0.64
(95% CI 0.63 to 0.66; p< 0.001; n = 4997 participants) over 18 months, based on participants returning a
completed falls risk screener and follow-up questionnaires at 12 and 18 months, respectively. A separate
analysis examined the utility of the risk screener at predicting fractures in participants with HES data
who returned a risk screener. The AUC for fracture prediction was slightly lower than for falls, with AUC




Between November 2011 and September 2014, a total of 84 therapists attended 24 training sessions:
49 (58%) physiotherapists, 14 (17%) therapy assistants, 13 (15%) exercise specialists and eight (10%)
occupational therapists. All worked in NHS specialist falls prevention services, community therapy
services or outpatient physiotherapy departments. Among those trained, 58 (69%) therapists delivered
one or more sessions of the PreFIT intervention. The remaining 26 (31%) therapists either moved to
another NHS department or left before delivering any intervention. Four therapists (4/58, 7%) received
follow-up visits for minor concerns regarding protocol adherence and/or issues related to paperwork
completion. The remaining quality control visits were graded as satisfactory.
Multifactorial falls prevention intervention
We trained 39 staff members at 16 MFFP training sessions between January 2012 and September
2014, of whom 16 (41%) were GP nurses or advanced nurse practitioners based in primary care,
seven (18%) were nurses from the Primary Care Research Network, eight (21%) were staff members
from a specialist consultant-led falls team (seven physicians and one falls nurse), six (15%) were falls
prevention staff members working in community-based falls services (including occupational therapy,
physiotherapy, nurse advisors for older people) and two were medical registrars (5%). Among the
39 staff members trained, eight did not undertake any MFFP assessments (five of whom were nurses).
Two staff members received follow-up quality control visits. In one case this was because of major
concerns and additional training was arranged and delivered by a geriatrician (Devon). Subsequent
quality control checks were satisfactory. The other quality control issue was a minor concern regarding
paperwork completed incorrectly (Worcestershire region). Remaining staff quality control assessments
were graded as satisfactory. Medication review training was given to general practitioners in 17 out
of 21 GPs randomised to MFFP. The remaining four GPs from Newcastle upon Tyne used a consultant-
led falls and syncope service in which experienced physicians reviewed all medications and wrote to
GPs specifying which medications were to be modified.
Uptake to exercise and multifactorial falls prevention interventions
Intervention uptake was good, with 65% (697/1079) of those invited attending their first exercise
appointment and 71% (762/1074) attending MFFP assessment. These numbers constitute a relatively
small proportion of the overall sample randomised to exercise and MFFP [697/3279 (21%) and 762/3301
(23%), respectively]. Five participants died before their first exercise assessment (5/1079, < 1%).
Characteristics of participants attending treatment are presented in Table 19. Reasons for not attending
the offered interventions included lack of time, difficulties with transport, being in poor health, already
doing enough exercise and being uninterested in either exercise or having a health check.
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TABLE 19 Characteristics of participants referred to interventions based on referrals determined from postal fall risk screener
Characteristic
Exercise intervention MFFP intervention MFFP and exercisea
Declined Attended Total Declined Attended Total Declined Attended Total
Participants, n (%) 382 (35) 697 (65) 1079 312 (29) 762 (71) 1074 96 (32) 203 (68) 299
Age (years), mean (SD) 80.2 (6.4) 79.3 (5.9) 79.6 (6.1) 80.5 (6.7) 78.7 (5.8) 79.2 (6.1) 80.8 (6.1) 79.8 (5.7) 80.1 (5.9)
Age (years), n (%)
70–79 190 (33) 378 (67) 568 153 (25) 455 (75) 608 45 (30) 104 (70) 149
≥ 80 192 (38) 319 (62) 511 159 (34) 307 (66) 466 51 (34) 99 (66) 150
Sex, n (%)
Male 161 (35) 296 (65) 457 112 (26) 323 (74) 435 34 (31) 77 (69) 111
Female 221 (36) 401 (64) 622 200 (31) 439 (69) 639 62 (33) 126 (67) 188
Risk of falling, n (%)
Intermediate 297 (38) 491 (62) 788 209 (28) 532 (72) 741 64 (37) 110 (63) 174
High 85 (29) 206 (71) 291 103 (31) 230 (69) 333 32 (26) 93 (74) 125
















































































































































































































































































































































Skill mix of delivery of multifactorial falls prevention intervention
All MFFP assessments conducted in Newcastle were completed by consultant physicians (seven
doctors completed 119/762 falls assessments; 16%). For other regions, registered nurses (practice
nurses or research nurses) delivered 505 out of 762 (66%) MFFP assessments and community-led falls
services comprising other health-care professionals carried out 138 out of 762 (18%) assessments.
The majority of assessments in Warwickshire were carried out by community-led falls services.
In summary, over 95% of the contacts delivered in each of the trial arms (MFFP and exercise) were
provided by NHS practitioners who were in the usual network of care providers for participants.
Five per cent of interventions were provided by research staff who were employed by the University
of Warwick or on research nurse only contracts in the NHS in exceptional circumstances.
Time from randomisation to start of treatment
Median time from randomisation to the first exercise assessment was 14 weeks [interquartile range
(IQR) 10–22 weeks]. This varied by region, from a median of 9 weeks in Birmingham and the Black
Country to a median of 21 weeks in Devon. This was due to staffing issues within services; in some
areas staff members were trained but then changed duties or departments at short notice. In the MFFP
group, median time from randomisation to assessment was 16 weeks (IQR 13–23 weeks), ranging from
13 weeks in Newcastle upon Tyne to 25 weeks in Worcestershire. Delays in assessments were due
to lack of availability of GP nurses to deliver assessments.
Exercise intervention
Adherence
Among the 697 participants attending exercise therapy, the overall median time spent in the programme
was 25 weeks (IQR 16–27 weeks). Among the 454 [out of a total of 697 (65%)] participants who fully
adhered to the recommended exercise programme, defined as having six or more contacts with the
therapist, median duration in the intervention was 27 weeks (IQR 25–28 weeks) (Table 20). One-third
of participants partially adhered to the intervention, defined as having fewer than six contacts with the
therapist (243/697, 35%). There were no differences in adherence by region. There were no differences
in adherence status by age or sex of participants.
Contacts with therapists
The 58 trained therapists had a total of 3842 contacts with 697 participants. Over half of the contacts
were face to face (2078/3842, 54%) and the remainder were by telephone (1764/3842, 46%). Although
up to six contacts were recommended, 295 out of 697 (42%) participants had seven or more therapy
contacts (Figure 6). Participants who fully adhered to the exercise programme had a mean of six contacts
TABLE 20 Duration (weeks) spent in exercise intervention
Treatment group
Time (weeks) spent in exercise intervention
Participants, n (%) Median (IQR)
Exercise (N = 697)
Partially adhered (fewer than six contacts) 243 (34.9) 10 (3–18)
Adhered (six or more contacts) 454 (65.1) 27 (25–28)
MFFP and exercisea (N= 203)
Partially adhered (fewer than six contacts) 79 (38.9) 12 (4–17)
Adhered (six or more contacts) 124 (61.1) 26 (25–30)
a MFFP and exercise = referrals to exercise programme based on MFFP risk assessment.
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(SD 1.3 contacts) with the therapist, and those who partially adhered had a mean of four contacts
(SD 2 contacts). There were no differences in mean number of contacts by region.
Change in leg strength over time
Among those randomised to the exercise intervention, we measured change in performance in the CST
and 4TBS over time. Final test data were available for those attending the final therapy session, either
session 6 or session 7. There was a statistically significant improvement in performance over time: the
mean CST score was 3.5 (SD 1.1) before intervention compared with 3.7 (SD 0.9) post intervention
[mean difference (MD) 0.15, 95% CI 0.08 to 0.23; p < 0.001; n = 454 participants] (Figure 7). We had
incomplete data on those who partially adhered because these participants did not attend for repeat
assessment of baseline tests (243/697, 35%).
Recorded data on total weight lifted (kg) and total repetitions were used to calculate work done
(weight × repetitions) over time. This was analysed by major muscle group: the quadriceps, hamstrings
and abductors. Data on work carried out were based on changes between first assessment and session 6
for full adherers (399/454). Among adherers, there was good evidence of an increase in muscle function
over time in the major muscle groups: quadriceps MD 5.5 (SD 15.4; paired t-test p < 0.001), hamstrings
MD 5.6 (SD 13.9; paired t-test p < 0.001) and abductors MD 5.1 (SD 13.8; paired t-test p < 0.001) (Figure 8;
see also Appendix 1, Table 31). Weights were progressed in 190 out of 454 (42%) participants who
complied with the intervention (among these, 32 participants had two or more increases in weights).
For those who partially adhered to the intervention, data on work carried out were based on changes
between assessment and session 3 (159/243). A decline in muscle strength was found over time for all
major muscle groups: quadriceps MD –2.4 (SD 8.4; paired t-test p < 0.001), hamstrings –2.1 (SD 7.2;
paired t-test p < 0.001) and abductors MD –2.1 (SD 7.2; paired t-test p < 0.001) (Figure 9). Weights were
not progressed in weaker participants.
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FIGURE 7 Change in CST score in participants who adhered to exercise intervention (n = 454).
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Change in balance over time
Balance problems were prevalent among those who attended exercise. Over half of participants (354/687,
52%) scored level 1 or 2 on the 4TBS on first assessment and, thus, either failed the test completely, being
unable to stand with feet together, or achieved only some of the basic balance challenge (Figure 10).
Mean scores improved from pre to post intervention in those who adhered to exercise [pre-intervention
mean balance level 2.63 (SD 1.0); post-intervention mean balance level 3.22 (SD 0.9); MD 0.57, 95% CI
0.50 to 0.65; p = 0.001; n = 454 participants].
Perceived improvement at discharge
At the final assessment, therapists asked each participant about their strength, balance and walking since
taking part in the programme (‘has your strength got better?’/‘has your balance improved?’/‘can you walk
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FIGURE 10 Change in 4TBS levels over time in 454 participants who adhered to exercise intervention.
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and attended their final assessment (454/697, 65%). Two-thirds of participants reported improvements
in their strength (271/454, 60%) and balance (270/454, 59%) at discharge (Figure 11). At the final
appointment, therapists were asked to report their own opinion on whether or not participants had
progressed. Progression was reported for 315 out of 454 (69%) participants; therapists thought that
122 out of 454 (27%) had not progressed (n = 17 missing).
Frequency of exercise at time of discharge
At the final appointment, participants who completed the intervention were asked how regularly they
were exercising: 314 out of 454 (69%) participants reported exercising three or more times per week
and the remainder were exercising fewer than three times per week. At the final appointment, all
participants were given an information leaflet describing opportunities for exercise classes in their
local community and were encouraged to engage with these.
Multifactorial falls prevention intervention
Onward referrals to other services
All 762 participants who underwent MFFP assessment were assessed for all risk factors. A total of
432 participants were given information leaflets containing advice on how to self-manage symptoms of
postural hypotension, foot care and recommended footwear, and/or tip sheets about risk management
in the home environment. Among the 762 participants who returned a medication screen, 459 (60%)
were referred either to their own general practitioner or to the PreFIT-nominated general practitioner
in the GP for a more detailed medication review (level 3). A total of 317 out of 762 (42%) participants
either failed the TUG (took ≥ 14 seconds) or had balance or gait problems or fears about falling (among
whom 299 were referred for PreFIT exercise therapy and 18 were referred to other services).
Fifty-eight (8%) onward referrals were made to a falls service doctor based on concerns raised in the falls
history interview or the postural hypotension check. In total, 762 completed assessments resulted in 971
referrals to other health-care professionals, for example general practitioners, consultant geriatricians,
PreFIT exercise therapists, podiatrists, occupational therapists or opticians, or social services (Table 21).
Checks of treatment referrals to other services
Based on 762 completed treatment logs returned to the research team, 459 full general practitioner-led
medication reviews were recommended. GP staff members (nurses or receptionists) were required to
arrange separate appointments for level 3 medication reviews, if these were not completed on the day of
MFFP assessment. Based on completed treatment logs, 79 out of 459 (17%) reviews led to medication
modifications by general practitioners and 339 out of 459 (74%) resulted in no changes; 41 out of

















FIGURE 11 Perceived self-reported changes in strength, balance and walking among participants who adhered to the
exercise intervention (n = 454).
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TABLE 21 Advice given and onward referrals from risk factors identified in 762 MFFP assessments
Risk factor identified Advice leaflet given Falls service doctor
Referral to another service (n)
Total
referrals (n)General practitioner Physiotherapist Podiatrist
Occupational
therapist Opticiana Other
Falls history/red flag N/A 50 28 17 0 0 0 4 99
Balance/gait N/A 0 0 299b 0 0 0 18 317
Postural hypotension 62 8 40 0 0 0 0 1 49
Culprit medications N/A 0 459 0 0 0 0 0 459
Vision N/A 0 0 0 0 0 84 7 7
Feet/footwear 143 0 0 0 11c 1 0 5 17
Social/home
environment
143 0 0 0 0 18 0 5 23
N/A, not applicable.
a Participants (n= 84) advised to attend optician (not a formal referral) for detailed vision assessment and/or new spectacles.
b Participants (n= 299) referred to the PreFIT exercise intervention.




























On completion of intervention delivery, visits were made by the trial team to all 21 GPs randomised
to MFFP to ascertain whether or not recommended referrals and actions had been completed and
recorded in primary care electronic systems. We found that the recording of recommended actions and
outcome was generally poor. We found documented evidence of action for only 36% of all treatments
recommended in the MFFP (e.g. referral to, or outcome of attendance at, other services such as falls
specialists, physiotherapy, consultant-led eye services). For medication reviews, there was documented
evidence in GP records that among the 459 general practitioner-led reviews only 238 had been completed
(52%) (Table 22).
It was possible to compare findings of searches of GP records with accurate treatment data obtained from
therapists for 203 participants who attended PreFIT exercise. There was evidence in GP records for only
56 out of the 203 (28%) onward referrals to PreFIT exercise. Therefore, GPs had no documented record
of either referral or completion of treatment for > 70% of trial participants attending exercise therapy.
Referral to exercise therapy
Uptake of multifactorial falls prevention and exercise intervention
Among the 762 participants who had a falls assessment, 299 (39%) were referred for PreFIT exercise
therapy. Uptake of exercise after the MFFP assessment was good, with 203 out of the 299 (68%)
participants referred attending their first appointment. The median time from MFFP assessment to
the start of exercise treatment was 6 weeks (IQR 3–11 weeks), ranging from 3 weeks (IQR 2–5 weeks)
in Newcastle upon Tyne to > 16 weeks (IQR 5–22 weeks) in Birmingham and the Black Country. Time
from randomisation to the start of exercise treatment was longer in the MFFP arm: on average 23 weeks
(IQR 17–32 weeks) from randomisation. Participant characteristics of those who attended and declined
are presented in Table 19.
Adherence
Among the 203 participants attending exercise therapy, 124 (61%) adhered to the full 6-month exercise
programme (mean 6.2 months, SD 1.1 months). Those who partially adhered (79/203, 39%) received
less than half of the recommended programme (median 12 weeks, IQR 4–17 weeks), similar to partial
adherers in the exercise treatment arm (see Table 20).
Contacts with therapists
The 28 therapists had a total of 1022 contacts with 203 participants; over half of these contacts were
face to face (584/1022, 57%) and the remainder were by telephone (438/1022, 42%). Although six
contacts were recommended, 51 (25%) participants had seven or more contacts with their therapist.
There were no differences in mean number of therapist contacts by region. Those who fully adhered to
the programme had a mean of six (SD 1.0) contacts with their therapist and those who partially adhered
had a mean of three (SD 1.5) contacts with their therapist. These findings are similar to findings for
participants randomised to exercise without a preceding falls assessment.
Change in leg strength over time
Final test data were available only for those attending the final therapy session, that is, those who
adhered to the intervention (124/203, 61%). The mean CST score was 3.2 (SD 1.2) pre intervention and
3.3 (SD 1.4) post intervention (MD 0.1, 95% CI –0.13 to 0.32; p = 0.39; n = 124 participants) (Figure 12).
Data on work done (weights × repetitions) were based on changes between assessment and session 6
for those who fully adhered to the intervention (105/124). There was evidence of a statistically significant
improvement in muscle function over time for the major muscle groups, that is, for quadriceps (paired
t-test p < 0.01), hamstrings (paired t-test p < 0.002) and abductors (paired t-test p < 0.001). Weights
were progressed in 48 out of 124 (39%) participants who complied with the intervention (weights were
increased once in 40 participants and twice in eight participants).
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TABLE 22 Verification of MFFP onward referrals from GP record searches in 21 MFFP GPs
Referral Falls history Balance/gait
Medication
review Postural hypotension Vision Feet Social/home Total















in GP records, n (%)
18 (18) 56 (18) 238 (52) 10 (20) 4 (57) 15 (88) 10 (43) 351 (36)
No confirmation found
in GP records, n (%)
81 (82) 261 (82) 221 (48) 39 (80) 3 (43) 2 (12) 13 (57) 620 (64)





























Data on work done over time were available for only 48 out of 79 (61%) participants who partially
adhered to the intervention, from baseline assessment to session 3. A decline in muscle strength
was observed over time, similar to that seen among those who partially adhered in the exercise
intervention arm, although these findings are based on a small sample: quadriceps (paired t-test
p < 0.09), hamstrings (paired t-test p = 0.11) and abductors (paired t-test p = 0.40).
Change in balance over time
Balance problems were common among these participants. Over half (114/198, 58%) scored only level 1
or level 2 on the 4TBS at first assessment, thus either failing the test completely or achieving only some
of the balance challenge (Figure 13). An improvement in balance was observed over time, with a higher
proportion of participants achieving levels 3 and 4 of the challenge post intervention (see Figure 13).
Perceived improvement at discharge
At the final assessment, therapists asked each participant about their strength, balance and walking
since taking part in the intervention. These data were available for those who adhered (124/203, 61%).
The proportion of participants reporting improvements in strength (65%) was similar to the proportion
who adhered, although a lower proportion reported improvements in balance (52%) and walking (44%)
than those randomised to the exercise arm (Figure 14). Therapists were also asked to report their own
opinion on whether or not participants had progressed at the final appointment. Progression was
reported in 57 out of 124 (46%) participants; therapists thought that 25 (20%) participants had not
progressed (n = 42 missing).
Frequency of exercise on discharge
Participants who completed the intervention were asked at their final appointment how frequently they




























FIGURE 13 Change in 4TBS over time among participants who adhered to MFFP and exercise intervention (n = 124).
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per week and 77 (62%) participants also reported doing balance exercises three or more times per week
(the remainder were exercising fewer than three times per week). As for those randomised to exercise,
all participants were given an information leaflet, describing opportunities for exercise classes in their
local community, at their final appointment and were encouraged to engage with these.
Process evaluation
Medication prescribing
Drug data were extracted from 59 out of 63 (94%) PreFIT GPs. The format of drug data varied by GP.
At the minimum, we obtained a summary of drug name and dose per participant with or without a
product issue date. For 19 out of 63 (30%) GPs, manual downloads of all prescriptions for individual
trial participants were obtained as separate Microsoft Excel® spreadsheets (Microsoft Corporation,
Redmond, WA, USA). For GPs using Egton Medical Information Systems (EMIS) (31/63, 49%), summary
reports were obtained on total number of trial participants prescribed psychotropics, bisphosphonates
and mineral supplements (e.g. 10% of PreFIT participants prescribed psychotropics). After data cleaning,
we had useable medication data from 56 out of 63 (89%) GPs. Among these, 18 (32%) GPs were
randomised to the advice arm, 19 (34%) GPs were randomised to the exercise arm and 19 (34%) GPs
were randomised to the MFFP arm. No differences were found in data format by intervention arm.
Prescribing across general practices
From the 56 GPs with useable data, we obtained drug data for a mean of 126.3 (SD 29.4) participants per
surgery pre randomisation and 127.9 (SD 26.8) participants post randomisation. Therefore, we had useable
drug data for 80.8% (126/156) of trial participants per practice pre randomisation and 82.1% (128/156)
per practice post randomisation. The mean number of all drug products prescribed by the 56 surgeries pre
randomisation was 727.2 (SD 227.0), with a mean of 5.6 drugs (SD 1.2 drugs) prescribed per participant.
Total drugs included all prescribed products for trial participants, excluding wound dressings, stockings
and syringes (i.e. culprit, non-culprit and psychotropic). We found a statistically significant increase in total
and mean prescribing over time, rising to a mean of 768.4 drugs (SD 218.8 drugs) per surgery (MD 41.1,
95% CI 19.4 to 62.9; paired t-test p < 0.001) and mean 5.8 drugs (SD 1.2 drugs) per patient post
randomisation (MD 0.28, 95% CI 0.1 to 0.4; paired t-test p < 0.001).
General practice prescribing
All general practices
A slight increase in prescribing of psychotropic medications was observed over time across all GPs,
from a mean of 18.1% of participants pre randomisation to 18.8% post randomisation (p < 0.02).
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FIGURE 14 Change in 4TBS over time among participants who adhered to the MFFP and exercise intervention (n= 124).
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24.3 (SD 7.8) (MD –1.2, 95% CI –2.2 to –0.2; p = 0.02). A slight increase in prescribing of bisphosphonates
was observed over time, from a mean of 9.7% to 10.1%; however, this increase was not statistically
significant (p = 0.49). An increase in prescribing of mineral supplementation was observed across all
practices over time, from 13.8% to 15.6% (p < 0.001).
Intervention arms
Although differences in prescribing were found in each intervention arm (Table 23), an independent
samples analysis of covariance was used to test for MDs in prescribing across intervention arms.
No differences were found in total drugs, mean drugs, psychotropics, bisphosphonates or mineral
supplementation prescribed by treatment comparisons.
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TABLE 23 Pre–post medication prescription data, by intervention arm
Analysis
Treatment arm, mean number (SD)
Advice (n= 18) Exercise (n= 19) MFFP (n= 19)
Pre Post MD (95% CI) p-valuea Pre Post MD (95% CI) p-valuea Pre Post MD (95% CI) p-valuea
Participants per surgery 131.2 (19.3) 131.6 (15.2) 130.1 (22.2) 132.4 (18.6) 117.7 (40.9) 119.9 (39.1)



















Drugs per participant 5.8 (0.9) 6.1 (0.8) 0.3 (0.1 to 0.5) 0.007 5.5 (1.0) 5.9 (1.0) 0.4 (0.2 to 0.5) < 0.001 5.5 (1.5) 5.6 (1.5) 0.2 (0.2 to 0.5) 0.27
Participants prescribed
psychotropics
26.1 (5.6) 26.6 (6.2) 0.5 (1.3 to 2.3) 0.57 22.4 (8.1) 23.8 (6.6) 1.5 (0.3 to 3.3) 0.10 21.0 (8.8) 22.6 (10.0) 1.6 (0.4 to 3.7) 0.11
Participants prescribed
bisphosphonates
11.9 (3.9) 12.2 (4.0) 0.2 (1.1 to 1.5) 0.72 12.0 (4.8) 12.1 (5.5) 0.1 (1.5 to 1.6) 0.94 10.1 (4.3) 10.6 (4.4) 1.5 (0.9 to 1.9) 0.44
Participants prescribed
mineral supplementation
15.8 (6.9) 17.7 (8.2) 1.8 (0.3 to 3.7) 0.05 16.8 (7.0) 19.2 (7.0) 2.4 (1.2 to 3.6) 0.001 15.7 (7.3) 19.1 (9.0) 3.4 (1.6 to 5.2) 0.001




























Chapter 5 Health economics
Overview of health economics analysis
We did a within-trial economic evaluation, with the objective of estimating the cost-effectiveness
of exercise and MFFP, both compared with advice. The economic evaluation took the form of a
cost–utility analysis, expressed in terms on incremental cost per quality-adjusted life-year (QALY)
gained, incremental net health benefit (INHB) and incremental net monetary benefit (INMB). The
analysis is based on an NHS and Personal Social Services (PSS) perspective, using the reference cost
framework as recommended by NICE.116
Measurement of resource use and costs
The incremental costs associated with the trial were determined using a comprehensive strategy that
encompassed two approaches: estimation of (1) costs associated with the delivery of the interventions
and (2) secondary care costs and broader health and PSS resource inputs and costs.
Costing of the PreFIT active interventions
A specific focus of the economic evaluation was the assessment of the cost of delivering the interventions
in the active intervention arms. Participants randomised to the control arm received only the Age UK
Staying Steady leaflet.22 Those allocated to exercise or MFFP were mailed a falls risk screener, which
was returned to their GP. Participants at risk of falling were invited to attend for further assessment
and treatment, either exercise or MFFP, depending on GP allocation.
The exercise intervention was adapted from the OEP.72 The OEP intervention manual is free to
download online, but slight modifications were made for delivery in the trial context (with permission
from the Otago research group). The PreFIT intervention consisted of individual or group sessions with
a trained therapist over 6 months. Two costing perspectives were adopted for costing the intervention:
one that considers delivery of the interventions but which considers adaptation of the MFFP and
exercise manuals for the purpose of the intervention to be sunk costs that not occur if treatments were
rolled out nationally; and one that implies consideration of both the adaptation and delivery. Our base-
case scenario is to use the delivery cost perspective and not include adaptation costs, although we
consider both perspectives in a sensitivity analysis. Unit costs for intervention delivery staff include
employers’ National Insurance plus a percentage of salary for employers’ contribution to superannuation.
Costs included minimal time for data collection; production of the manual; cost of training the PreFIT
team in the formal OEP training; health-care professional training; production of participant materials,
including exercise booklets and exercise equipment; and staff time for the actual delivery of the
intervention (Table 24). For the sensitivity analyses, costs of revising and adapting the exercise and MFFP
manuals were included.
The MFFP assessment consisted of a single risk assessment session, after which participants were
potentially referred to other health-care professionals and services based on their assessment results.
The intervention was based on the Tinetti et al.9 MFFP programme and modified for the PreFIT. The
delivery of the MFFP intervention consisted of an individualised risk assessment conducted within a
1-hour appointment with a trained assessor.
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TABLE 24 Intervention costs: exercise
Identified cost Unit of measure Unit Unit cost (£)
Updated cost (£) to
2015–16 using the
HCHS index Total (£) Price source
Development of intervention manual and data collection forms
Principal research fellow (grade 8) FTE 3 weeks (100% FTE) 49,539 53,173.41 3323.34 University of Warwick 2011
prices117
Trial co-ordinator, for editing FTE 1 week (2.2% FTE) 37,251 39,983.91 439.82 University of Warwick 2011
prices117
Production of exercise manual Number of
manuals printed
42 2.89 3.10 130.20 Trial finance data
Data entry clerk for assembly
(1 hour/manual)
FTE 20 hours (1.2% FTE) 15,353 16,479.37 98.88 University of Warwick 2011
prices117
Delivery of training to physiotherapy staff (21 sessions delivered × 6 hours = 126 hours = 7.4% FTE)
Principal research fellow (grade 8) FTE 7.4% FTE 49,539 53,173.41 1967.40 University of Warwick 2011
prices117
Research fellow (grade 7) FTE 7.4% FTE 40,280 43,235 1599.70 University of Warwick 2011
prices117
Physiotherapy training 126 hours 51.00 6426.00 PSSRU 2015.118 Non-consultant-led
physiotherapy
Mailing of screening forms to participants
Royal Mail postage Number of
stamps
3301 0.66 2178.66 Royal Mail119
Screening forms data entry (15 seconds per form)
Data entry clerk FTE 13.5 hours (0.80% FTE) 15,353 16,479.37 135.13
Delivery of intervention
Participant exercise booklets Number of
booklets
697 0.22 0.24 167.28 Trial finance data




































Identified cost Unit of measure Unit Unit cost (£)
Updated cost (£) to
2015–16 using the
HCHS index Total (£) Price source
Labour
Hospital physiotherapy (outpatients) Number of
contacts
1518 34 36 54,648.00 PSSRU 2015.118 Non-consultant-led
(non-admitted) follow-up
physiotherapy attendance
Community physiotherapy (home visits) Number of
contacts




Community physiotherapy (telephone) Number of
contacts
1764 31.11 33 58,212.00 No data on unit cost of
telephone physiotherapy contact:
based on GP telephone
consultations, assume unit cost
for physiotherapy telephone
contact is 61% of face to face
Community physiotherapy (group) Number of
contacts
29 14 14 406.00 PSSRU 2016.121 Assume same




FTE, full-time equivalent; HCHS, Hospital and Community Health Service; PSSRU, Personal Social Services Research Unit.
















































































































































































































































































































































The total cost of confirmed referral visits emanating from the MFFP assessment were included in the
intervention costs (Table 25). It was possible to confirm attendances for those referred to exercise
and for general practitioner-led medication reviews based on treatment logs. A decision was made
to report the cost of adaptation, manualisation and delivering the interventions separately from the
resource use cost. Possible double-counting of intervention data and self-reported resource use data
was dealt with in the analyses. The mean cost per participant was calculated by dividing the total cost
of the intervention by the total number of participants randomised to the treatment arm (Table 26).
Collection of secondary care use data
Data on inpatient hospital spells and A&E and outpatient attendances over the duration of the trial
were sourced from HES data provided by NHS Digital for financial years 2011/12 to 2015/16. As
these data are obtained centrally and not self-reported, we assumed that these data were complete.
The completeness of hospital data and the ability to identify when participants had prolonged periods
in hospital and/or A&E visits was exploited in the MI approach used to estimate missing self-reported
responses. Inpatient spells during the study and other hospital-based care costs were determined
by linking HES data with 2015/16 Healthcare Resource Groups (HRGs), using 2015/16 reference
cost grouper software from NHS Digital, and then costed using NHS Reference Costs 2015–2016.123
Inpatient and outpatient spell costs included unbundled costs (such as high-cost drugs) and excess
bed-day costs, when applicable. All costs were discounted using a rate of 3.5% per annum.
Collection of broader resource use data
We collected data on health-care resource use from participant self-report questionnaires from
randomisation to 4, 8, 12 and 18 months post randomisation. Data included use of primary and
community-based health care, community-based social care, residential or nursing care and aids
and equipment for each time point. Broader health-care resource use costs were valued by applying
unit costs from the Personal Social Services Research Unit (PSSRU) national tariffs.120 Mean annual
equipment costs include the costs of installing equipment and making adaptions. The Hospital and
Community Health Services index was used to adjust costs, when necessary, to 2015/16 prices.121
All costs were discounted using a rate of 3.5% per annum. Resource use values at the individual
participant level were combined with unit costs for each resource item to estimate economic costs
for resource use (Table 27).
Calculation of utilities and quality-adjusted life-years
The economic evaluation estimated QALY profiles for trial participants, based on participant reports of
preference-based HRQoL outcomes at each follow-up time point, using the EQ-5D-3L.127 The EQ-5D-3L
uses a descriptive system that defines HRQoL across five dimensions: (1) mobility, (2) self-care, (3) usual
activities, (4) pain/discomfort and (5) anxiety/depression. Responses in each dimension are categorised
into three ordinal levels: (1) no problems, (2) some or moderate problems and (3) severe or extreme
problems. For the purposes of the economic evaluation, the UK time trade-off tariff was applied to each
set of responses to generate an EQ-5D-3L utility score (preference weight) for each trial participant.127
Participants who died during the study were allocated a utility of zero at all following time points. QALYs
were calculated as the area under the baseline-adjusted utility curve and were calculated using linear
interpolation between utlity scores at baseline and 4, 8, 12 and 18 months. QALYs were discounted using
a rate of 3.5% per annum.
HEALTH ECONOMICS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
66
TABLE 25 Intervention costs: MFFP
Identified cost Unit of measure Unit Unit cost (£)
Updated cost (£) to
2015/16 using the
HCHS index Total (£) Price source
Development of MFFP manual and data collection forms
Principal research fellow (grade 8):
MFFP manual
FTE 3 months (100% FTE) 49,539 53,173.41 13,293.35 University of Warwick 2011
prices117
Principal research fellow (grade 8):
exercise manual
FTE 3 weeks (100% FTE) 49,539 53,173.41 3323.34 University of Warwick 2011
prices117
Trial co-ordinator for editing
MFFP manual
1 week (2.2% FTE) 37,251 39,983.91 879.65 University of Warwick 2011
prices117
Trial co-ordinator, for editing
exercise manual
0.5 week (2.2% FTE) 37,251 39,983.91 439.82 University of Warwick 2011
prices117
Production of MFFP manual Number of
manuals printed
39 2.66 2.86 111.54 Trial finance data
Data entry clerk for assembly
(1 hour/MFFP manual)
20 hours (1.2% FTE) 15,353 16,479.37 197.75 University of Warwick 2011
prices117
Production of exercise manual Number of
manuals printed
42 2.89 3.10 130.20 Trial finance data
Data entry clerk for assembly
(1 hour/exercise manual)
10 hours (0.6% FTE) 15,353 16,479.37 98.88 University of Warwick 2011
prices117
Mailing of screening forms to participants
Royal Mail postage Number of stamps 3301 0.66 2178.66 Royal Mail119
Screening forms data entry (15 seconds per form)
Data entry clerk FTE 13.5 hours (0.82% FTE) 15,353 16,479.37 135.13
Delivery of training (11 sessions delivered × 6 hours = 66 hours = 4% FTE)
Principal research fellow (grade 8) FTE 4% FTE 49,539 53,173.41 2126.94 University of Warwick 2011
prices117

















































































































































































































































































































































TABLE 25 Intervention costs: MFFP (continued )
Identified cost Unit of measure Unit Unit cost (£)
Updated cost (£) to
2015/16 using the
HCHS index Total (£) Price source
Delivery of intervention
Practice nurse for MFFP assessment Number of
participants
551 56 56.75 31,269.25 PSSRU 2015.118 Unit costs available
2014/15 (costs including
qualifications given in brackets)
per hour of face-to-face contact
Consultant-led MFFP assessment Number of
participants
119 118 119.57 14,228.83 PSSRU 2015.118 Consultant-led
outpatient attendances
Community physiotherapy/occupational
therapy for MFFP assessment
Number of
participants
92 51 52.14 4796.88 PSSRU 2014.120 Cost for a one-to-one
contact with physiotherapy services
for 2013/14
Onward referrals
Participant exercise booklets Number of
booklets
203 0.22 0.24 48.72 Trial finance data
Ankle weights 212a 3.80 3.80 805.60 Trial finance data
Labour
Hospital physiotherapy (outpatients) Number of
contacts
437 34 14,858.00 PSSRU 2015.118 Non-consultant-led
(non-admitted) follow-up
physiotherapy attendance
Community physiotherapy (home visits) Number of
contacts
167 51 8517.00 PSSRU 2014.120 Cost for a one-to-one





































Identified cost Unit of measure Unit Unit cost (£)
Updated cost (£) to
2015/16 using the
HCHS index Total (£) Price source
Community physiotherapy (telephone) Number of
contacts
438 31.11 13,626.18 No data on unit cost of telephone
physiotherapy contact. Based on
GP telephone consultations, assume
unit cost for physiotherapy
telephone contact is 61% of the
cost of face-to-face contact
Community physiotherapy (group) Number of
contacts
4 14 56.00 PSSRU 2016.121 Assume same cost
(per service user) as mindfulness-
based cognitive therapy group-
based intervention
GP medication review Number of face-
to-face contacts
287 36 10,332.00 PSSRU 2016121
Telephone
contacts
132 27 27.36 3611.52 PSSRU 2015118
FTE, full-time equivalent; HCHS, Hospital and Community Health Service.
















































































































































































































































































































































TABLE 26 Average intervention costs
Intervention Randomised (n)
Average cost (£) per patient
(ITT population)
Average cost (£) per patient, including
manual development (ITT population)
Advice 3223 0.66 0.66
Exercise 3279 48.13 49.28
MFFP 3301 39.44 44.87





































Social worker 28.50 Assume 30-minute
visit
Home help or care
worker
12.00 Per visit lasting
30 minutes
Day centre 46.00 Per client session
lasting 3.5 hours










15.00 15.20 30-minute session









£57 cost per hour 
including qualification
PSSRU 2016121
£24 per hour on a 
weekday
PSSRU 2016121
Local authority day 
care for older people
Assumption
The Information 
Centre (2012)125 PSS 
EX1 2010/11
PSSRU 2015118
£30 cost per hour 
PSSRU 2013124
£750 establishment 
cost per permanent 
resident week (private 
sector)
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Missing data
Multiple imputation using the method of chained equations was used for the base-case analysis to
impute missing data. This avoids potential biases associated with complete-case analysis and is consistent
with good practice guidance.128 Data were assumed to be missing at random. MI of missing self-reported
HRQoL data and self-reported costs was conducted on a full analysis data set of combined baseline data,
self-reported HRQoL and costs and complete HES data. The inclusion of the HES data and the ability
to condition imputation on observed and assumed complete secondary care use make the assumption
that data were missing at random more plausible. The MI analysis was conducted using the PROC MI
command in SAS® software version 9.4 (SAS Institute Inc., Cary, NC, USA). A total of 100 imputations
were calculated.
Analyses of resource use, costs and outcome data
Multilevel linear models (MLMs) were used to identify the incremental impact of interventions over
time while recognising the cluster structure of the trial and accommodating patient and practice
heterogeneity. MLM addresses clustering by including random-effects parameters, which represent
the differences in the cluster mean outcomes and costs from the overall mean outcome and costs in
each trial arm. Three-level models were estimated with random effects for individuals and practices
because data were clustered within individuals within GPs. The MLM regression-based correction is
used to accommodate potential differences in mean baseline HRQoL scores and reported health and
social care use between trial arms, which are expected despite randomisation. Such imbalances at
baseline are important to account for when calculating the differential effects between trial arms
because a participant’s HRQoL score at baseline is likely to be correlated with their subsequent
HRQoL scores over the follow-up period.129



































Hoist 319.00 335.37 Mean annual
equipment cost
PSSRU 2012126
Stair lift 402.00 415.57 Mean annual
equipment cost
PSSRU 2012126
Grab rail 6.00 6.20 Mean annual
equipment cost
PSSRU 2012126
HCHS, Hospital and Community Health Service.
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Cost-effectiveness analyses
The incremental cost-effectiveness ratio (ICER) was estimated as the difference between the trial
comparators in mean total costs divided by the difference in mean total QALYs. Value for money was
determined by comparing the ICER with a cost-effectiveness threshold value, typically the NICE
cost-effectiveness threshold for UK studies ranges of between £20,000 and £30,000 per QALY.
This represents society’s willingness to pay for an additional QALY; when incremental utility gains are
positive, lower ICER values than the threshold could be considered cost-effective for use in the NHS.
The INMB and INHB measures were also reported at a range of cost-effectiveness thresholds and
represent the cost-effective argument in single metric, either as a monetary value in INMB, when
the HRQoL is converted to a monetary value via the willingness to pay, or in HRQoL terms, when
incremental monetary differences are converted into an expected impact on HRQoL via the use of
that money elsewhere in the system. In both cases, positive values indicate that the intervention is
cost-effective at the given threshold.
Sensitivity analyses
Uncertainty was assessed using a within-trial probabilistic sensitivity analysis (PSA), undertaken by
drawing model parameter values from the variance–covariance matrices from the cost and utility
multilevel regression models, with results presented as cost-effectiveness acceptability curves (CEACs).
The CEAC illustrates the likelihood that interventions are cost-effective as the cost-effectiveness
threshold varies. All analyses and cost-effectiveness modelling were conducted in SAS. Complete-case
analysis was used as an additional sensitivity analysis.
Results
Cost of interventions
For the advice intervention, the only costs identified related to mailing of the Age UK Staying Steady
leaflet.22 Estimates of the total costs of delivering the exercise and MFFP interventions were summarised.
The cost components are aggregated into headings for exercise as follows: (1) development of intervention
manual and data collection forms (included in sensitivity analysis only); (2) mailing of screening forms and
data entry on returned forms; (3) cost of training PreFIT staff; (4) delivery of training to physiotherapists;
and (5) delivery of intervention, inclusive of staff time and equipment (see Table 24). For MFFP the
headings are (1) development of intervention manual and data collection forms, (2) mailing of screening
forms and data entry of returned forms, (3) cost of training assessors, (4) delivery of intervention and
(5) onward referrals (see Table 25).
Total intervention costs were £2127 for advice, £157,823 for exercise and £130,185 for MFFP.
Estimates of average cost per participant randomised to a specific intervention were £0.66 for advice,
£48.13 for exercise and £39.44 for MFFP (see Table 26). Including manual development costs increased
the total intervention costs for exercise and MFFP to £161,586 and £148,121, respectively, with
average costs per participant of £49.28 for exercise and £44.87 for MFFP. Advice costs are unchanged.
Although intervention costs per participant are measured as simple averages, all other costs for secondary
care and broader resource use are measured over time and modelled in a regression framework.
Secondary care and broader resource use costs
Figures 14 and 15 show observed average complete-case secondary care costs and imputed broader
resource use over time by treatment arm. Table 24 presents the corresponding average regression-
corrected monthly costs, respectively, for secondary care and broader resource use costs by trial
allocation and study period. Owing to the well-balanced nature of the trial, the regression analyses,
which accommodate the clustering of outcomes within patients and practices over time, do not
substantially change the picture that emerges from inspection of the raw and imputed data (Table 28).
We see that secondary care monthly costs exceed resource use costs and both show an increasing
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trend over time (Figures 15 and 16). The trend appears more pronounced in the secondary care data.
Inspection of the HRGs in the secondary care data demonstrates that the majority of secondary care
costs are not directly related to falls, but rather to other comorbidities (e.g. cancer) (see Appendix 1,
Table 33).
The total expected average net present value (NPV) broader resource use costs over the 18-month
period are £951.10 for advice, £924.52 for exercise and £971.23 for MFFP. For secondary care, the
modelled expected average NPV secondary care costs are £2785.66 for advice, £2747.79 for exercise
and £2930.25 for MFFP. Although MFFP is systematically related to higher expected costs than either
advice or exercise, regression results showed no statistically significant differences between the trial
groups at any time point in any cost regression (see Appendix 1).
TABLE 28 Secondary care and resource use monthly costs over time
Time point
Advice Exercise MFFP
Mean (£) % imputed Mean (£) % imputed Mean (£) % imputed
Secondary care
–4 months to randomisation 115 0 108 0 100 0
Randomisation to 4 months 126 0 112 0 116 0
4 to 8 months 152 0 137 0 147 0
8 to 12 months 172 0 162 0 161 0
12 to 18 months 172 0 167 0 165 0
Resource use
Randomisation to 4 months 49 8.2 43 8.3 47 8.9
4 to 8 months 50 12.3 50 13.4 53 13.2
8 to 12 months 52 15.9 47 16.5 55 17.6
12 to 18 months 60 22.0 62 23.6 61 23.8
Treatment arm
      Advice
      Exercise
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FIGURE 15 Secondary care monthly costs over time, complete cases.
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Total costs
Total costs consist of intervention, secondary care and broader resource use costs. The expected average
NPV total costs for each intervention are £3737.42 for advice, £3720.44 for exercise and £3940.92 for
MFFP. Resource use and secondary care costs account for by far the greatest component of total costs,
and much more than intervention costs, with approximately 75% of all costs being secondary care costs
(inpatient, A&E and outpatient attendance). Including the sunk costs of manual adaptation raises the
expected costs to £3721.59 for exercise and £3946.35 for MFFP (relatively modest increases over the
18 months).
Inspection of the modelled regression-based expectations for participants over time shows a similar
gradual increase in costs over time for all interventions, with MFFP having a small but systematically
higher incremental cost at all time points. There is almost no distinguishable difference in modelled
expected costs over time between advice and exercise (Figure 17).
Treatment arm
      Advice
      Exercise
































FIGURE 16 Imputed broader resource use monthly costs over 18 months.
Treatment arm
      Advice
      Exercise
      MFFP
Months









NPV total costs (£)
Advice:       3737
Exercise:    3720


















FIGURE 17 Modelled regression-based monthly costs over 18 months.
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Over 18 months, a participant in the MFFP arm is expected to generate an incremental cost of £204
relative to advice and of £220 relative to exercise. The cost per participant of the advice leaflet is
only £17 more than the cost of exercise (equivalent to approximately £1 per month). These are very
marginal differences and, from the regression results, and we know that they are measured with a
relatively large SE.
The mean expected values over the PSA simulations are £3739.83 for advice, £3713.42 for exercise
and £3942.76 for MFFP, leading to almost identical incremental differences in costs as calculated in
the deterministic model.
For complete-case analysis, the total costs are £3506.98 for advice, £3492.38 for exercise and
£3683.12 for MFFP. These figures are lower than those obtained from the imputed data because data
for self-reported resource use are more likely to be missing when there are A&E attendances or longer
hospital stays. Imputation on a data set containing HES data leads to higher than overall average costs
being imputed when missing; this is intuitively appealing because the expectation is that all resource use
costs will be higher when A&E admission occurs. The incremental differences are similar but slightly
smaller, with MFFP being the most expensive intervention, followed by advice. For example, the
incremental costs of MFFP relative to advice and to exercise are now £30 smaller, at £176 and £191,
respectively. Between advice and exercise, advice is more costly by £15.
Health-related quality-of-life outcomes
Figure 18 shows the pattern of EQ-5D-3L utility values over 18 months. Table 25 shows mean EQ-5D-3L
values by trial allocation and by study period. The three intervention arms show EQ-5D-3L mean utility
values decreasing at each time point. The regression results for the imputed EQ-5D-3L utilities show no
statistically significant differences between exercise and advice, and between advice and MFFP, but there
are statistically significant differences between exercise and MFFP at months 4, 12 and 18, with exercise
having small but systematic incremental gains in self-reported HRQoL (0.011 at months 4 and 12 and
0.0016 at month 18). The complete-case regressions yield very similar results (Table 29).
Treatment arm
      Advice
      Exercise
























FIGURE 18 Pattern of EQ-5D-3L utility over 18 months.
DOI: 10.3310/hta25340 Health Technology Assessment 2021 Vol. 25 No. 34
© Queen’s Printer and Controller of HMSO 2021. This work was produced by Bruce et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
75
Modelling regression-based expectations over time, Figure 19 shows a consistent pattern, with exercise,
followed by advice, yielding the highest HRQoL at all time points. Although it is difficult to extrapolate
with within-trial models, the gap between exercise and MFFP appears to be increasing over time,
leading to the expectation that if the trial period were to be extended we would see an increasing
incremental difference. The NPV QALYs show an average expectation of 1.1137 for advice, 1.1195 for
exercise and 1.1064 for MFFP, leading to a small incremental gain of 0.006 QALYs for exercise relative
to advice and a further gain of 0.007 QALYs relative to MFFP. The incremental difference between
exercise and MFFP over the 18 months of 0.013 is approximately equivalent to an additional 5 days in
perfect health.
Complete-case analysis estimates expected NPV QALYs of 1.1166 for advice, 1.1206 for exercise and
1.1082 for MFFP. Although the expected NPVs are higher in all cases (a function of missing EQ-5D-3L
data being most likely when hospitalisations occur, with imputation correcting for this via imputation
with HES linked data), the incremental differences are similar and the substantive picture does not
change. PSA-simulated means for the imputed data are 1.1136 for advice, 1.1193 for exercise and
1.1063 for MFFP, in all cases almost identical to the figures in the deterministic model.
TABLE 29 EuroQol-5 Dimensions, three-level version, utility by treatment arm over time
Time point
Advice Exercise MFFP
Mean % imputed Mean % imputed Mean % imputed
Randomisation 0.774 4.4 0.778 4.4 0.765 5.2
4 months 0.761 11.7 0.772 11.7 0.748 11.8
8 months 0.753 15.5 0.758 15.6 0.741 16.4
12 months 0.745 18.6 0.754 19.5 0.730 20.1
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Advice:       1.114
Exercise:    1.120
MFFP:         1.107
FIGURE 19 Modelled EQ-5D-3L utility over 18 months (AUC).
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The incremental cost-effectiveness results are shown in Table 30, with costs and QALY data subject to
MI. The exercise intervention predicts the highest expected QALYs and lowest expected costs, and so it
dominates both advice and MFFP. As the intervention with the lowest expected QALYs and highest
costs, MFFP is dominated by both advice and exercise.
The mean INMB associated with exercise relative to advice at cost-effectiveness thresholds of £20,000
and £30,000 per QALY was £132.98 and £190.98, respectively (see Table 30). For exercise compared
with MFFP the figures are £482.48 and £613.48, respectively. For advice compared with MFFP, the
figures are £349.50 and £422.50, respectively. The mean INHBs for exercise relative to advice are
0.0066 and 0.0064 for threshold values of £20,000 and £30,000, respectively. For exercise relative to
MFFP the figures are 0.024 and 0.020, respectively, and for advice relative to MFFP the figures are
0.0175 and 0.0141, respectively.
In conclusion, the deterministic analysis of the imputed trial results shows that exercise dominates
both advice and MFFP by providing a higher expected QALY output and lower expected costs.
Similarly, advice dominates MFFP. Furthermore, because the ordering of expected costs and HRQoL
is consistent across time points, this conclusion would hold if the trial had terminated at 12 months,
8 months or, indeed, at 4 months. However, the relatively low magnitudes of the INMB and INHB
figures indicate that cost and QALY differences are rather small.
Sensitivity analyses
The key finding from the analysis is that exercise dominates both advice and MFFP in terms of
producing higher QALYs at a lower expected cost. However, we also recognise that the practical
differences between the QoL and costs estimated between treatment choices are modest, particularly
between advice and exercise. For example, we expect an incremental £1 per month cost difference
between advice and exercise. Given that the patient population is extremely heterogeneous in terms of
underlying QoL and pre-baseline costs, and had in excess of 20% missing data for HRQoL at month 18,
it is important to assess the extent to which the economic conclusions are robust to the sampling
variation and variation due to MI that can occur when applied to a heterogeneous population and
TABLE 30 Cost-effectiveness (imputed) and sensitivity analysis (complete-case) results
Treatment NPV QALYs NPV costs (£)
ICER (relative
to Advice)
INMB (£) at £20,000
(relative to advice)




Exercise 1.1195 3720 Dominates 132.98 190.98
MFFP 1.1064 3940 Dominated –349.50 –422.50
Sensitivity analysis: cost-effectiveness, imputed data PSA means
Advice 1.1136 3740
Exercise 1.1193 3713 Dominates 139.48 196.01
MFFP 1.1063 3943 Dominated –350.12 –423.72
Sensitivity analysis cost-effectiveness, complete case
Advice 1.1166 3507
Exercise 1.1206 3492 Dominates 93.96 133.63
MFFP 1.1083 3683 Dominated –342.97 –426.39
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addressing missing data. Despite these issues, we may still be relatively certain about the substantive
conclusions, because the trial size was very large, the heterogeneity was well balanced across arms and
there was consistency in findings across time.
Probabilistic sensitivity analysis combined with further critical appraisal of results provides the main
opportunity for assessing the robustness of the results. In PSA, alternative estimates of parameter
values for utility and costs under each treatment arm are generated and repopulate the existing model
structure to produce alternative possibilities of expected QALYs and costs and, hence, incremental
values. As with MI, there are a set number of alternatives drawn and the incremental outcomes
recorded. Inference is then drawn by looking at the results across the population of alternatives,
looking at the distribution of incremental outcomes via a cost-effectiveness plane and the proportion
of times each intervention looks cost-effective at various threshold values via a CEAC.
The alternative parameter values for costs and HRQoL at each time point under different treatments
were drawn from the regression estimate and variance–covariance matrices, which in combination
define probabilistic distributions for estimated parameters. As the variance–covariance matrices
accommodate uncertainty from both sampling and imputation processes, it was considered a more
efficient method than bootstrapping across all imputed data sets and more accurate than just
bootstrapping across a complete-case data set. The notion of conducting PSA from the regression
variance–covariance matrix was pioneered by Hoch et al.130 Simulation via the relevant regression
matrices was conducted using PROC IML of SAS and 10,000 simulations were conducted.
Figure 20 shows the simulated costs and QALYs outcomes of MFFP and exercise relative to advice.
The figure in the bottom right of the composite diagram shows the standard scatterplot of costs and
QALYs from the same simulation, with advice at the (0, 0) reference point and threshold lines annotated
over the plot. In addition to the scatterplot, we have also included univariate histograms of the simulated
incremental costs and QALYs in isolation: the cost histograms are to the right of the scatterplot and the
QALY histogram is located above the scatterplot.
The cost-effectiveness scatterplot shows the two clouds of simulated paired incremental outcomes of
MFFP and exercise relative to advice. The MFFP cloud is mainly located in the north-west quadrant,
indicating that it is less effective (by being on the west side) and more expensive (by being on the
north side) than advice. The clear majority of simulated points lie to the left of the threshold lines,
indicating a high probability that MFFP is not cost-effective relative to advice. We note that some of
the simulations lie in the south-west quadrant and to the right of the threshold lines, indicating that
some simulations find MFFP cost-effective relative to advice, on the grounds that, although it is less
effective, the expected cost-savings would be of a magnitude that allowed the freed-up costs to more
than offset the QALY loss to the patients receiving MFFP. The cloud of simulations for exercise relative
to advice is on the east side of the graph, indicating a relatively high degree of certainty regarding the
incremental QALY gain, but the points are split fairly evenly over the north and south quadrants,
indicating a large degree of uncertainty regarding the incremental cost estimate.
The univariate histograms reinforce this perspective. If we consider the cost histogram, we notice
several elements. First, the distribution of incremental costs of exercise relative to advice is virtually
centred over zero and has relatively wide tails stretching from being £894 more expensive to £903
cost saving; a relatively wide distribution. Second, we also notice that the distribution of incremental
costs of MFFP relative to advice is fairly wide and, although the body of the distribution indicates that
MFFP is more expensive, there is some substantial proportion of the distribution indicating a potential
cost saving outcome.
The QALY perspective looks more certain. The range of simulated QALY differences is quite small and,
importantly, there are clear differences between the central locations of the distribution and that
of zero incremental effect. The PSA shows that, although the magnitude is small, the uncertainty
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stemming from sampling a heterogeneous population with imputation is relatively minor, with
only a small possibility that MFFP is more effective than advice and that advice is more effective
than exercise.
The CEAC provides a consolidated means of summarising these findings. At the left-hand side of the
graph, where we value QALYs at £0, the economic argument is solely driven by the cost argument.
The uncertainty is so substantial that it is almost impossible to determine whether advice or exercise
is the most cost-effective. Indeed, the uncertainty is so substantial that there is a non-zero possibility
that MFFP is the most cost-effective.
However, as we move along the x-axis and afford greater value to the QALY component of the
cost-effectiveness argument, the greater certainty that have that the estimates of incremental QALYs
will start to have a bigger impact. Overall, the CEACs show that exercise is always expected to be the
most cost-effective intervention (Figure 21), ranging from a 50% probability based on costs alone to
80.5% as QALYs dominate. Over the conventional range of amounts that decision-makers are willing
to pay for an additional QALY, that is, between £20,000 and £30,000, the probability that the exercise
intervention is cost-effective varies between 70% and 75%, driven by the incremental differences in QALY
expectations. Over that range, MFFP is the most cost-effective option approximately 1% of the time.
This allows us to draw a number of conclusions. First, there is some substantial uncertainty in the
incremental cost differences between all treatments and at face value those uncertainties translate to
reasonably substantial cost differences. Second, there is relatively more certainty within the QALY
calculations. Third, and as a consequence of the first two conclusions, as the ‘value’ of a QALY
increases, the more certain QALY component starts to exceed any possible differences in costs. As a
result, we can conclude that the uncertainty in costs is not particularly important in establishing which
is the most cost-effective treatment. The CEACs rise more steeply before the £20,000 threshold and
more broadly flatten beyond this. Therefore, resolving the uncertainty we have in costs has merit only
if we value QALYs < £20,000.
In addition to the imputed model, PSA was also conducted on the complete-case analysis as a sensitivity
analysis. The probability that the exercise intervention is cost-effective is lower than in the baseline
analysis, ranging from 64.5% to 68.5% between £20,000 and £30,000 thresholds, and asymptotes at
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FIGURE 21 Cost-effectiveness acceptability curve baseline analysis.
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Discussion
The trial-based economic evaluation is based on a large randomised trial with well-balanced cohorts at
baseline. Although there was an increasing pattern of missing self-reported data on broader resource
use and HRQoL over time, the pattern was very well balanced across interventions. MI was used to
address missing data and was further bolstered by the addition of what is considered complete secondary
care data (using HES), which allows us to estimate broader costs and HRQoL on fully observed patterns
of secondary care use. Multilevel linear regression models were used to accommodate the clustering of
results of HRQoL, broader resource use and secondary care costs within participants within GPs and
provided regression-corrected expectations for use in the economic modelling. Although the modelling
shows substantial differences between individuals, in terms of expected costs and QALYs over time,
the well-balanced nature of the cohorts and large sample size mean that simply comparing raw sample
averages across interventions gives a generally valid impression of relative effectiveness. Because
missing data are more likely when there are large secondary care costs and when the participant has an
A&E episode, and, as observed, HRQoL is generally lower and broader resource use costs are generally
higher when there is an A&E episode, imputation has the effect of lowering QALYs and increasing costs.
However, as the pattern of missingness is very similar across treatment arms, the impact of imputation
on the incremental differences between interventions is minimal.
We found increasing costs over time in all interventions for both broader resource use and secondary
care costs. The increase is greatest in secondary care costs, which dominate the overall cost generation,
with approximately 75% of costs occurring here. Examination of the HRGs associated with the secondary
care costs shows that the majority of these costs are unrelated to falls, being mainly due to chemotherapy
(see Appendix 1). Overall, there is an expectation that exercise generates lower costs than advice, which
generates lower costs than MFFP. Although the differences are small (approximately £1 per month
for exercise vs. advice, rising to £12 per month for exercise vs. MFFP) and not statistically significantly
different, the pattern is consistent, with MFFP being the most costly intervention at all time points.
There was virtually no difference in expected costs between advice and exercise.
There was a more observable difference in incremental QALYs between interventions, although the
order is the same and as consistent, with exercise delivering the highest HRQoL over time, followed by
advice and then MFFP. The incremental differences between interventions appear to be increasing over
time and the regression model finds small but statistically significant differences between exercise
and MFFP at months 4, 12 and 18. In all cases, HRQoL is falling over time. The incremental difference
between exercise and MFFP is 0.013 QALYs (approximately an extra 5 days in perfect health spread
over 18 months). For exercise compared with advice, this is 0.006 QALYs.
Applying these expectations in the NICE reference case framework finds that, as exercise produces the
highest expected QALYs and the lowest expected costs, it dominates both advice and MFFP. Similarly,
advice dominates MFFP. However, although the ordering and conclusions are clear, the magnitudes of
the INHB and INMB are small, indicating marginal practical differences in cost and QALY outcomes
between interventions. The INMB between exercise and MFFP valued at £30,000 per QALY is £613
and between exercise and advice the equivalent figure is £191. These results are robust to using
complete-case analysis and the means from the PSA.
The PSA is driven by uncertainty in the regression results, as captured by the variance–covariance
matrix. The impact on the imputed results of PSA is to suggest that exercise is the most cost-effective
treatment approximately 67–75% of the time as the willingness to pay for a QALY rises from £20,000 to
£30,000. At the extremes, when either costs (willingness to pay = £0) or QALYs (maximum willingness to
pay is infinite) dominate the evaluation, the figure is 49–81%. MFFP is almost never simulated to be cost-
effective as the willingness to pay increases. The probability that MFFP is cost-effective is approximately
8% when QALYs are not valued and falls to 1% when the threshold value is £20,000 per QALY. Therefore,
any uncertainty about the most cost-effective treatment is between exercise and advice.
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Nevertheless, because of the large size of the trial and the balance across cohorts, the economic
conclusion is largely robust to PSA, despite the heterogeneity and the impact of exogenous factors.
Any uncertainty about the most cost-effective treatment is between advice and exercise, because
MFFP is only very possibly cost-effective when only costs are considered (and even then, it is unlikely
to be cost-effective). As the value of QALYs grows, it becomes more likely that exercise is the most
cost-effective treatment. It is possible that the impact of exercise on HRQoL is not just related to the
likelihood of falls.
HEALTH ECONOMICS
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Chapter 6 Discussion
Study findings and key messages
This trial is the first large-scale, pragmatic, definitive trial to investigate the clinical effectiveness and
cost-effectiveness of different falls prevention interventions embedded within UK primary care services.131
The trial was designed to reflect a significant and contemporary dilemma in UK health policy, which is
whether or not to introduce systematic screening and linked interventions from primary care for falls
prevention. We aimed to provide evidence to inform UK health-care practitioners about the options for
preventing falls and fractures in older people. Using this population screen-and-treat model in a sample
of older people, we found no statistically significant difference in fractures between treatment arms.
We found evidence of interim benefits in rate of falls and QoL outcomes in those undertaking exercise,
and these findings, along with differences in secondary care usage, led to marginal cost-effectiveness
benefits in the exercise group relative to MFFP. Overall, exercise dominated advice and MFFP, suggesting
that exercise might be the most cost-effective intervention for future investment.
Key findings from the PreFIT contrast with recent systematic reviews reporting that these interventions
lead to a reduction in falls and fractures, and we therefore consider possible reasons for these differences.
Issues relating to internal and external validity of the trial are discussed, with consideration given to the
characteristics of our participant cohort. We then consider the wider clinical and public health policy
implications of our findings on falls prevention services in the NHS.
Internal and external validity
We approached > 29,000 older people and recruited almost 10,000 participants, with an age range
spanning 30 years. GP deprivation was representative of practices across England, with a good
sociodemographic spread of GPs recruited from more deprived inner cities to affluent urban, rural
and semi rural localities. GP recruitment was staggered to avoid overburdening local services and
spanned several years, allowing for seasonal variation in falls and hospital admissions. We used several
strategies to maximise the efficiency of the study design, including controlling cluster size through
random sampling in primary care and the use of random subsampling for falls data collection. The very
large sample size and robust approaches to capture fractures and falls allowed for comprehensive
analyses of outcomes and secondary analyses of treatment effects by important clinical covariates.
Data collection
We triangulated multiple sources of evidence for incident fracture events over time by purchasing multiple
waves of national statistics of hospital attendances and admissions and by completing comprehensive
searches of primary care records (62 out of 63 GPs). Hospital discharge letters and radiological reports
were obtained for fractures reported in GP records, whenever possible. Self-reported fracture events
were neither necessary nor sufficient in themselves for fracture confirmation. NHS HES data are widely
used for epidemiological and health services research. Data quality and accuracy is reportedly higher
in the more recent data sets (from 2011 onwards), and in the more established data sets (such as the
acute patient care and A&E data sets that we used in our analysis). We used ICD-10 three- and four-digit
diagnostic coding and carefully screened all relevant injury and falls codes as per the prespecified analysis
plan. Accuracy of ICD-10 coding for primary diagnoses in HES has been reported at 96% (IQR 89–96%).
The adjudication panel were blind to treatment allocation and thus we are very confident of low risk of
ascertainment or detection bias for our primary outcome.
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For secondary outcomes, two methods, retrospective (with a short time frame) and prospective, were
used to capture participant self-reported falls outcomes. Using a within-trial, random-sampling strategy,
we restricted prospective diaries to a 4-month period over the first year of follow-up, rather than
over 12 months. This revealed a higher mean rate of falling per month reported on prospective diary
cards and also a small, but important, impact of diary card allocation on withdrawals from the trial over
time. Extending prospective falls data collection to 12 months, as recommended by international falls
prevention groups, would have had a significant impact on study attrition and would have required
postal administration of 117,648 diaries. Our innovative approach reduced burden on participants and
administrative burden through unnecessary follow-up of falls outcomes that did not require as much
statistical power for definitive analysis. Latest research testing wearable technologies for monitoring
balance and falls is being undertaken in hospitalised patients; however, these technologies are in the
early stages of development and their use in large population studies is not yet feasible.132
Uptake to trial
We found that uptake to the PreFIT (33%) was reasonable compared with other trials recruiting older
adults via primary care. Recent preventative lifestyle trials using similar methods to identify and approach
older people via primary care yielded lower uptakes (e.g. the UK Lifestyle Matters RCT mailed 18,331
people aged ≥ 65 years and achieved 2% uptake).133,134 Using a similar design, the high-quality UK
ProAct65+ cluster trial,74 comparing OEP and FaME with advice, recruited 6% of 20,500 people aged
≥ 65 years invited from primary care. Our invitation letters referred to a study investigating how to
remain fit and active, and how to prevent falls and fractures, rather than specifically mentioning
exercise per se. People aged ≥ 80 years, sometimes termed the oldest old, are also under-represented
in clinical trials and are considered a hard-to-reach population, despite being the fastest-growing age
group in the UK.135 One-third of our sample were aged ≥ 80 years (n = 3247), of whom 300 were aged
≥ 90 years on recruitment. We piloted materials with older people, using larger font size and clear
instructions along with provision of a freephone telephone number to encourage participants to ring for
help with completion of questionnaires and falls diaries. We believe that these strategies contributed to
high uptake and retention over time.
Participant characteristics
Perhaps unsurprisingly, people who did agree to participate in the trial were fairly active, with
approximately 90% being cognitively intact and self-reporting high levels of activity at baseline.
Very few participants had substantial problems with ADL or severe mobility restrictions and we
acknowledge that there may be a risk of healthy respondent bias. Nevertheless, despite being
predominantly active and mobile, one-third of participants had fallen in the year prior to recruitment,
suggesting that our sample were representative of community-dwelling older people. These data have
changed little over the last 30 years: early epidemiological studies9,10 reported that up to one-third of
older people fall once or more per year. The risk algorithm, using responses in the baseline questionnaire
for the whole cohort, found that 44% of participants were considered at risk of falling. One-fifth of
participants had symptoms of frailty (20%), predominantly sensory deficit problems, although the
Strawbridge questionnaire is weighted towards measurement of sensory deficits. Frailty was correlated
with older age, falls history and other characteristics. As with other falls prevention trials,74 those who
were older and frail were more likely to withdraw from the trial, although we found no differences in
either rate of mortality or withdrawals by treatment arm. Our treatment groups were well balanced
across arms, although a non-statistically significant higher falls rate in those randomised to the
multifactorial intervention was observed; this was due to five extreme fallers. When extreme
observations were removed, fall rates in the three treatment arms were very similar.
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Our population was predominantly white (98%) and, thus, under-representative of the overall black
and ethnic minority population in England (UK 2011 Census:136 86% white). However, when age is
taken into account, only 4.6% of the English population aged ≥ 70 years is non-white. The mean age at
leaving school was 16.8 years. We did not record highest qualification after leaving school, although
the UK Office for National Statistics data5 show that over half of adults aged ≥ 65 years left school
without any formal qualification.
Quality of life
We followed validated scoring guidelines for all measures. QoL in the PreFIT sample was high compared
with both US and UK population norms. Population normative scores on the SF-12 scale for adults aged
≥ 75 years are lower for physical health, but mental health scores are comparable to those in our trial
cohort [population mean SF-12 PCS, 38.7 (SD 11.0); population mean MCS, 50.1 (SD 10.9)].32,137 In the
ProACT65+ trial, mean SF-12 PCS and MCS scores were 36.9 (SD 6.6) and 48.8 (SD 6.3), respectively.74
The PreFIT trial participants, therefore, had better physical health than and comparable mental health to
other research populations of similar age, despite being an older cohort than recruited to ProACT65+.74
Missingness was low at baseline for QoL scales but increased over time. Comparison of complete-case
and imputed data (n = 460) for EQ-5D-3L scores used in cost-effectiveness analysis did not
change estimates.
Screening in primary care
We found that risk screening in primary care was feasible and cheap to undertake; almost 90% of
people approached by their GP responded to the fall risk screener. Utility of the screener was good
and prediction was comparable to accuracy values reported in studies using longer, more complex,
falls risk screening tools. A short, annual screening questionnaire administered to older people in
primary care will yield good-quality information about falls and balance problems. The more challenging
and controversial issue is how best to intervene once those at risk have been identified.
Referrals and uptake to intervention
We extended participant follow-up to 18 months to allow time for postal screening by primary care teams
and risk stratification before arranging referrals to active treatment. Mean time to first treatment was
approximately 8 weeks, although some localities took longer. However, overall, this was acceptable and
likely to be reflective of current NHS services. The longer follow-up period of 18 months allowed for
the capture of treatment effects on fracture and falls outcomes. Uptake of and adherence to trial
interventions was very good and comparable with that seen in other falls prevention clinical trials.138
Comparison with other studies
Multifactorial falls prevention
The early trials investigating MFFP interventions were very promising,9,10 but these have proven
difficult to replicate in large, multicentre, pragmatic trials. Recent Cochrane reviews have separately
investigated trials testing multifactorial and exercise interventions.16,139 The latest review16 of multifactorial
interventions based on risk factor assessment and recommended treatment, most commonly to exercise,
environment or assistive technologies, medication review and psychological interventions, included
44 RCTs (15,733 participants). Median trial size was 303 participants. In marked contrast to our findings,
multifactorial interventions were found to reduce the rate of falls compared with control (RaR 0.77,
95% CI 0.67 to 0.87; n = 19 RCTs; n = 5853 participants; I2 = 88%), but there was considerable
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statistical and methodological heterogeneity, weakening confidence in the treatment effect. Most of
these trials attempted to select participants at higher risk of falling. There was very little evidence
for the effect of multifactorial interventions on other fall-related outcomes. Only 11 out of 44 (25%)
trials testing multifactorial interventions reported fracture outcomes and data were extracted for
meta-analysis from nine trials [totalling 147 people sustaining one or more fractures out of 2850
participants (5.2%)]. Subgroup analyses of trials at low risk of selection bias found no difference
between treatment groups (RaR 0.78, 95% CI 0.49 to 1.23; four trials; n = 1521 participants; I2 = 0%).
However, when analyses were restricted to three trials at low risk of detection bias for fractures, the
results were strongly in favour of a multifactorial intervention reducing risk of fractures (RaR 0.47,
95% CI to 0.24 to 0.93; three trials; n = 1055 participants; I2 = 0%), but this finding is based on only
39 people with a fracture (3.7%).
Our primary ITT analysis found an increased rate of fractures in participants randomised to MFFP
compared with participants randomised to advice, which was of borderline statistical significance
(RaR 1.30, 95% CI 0.99 to 1.71; p = 0.06). These findings are based on a much larger event rate and
population, with 253 people sustaining a fracture over 18 months [out of 6524 participants randomised
to advice and MFFP (3.9%)]. Importantly, we have tested a screen-and-treat approach in an unselected
population. This means that our findings are directly applicable to a community strategy for reducing
falls injuries.17,82 We have not, in contrast to other studies,16,138 tested our approach on a highly selected
population. Our findings indicate, beyond any reasonable doubt, that our approach to screening for falls
risk and offering our MFFP intervention will not reduce fractures and is not cost-effective.
Exercise
Our exercise intervention did not reduce fractures (RaR 1.20, 95% CI 0.91 to 1.59). The 2019 Cochrane
review139 included 10 trials reporting fall-related fracture outcomes: smaller trials (< 100 participants)
suggest a trend towards fracture reduction, whereas larger, high-quality trials find no evidence of effect.140
Although the 2019 Cochrane review139 concluded that exercise programmes may reduce fall-related
fractures, this was considered low-certainty evidence.
Exercise has been shown in many other studies to reduce both rate of falls and number of fallers.
The 2019 Cochrane review included 108 trials (23,047 participants) and reported a 23% reduction in
falls (RaR 0.77, 95% CI 0.71 to 0.83; n = 59 studies) based on high-certainty evidence.139 Exercise also
reduced the number of people experiencing a fall by 15% (equivalent to 72 fewer fallers over 1 year
in the exercise group than in the control group; n = 63 studies).139 Overall, we found no difference in
falls rate (RaR 0.99, 95% CI 0.86 to 1.14). Nevertheless, we did find that exercise reduced the falls
rate between the 4-month and 8-month follow-ups (RaR 0.78, 95% CI 0.64 to 0.96). To put this into
context, the crude analysis of number of fallers (falls risk) in the PreFIT revealed a difference of 81 people
between 4 and 8 months (539 fallers in the control vs. 458 fallers in exercise group). Although we cannot
exclude the possibility that this is a chance finding because of multiple comparisons, it is potentially an
important observation. However, this effect was transitory; very few behavioural, physical or, indeed,
pharmacological interventions have sustained treatment benefits for months or years beyond end of
active therapy.
Exercise to prevent falls is premised on modifying gait and balance problems. The timing of the
transient reduction that we observed in the rate of falls at 8 months in the exercise arm corresponded
with the completion of the 6-month exercise programme. We also found improvements in muscle
strength and balance in those who adhered to the full exercise intervention. Incremental improvements
in lower leg strength were largely attributed to improved ability to undertake more repetitions while
wearing ankle weights rather than to an increase in weight lifted. Owing to the model of the exercise
programme, physiotherapists recommended increases in repetitions much more often than increases in
weight, although almost half of participants who complied with the programme transitioned to heavier
weights. The ProAct65+ trial73,74 is, to the best of our knowledge, the only other UK-based study to
deliver a 6-month OEP, although contacts were with peer mentors rather than therapists; a reduction
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in falls was observed in those who achieved 75% of the exercise intervention.73,74 In the PreFIT, among
those who complied with the exercise intervention, work done during a session increased by 60%
over time. We found marked improvements in balance: half of our participants were in the poorest
balance categories on starting the exercise programme, reducing to 20% of participants on completion.
This substantial improvement in balance transition exceeded that observed in other community-based
trials74 despite the fact that our participants were, on average, slightly older. Those who dropped out
of the programme had weaker leg strength initially and over time, although attrition limited our ability
to compare leg strength in non-adherers in the longer term. Overall, the reduction in rate and number
of fallers would be substantial if replicated at a population level, and if efforts at exercise could be
continued over time with sustained progression and the reduction in falls maintained. However,
there is no indication of an effect on fracture, our primary outcome of interest. Nevertheless, our
intervention is likely to be cost-effective and was designed to be implementable within the NHS.
Interpretation of study findings
There are important issues to consider when interpreting our findings. Possible issues include failure
of our screening process to identify those most at risk, targeting the wrong risk factors in the
multifactorial intervention, delivering diluted interventions and concerns over intervention fidelity.
We failed to detect a meaningful treatment effect, yet we may have identified the true treatment
effect of these interventions on fracture outcomes. It is plausible that falls prevention services do not
prevent fracture outcomes. Falls prevention interventions may reasonably prevent falls, but the causal
pathway from falls prevention to prevention of fractures is perhaps weak. A range of contributory
factors were identified during fracture adjudication, including comorbidity and alcohol, which were not
targeted by our interventions.
Our multifactorial intervention assessed for the main risk factors tested in many other trials and for
which there was some suggestion of an association with increased risk of falling. Over 400 risk factors
have been identified for falling. Multifactorial assessments are complex interventions and involve many
dimensions of complexity, as recognised by the Medical Research Council. These include multiple
interacting components, multiple behaviours required by those delivering and receiving the intervention,
more than one organisational group targeted by the intervention and extent or degree of flexibility
permitted (e.g. potential variability when interviewing older people, staff skill mix in different NHS
settings). Our underlying assumption was that assessors, general practitioners and older participants
would adhere to all prescribed behaviours and act on recommendations for onward referral and
treatment. We closely monitored all referrals to exercise and to other health-care professionals and
general practitioner-led medication reviews, but it was not possible to track whether or not participants
acted on all other advice and recommendations for behaviour change. Despite attempts to control and
standardise interventions, we recognise the influence of underlying contextual factors on the delivery
of a complex intervention, such as multifactorial falls assessment. Another notable finding was that
less than half of participants (42%) attending MFFP were referred for exercise therapy, despite these
participants being considered at risk of falling based on their self-completed risk screener. Clinical
teams were asked to assess gait balance problems using two methods: (1) the TUG and/or (2) visual
assessment for any balance and gait problems or fear of falling. This is entirely consistent with the
original Tinetti et al.9 model of MFFP (observe gait and balance during transitioning).141
Importantly, we found that the point estimate of the effect was for an increased fracture risk. For the
MFFP comparison, this approached statistical significance. Therefore, a radically different approach
is needed to effect a meaningful change in fracture rates. Simply using ‘stronger’ interventions or
improving adherence to the interventions is likely to increase the existing trend to increased fractures
in the intervention groups.
DOI: 10.3310/hta25340 Health Technology Assessment 2021 Vol. 25 No. 34
© Queen’s Printer and Controller of HMSO 2021. This work was produced by Bruce et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
87
Intervention fidelity
Intervention fidelity is an important consideration in multicentre intervention trials. Complex interventions
have more scope for variation in delivery and are more vulnerable than simple interventions to failure to
implement components as they should be implemented.142 However, we developed clear protocols and
treatment pathways for each risk factor and had substantial expert input into developing interventions.
Several elements of the falls assessments were novel for primary care staff (e.g. falls interview and the
Snellen eye chart test). Every staff member received training from a geriatrician, and assessors were
required to successfully undertake assessments of every risk factor before training certificates were signed.
We provided clear supportive materials (e.g. laminated prompt sheets of interview questions, listings of
culprit drugs to screen for during medication reviews). Quality of training delivered was assessed during
the pilot phase and adaptations were made to include simple and complex case study examples. We did
not undertake video-recording of face-to-face participant consultations, nor did we tape or video-record
general practitioner discussions with trial participants about medication changes, which may have
provided more insight into quality of delivery. Intervention staff members were observed by a trained
assessor, as per usual recommended evaluations checks of fidelity for complex intervention trials.
We are confident that the MFFP intervention was delivered as recommended, albeit within the
limitations of existing NHS services. Access to NHS podiatry was very limited and so participants
were advised to book appointments with a private chiropodist or podiatrist in regions with excessively
long waiting lists; the exception was for people with diabetes who could be directly referred to NHS
diabetic podiatry services. It was not possible to trace non-health-care referrals or attendance at private
podiatry or opticians for eye checks (free to those aged ≥ 70 years). One region delivered consultant-led
geriatrician services and in other regions assessments were undertaken in primary care by nursing staff
or by non-consultant falls teams. This non-geriatrician model is currently recommended by the British
Geriatrics Society, which suggests that any member of the primary health-care team should be able to
co-ordinate a comprehensive geriatric assessment; thus, nurses, general practitioners and pharmacy
staff members can all undertake medication reviews.143,144 Only complex cases should be referred to a
geriatrician.144 We undertook post hoc exploratory analysis on skill mix for multifactorial delivery, finding
no effect. Therefore, the PreFIT MFFP intervention followed a service model not only recommended in
2011 at trial launch but also recommended and used in many clinical services today.
Medication reviews
Medication reviews are complex interventions in themselves and can be challenging and time-consuming
to carry out. The 2017 cluster Opti-Med RCT,145 testing clinical medication reviews in older people in
primary care with ‘geriatric problems’ (including mobility problems, falls and fear of falling), aimed to
reduce inappropriate drug use and found no difference in QoL, geriatric problems, satisfaction with
medication or self-reported medication adherence. These intensive, detailed reviews were undertaken
by expert teams, and specific recommendations were made to general practitioners. However, the
authors found that only 41% of medication changes (442/1084) recommended by the expert team were
implemented or partially implemented by general practitioners, who were significantly more likely to
implement the addition of a drug than the cessation of a drug (47% vs. 35%, respectively; p = 0.002).146
Intervention studies aiming to reduce inappropriate prescribing have not resulted in measurable
changes in patient outcomes and it has been argued that efforts should focus on high-risk patients.
Willeboordse et al.146 report a low uptake of recommended medication changes comparable to rates
found in other studies (less than half of recommendations are actioned), although this can be higher
if the patients’ own general practitioner is involved in the screening process.146 Other research on
polypharmacy and multimorbidity has found that general practitioners’ medication management
strategies vary, leading to differences in proposed medication changes.147
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Fracture prevention
Although we have evidence of interim benefits from secondary outcomes and process evaluation to
suggest that HRQoL and leg strength improved, this did not translate into a reduction in number of
fractures. It is plausible that risk of harm is higher from exercise than multifactorial interventions
owing to increased mobility and encouragement of activity. The ProAct65+ trial148 examined bone
density changes in those who undertook two falls prevention exercise programmes (OEP and FaME)
but found no effect on bone mineral density or bone structural parameters. The ProAct65+ trial148
suggested that 6 months of exercise intervention was insufficient to lead to bone mineralisation
changes and that a greater magnitude of progressive loading and/or longer duration of exercise was
required to achieve changes in bone density.148 Recent expert statements for patients with osteoporosis
recommend impact exercise, in addition to strength exercise, to promote bone health.149
Strengths of the study
Undoubtedly, the major strength of PreFIT is the size and rigorous quality of the trial: it is the largest
population-based fracture and falls prevention study carried out in the UK setting. The cluster trial design,
in which clusters are assembled and participants randomly sampled and enrolled prior to randomisation,
provides methodological rigour and avoids contamination bias.We obtained individual signed informed
consent rather than gatekeeper consent, as per good practice guidelines for cluster trials.19 We carefully
tracked uptake, screening and referral to treatments at different stages. Treatment protocols were
developed with experienced geriatricians and carefully piloted and tested before roll-out.We triangulated
multiple data sources to ascertain the primary outcome. We achieved high follow-up rates over 12 and
18 months for all secondary outcomes and used strategies to capture falls outcomes prospectively and
retrospectively. Importantly, imputation for missingness on QoL outcomes used for cost-effectiveness
analyses did not change utility estimates.
Limitations of the study
We observed a lower than anticipated fracture event rate for the population, but this was offset by
exceeding our planned sample size of 9000 by 9%, increasing follow-up time and achieving 99.9% data
collection for the primary outcome. This allowed all prespecified statistical analyses to be completed
with certainty. Our total fracture event rate, even within individual intervention arms, exceeds aggregated
values reported in recent systematic reviews. The rate of observed fractures was lower than in the original
sample size estimate. However, we used more efficient statistical techniques than originally planned to
account for the lower fracture rate.We used linear mixed models, rather than generalised estimating
equations, to account for data format and overdispersion. As with cluster randomised designs,150 there
is a small risk of baseline imbalance in GP characteristics, because we did not incorporate stratification.
This would have been challenging to achieve, given the requirements for inclusion (i.e. ability to provide
intervention or access to services in the locality that could provide interventions). We adjusted for GP
deprivation and examined GP characteristics by treatment arm.
Patient and public involvement
We included a lay member on one external committee, who provided input at all stages. Trial materials
were developed and piloted in the early stages, with older volunteers attending a lunch social club in
Coventry. In November 2018, we hosted a patient dissemination event at the University of Warwick to
feed back results to a sample of participants. Owing to trial size, it was not possible to invite all participants
and therefore invitations were sent to those resident in Warwickshire, with confirmation given to the
earliest respondents. A total of 48 older people and their partners or carers attended the event.
This event proved very successful and participants were very keen to learn of study findings.
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Cost-effectiveness findings
We found small but relatively systematic and consistent differences between the expectations in QALYs
and costs for the three interventions. Evidence across all time points suggests that exercise produces
higher expected QoL and lower costs than either advice or MFFP. We noted that the population of
participants was highly heterogeneous, with marked differences in expected costs and QALYs over time
between individuals. Inspection of the secondary care data indicated that the majority of the secondary
care costs were unrelated to falls and attributable instead to cancer treatment and cataract surgery
procedures. Although it is not possible to demonstrate, one can surmise that QoL is equally highly
influenced by the presence and/or treatment of cancer.
This heterogeneity was mitigated by the trial being appropriately powered and extremely well balanced
across arms, such that the impact of heterogeneity is minimised. In addition, random-effects models
were used to inform the economic models and accommodate patient-level heterogeneity in the health
economic analysis.
The results from the cost-effectiveness analysis are consistent with a recent literature review conducted
to identify cost-effective interventions to prevent falls in older people living in the community and
published by Public Health England.82 The review found that the majority of studies assessing the
cost-effectiveness of multifactorial assessments reported negative results. Evidence on exercise was,
however, mixed and related mainly to group-based interventions studies.
The main strength of the health economic analysis was that the trial was prospectively designed for
a cost-effectiveness analysis using individual-level data on a very large number of older individuals
well balanced across intervention arms. Costs and outcomes were carefully considered in the trial
design, with the purpose of reaching a robust conclusion with respect to cost-effectiveness. The main
limitation was that the analysis was limited to the trial horizon and the potentially large impact of
exogenous factors on costs and QoL, which means that, even with a sample size this large, there
is some non-marginal uncertainty left. Several factors were fundamental to our decision not to
construct a decision-analytic model. The observed time period was sufficient to draw inference on
the relative cost-effectiveness of each treatment and there was, therefore, no underlying need
to extrapolate the results over time (i.e. the conclusions would not be changed by taking a
longer-term perspective).
The underlying structure of costs and QALY generation, which we initially assumed to be mainly
driven by falls and fractures, was less well established than expected and became less certain over
the duration of the project. We do not believe that the differences in QALYs we observed were solely
generated by an impact on falls and fractures and therefore do not believe that a model structured
around falls and fractures captures the impact. As the relative pattern of QoL over time is consistent
and increasing in incremental differences, we do not believe that extending the duration of observation
over a longer time frame would change the results.
Future recommendations
Falls and fracture prevention remains an important target of preventative health care. Exercise remains
the most promising intervention for primary care. However, future work should focus on improving
uptake and adherence to strength and balance programmes within a broader framework or focus on
a family of interventions to target geriatric syndromes.
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Conclusions
In conclusion, the PreFIT tested the delivery of alternative fall prevention strategies embedded within
the UK primary care setting and found that neither a multifactorial falls assessment intervention nor
exercise reduced fractures in older people living in the community. We found no differential differences in
fracture rates by sex, age or falls history in our subgroup analyses. We found an interim reduction in falls
and small improvements in HRQoL in those randomised to exercise, compared with advice, but this was
not sustained in the longer term. Nevertheless, the QoL benefits observed in the exercise arm dominated
in the health economic analyses.
The PreFIT exercise intervention may reduce falls in the short term, but there is no evidence to support
a reduction in falls over the longer term and no evidence for any reduction in fractures outcomes.
The PreFIT MFFP intervention does not reduce rates of fractures or falls. The health economic results
suggest that exercise therapy, when compared with advice and MFFP, is cost saving and has a small
effect on overall QoL.
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Appendix 1 Supplementary tables
TABLE 31 Flow of participants from GP screening to randomisation by intervention
Participant flow
Denominator for
percentages Advice, n (%)
Exercise,
n (%) MFFP, n (%) Total, n (%)
Total GP list size a 222,051 (36.9) 182,942 (30.4) 197,070 (32.7) 602,063
Aged ≥ 70 years b 28,576 (12.9) 28,772 (15.7) 23,727 (12.0) 81,075 (13.5)
Total excluded (nursing
home/residential care)
c 1145 (4.0) 954 (3.3) 736 (3.1) 2835 (3.5)
Total patients eligible
to approach
c 27,431 (96.0) 27,818 (96.7) 22,991 (96.9) 78,240 (96.5)
Total randomly selected
for invitation
d 9603 (35.0) 9548 (34.3) 9859 (42.9) 29,010 (37.1)
Total exclusions by general
practitioner
e 1003 (10.4) 794 (8.3) 762 (7.7) 2559 (8.8)
Total invited e 7782 (81.0) 8720 (91.3) 7886 (80.0) 24,388 (84.1)
Total consented f 3232 (41.5) 3284 (37.7) 3305 (41.9) 9821 (40.3)
Total consented, returned
baseline
f 3230 (41.5) 3284 (37.7) 3305 (41.9) 9819 (40.3)
Withdrawals prior to GP
randomisation
g 4 (0.12) 4 (0.12) 1 (0.03) 9 (0.09)
Deaths prior to GP
randomisation
g 3 (0.09) 1 (0.03) 3 (0.09) 7 (0.07)
Total participants
randomised
g 3223 (99.8) 3279 (99.8) 3301 (99.9) 9803 (99.8)
a Per cent of all patients from the total list size.
b Per cent of people aged ≥ 70 years identified on the list.
c Per cent of older people excluded/eligible to approach.
d Per cent invited of those eligible to approach.
e Per cent excluded/invited of those eligible to approach.
f Per cent consented of those invited.
g Per cent of those patients who consented.
TABLE 32 Participant flow from randomisation through follow-up, by intervention
Participant flow Advice, n (%) Exercise, n (%) MFFP, n (%) Total, n (%)
Participants consented/returned baseline data 3230 3284 3305 9819
Withdrawals prior to randomisation of GP 4 (0.12) 4 (0.12) 1 (0.03) 9 (0.09)
Deaths prior to randomisation of GP 3 (0.09) 1 (0.03) 3 (0.09) 7 (0.07)
Total participants: GP randomised 3223 (99.8) 3279 (99.8) 3301 (99.9) 9803 (99.8)
Completion between GP randomisation and 4-month follow-up
Participant contacted for follow-up 3223 3279 3301 9803
Withdrawals during the follow-up period 102 (3.2) 119 (3.6) 98 (3.0) 319 (3.3)
continued
DOI: 10.3310/hta25340 Health Technology Assessment 2021 Vol. 25 No. 34
© Queen’s Printer and Controller of HMSO 2021. This work was produced by Bruce et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
111
TABLE 32 Participant flow from randomisation through follow-up, by intervention (continued )
Participant flow Advice, n (%) Exercise, n (%) MFFP, n (%) Total, n (%)
Died during the follow-up period 21 (0.7) 16 (0.5) 27 (0.8) 64 (0.7)
Non-respondents 114 (3.5) 101 (3.1) 141 (4.3) 356 (3.6)
Reached follow-up and responded to the
4-month CRF
2957 (91.8) 3006 (91.7) 3008 (91.1) 8971 (91.5)
Reached follow-up and responded to the
4-month core outcomes
29 (0.9) 37 (1.1) 27 (0.8) 93 (1.0)
Total (CRF + core outcomes) 2986 (92.7) 3043 (92.8) 3035 (91.9) 9064 (92.5)
Completion between 4- and 8-month follow-up
Participant contacted for follow-up 3100 3144 3176 9420
Withdrawals during the follow-up period 98 (3.2) 129 (4.1) 133 (4.2) 360 (3.8)
Died during the follow-up period 18 (0.6) 20 (0.6) 18 (0.6) 56 (0.6)
Non-respondents 145 (4.7) 137 (4.4) 144 (4.5) 426 (4.5)
Reached follow-up and responded to the
8-month CRF
2813 (90.7) 2826 (89.9) 2842 (89.5) 8481 (90.0)
Reached follow-up and responded to the 8-month
core outcomes
26 (0.8) 32 (1.0) 39 (1.2) 97 (1.0)
Total (CRF + core outcomes) 2839 (91.5) 2858 (90.9) 2881 (90.7) 8578 (91.0)
Completion between 8- and 12-month follow-up
Participant contacted for follow-up 2984 2995 3025 9004
Withdrawals during the follow-up period 96 (3.2) 119 (4.0) 121 (4.0) 336 (3.7)
Died during the follow-up period 21 (0.7) 14 (0.5) 29 (1.0) 64 (0.7)
Non-respondents 169 (5.7) 131 (4.4) 168 (5.5) 468 (5.2)
Reached follow-up and responded to the
12-month CRF
2674 (89.6) 2711 (90.5) 2678 (88.5) 8063 (89.5)
Reached follow-up and responded to the
12-month core outcomes
24 (0.8) 20 (0.7) 29 (1.0) 73 (0.8)
Total (CRF + core outcomes) 2698 (90.4) 2731 (91.2) 2707 (89.5) 8136 (90.3)
Completion between 12- and 18-month follow-up
Participant contacted for follow-up 2867 2862 2875 8604
Withdrawals during the follow-up period 57 (2.0) 57 (2.0) 84 (2.9) 198 (2.3)
Died during the follow-up period 33 (1.2) 39 (1.4) 33 (1.1) 105 (1.2)
Non-respondents 284 (9.9) 266 (9.3) 261 (9.1) 811 (9.4)
Reached follow-up and responded to the
18-month CRF
2459 (85.8) 2458 (85.9) 2455 (85.4) 7372 (85.7)
Reached follow-up and responded to the
18-month core outcomes
34 (1.2) 42 (1.5) 42 (1.5) 118 (1.4)
Total (CRF + core outcomes) 2493 (87.0) 2500 (87.4) 2497 (86.9) 7490 (87.1)
CRF, case record form (postal questionnaire).
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TABLE 33 Secondary care cost items in advice, exercise and MFFP arms
HRG Number of episodes Cost (£)
Advice arm
SB97Z: same day chemotherapy admission or attendance 285 282,968
BZ34C: phacoemulsification cataract extraction and lens implant with CC score 0–1 270 238,664
HN12F: very major hip procedures for non-trauma with CC score 0–1 37 230,339
HN22E: very major knee procedures for non-trauma with CC score 0–1 24 141,536
HN22D: very major knee procedures for non-trauma with CC score 2–3 21 135,807
AA35D: stroke with CC score 7–9 15 127,345
WH09G: tendency to fall senility or other conditions affecting cognitive functions
without interventions with CC score 0–1
31 114,702
HN12E: very major hip procedures for non-trauma with CC score 2–3 17 112,159
WD11Z: all patients ≥ 70 years with a mental health primary diagnosis treated by a
non-specialist mental health service provider
18 93,384
LA04Q: kidney or urinary tract infections without interventions with CC score 4–7 14 86,209
Exercise arm
SB97Z: same day chemotherapy admission or attendance 331 349,392
BZ34C: phacoemulsification cataract extraction and lens implant with CC score 0–1 215 190,047
HN22E: very major knee procedures for non-trauma with CC score 0–1 23 134,700
HN12E: very major hip procedures for non-trauma with CC score 2–3 20 132,834
HN12F: very major hip procedures for non-trauma with CC score 0–1 18 113,178
HN22D: very major knee procedures for non-trauma with CC score 2–3 17 110,751
SA12K: thrombocytopenia with CC score 0–1 72 106,593
BZ86B: intermediate vitreous retinal procedures 19 years and over with
CC score 0–1
96 99,779
LA04Q: kidney or urinary tract infections without interventions with CC score 4–7 21 96,848
WJ11Z: other disorders of immunity 56 86,361
MFFP arm
SB97Z: same day chemotherapy admission or attendance 231 296,339
HN22E: very major knee procedures for non-trauma with CC score 0–1 32 194,348
BZ34C: phacoemulsification cataract extraction and lens implant with CC score 0–1 198 175,020
HN12F: very major hip procedures for non-trauma with CC score 0–1 25 166,471
HN22D: very major knee procedures for non-trauma with CC score 2–3 21 148,434
WD11Z: all patients ≥ 70 years with a mental health primary diagnosis treated by a
non-specialist mental health service provider
22 99,239
BZ86B: intermediate vitreous retinal procedures 19 years and over with
CC score 0–1
90 93,029
AA35A: stroke with CC score 16+ 5 80,188
HN12E: very major hip procedures for non-trauma with CC score 2–3 12 78,700
DZ11U: lobar atypical or viral pneumonia without interventions with CC sore 4–6 22 71,994
CC, complications and comorbidities.
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